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Abstract 
 
Cu, Zn superoxide dismutase (SOD1) is a dimeric, β-sandwich, metalloenzyme 
responsible for the dismutation of superoxide. Mutations covering nearly 50% of the 
amino acid sequence of SOD1 have been found to acquire a toxic gain-of-function 
leading to amyotrophic lateral sclerosis. A hallmark of this disease is the presence of 
insoluble aggregates containing SOD1 found in the brain and spinal cord. While it is 
unclear how these aggregates or smaller, precursor oligomeric species may be the source 
of the toxicity, mutations leading to increased populations of unstable, partially folded 
species along the folding pathway of SOD1 may be responsible for seeding and 
propagating aggregation.  
 
In an effort to determine the responsible species, we have systematically characterized 
the stability and folding kinetics of five well studied ALS variants: A4V, L38V, G93A, 
L106V and S134N. The effect of the amino acid substitutions was determined on a 
variety of different constructs characterizing the various post-translational maturation 
steps of SOD1: folding, disulfide bond formation and Zn binding. Zn was found to bind 
progressively tighter along the folding pathway of SOD1, minimizing populations of 
monomeric species. In contrast, ALS variants were found to have the greatest 
perturbation in the equilibrium populations of the folded and unfolded state for the most 
ix 
 
immature, disulfide-reduced metal-free SOD1. In this species, at physiological 
temperature, four out of five ALS variants were >50% unfolded. 
 
Finally the energetic barriers in the folding and unfolding reaction were studied to 
investigate the unusually slow folding of SOD1. These results reveal that both unfolding 
and refolding are dominated by enthalpic barriers which may be explained by the 
desolvation of the chain and provide insights into the role of sequence in governing the 
folding pathway and rate. 
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Chapter I. Cu, Zn Superoxide Dismutase Mediated Amyotrophic 
Lateral Sclerosis 
2 
 
Introduction 
 
The ability for proteins to fold correctly in the cell is a critical component of human 
health. Mutations in genes and/or environmental stresses can lead to defects in the 
sequence of proteins or the cellular environment leading to the expression of misfolded 
proteins. Non-native interactions between these misfolded proteins are thought to be the 
underlying cause of protein aggregation diseases including, Alzheimer’s disease, 
Parkinson’s disease, Huntington’s disease and amyotrophic lateral sclerosis.1; 2 While the 
natural proteostatis machinery exists in the cell to deal with such lesions, the loss of 
efficacy of these mechanisms with age is consistent with the late-onset of these diseases.3; 
4 
 
With a lifetime risk of 1 in 2000, amyotrophic lateral sclerosis (ALS) is the most 
common motor neuron disease and the fourth most common neurodegenerative disease 
behind Alzheimer’s, Pick’s and Parkinson’s disease.5;6 ALS, more commonly known as 
Lou Gehrig’s disease in North America, is characterized by the death of motor neurons in 
the brain and spinal cord, leaving the patient paralyzed and eventually leading to death by 
asphyxiation. It is a late-onset disease, with patients exhibiting initial symptoms at 45-55 
years of age. Regardless of the age of onset, most cases of ALS progress very rapidly. 
Typical survival time of patients after diagnosis is 3-4 years.7 This rapid progression was 
classically displayed by Lou Gehrig himself, who was a star baseball player for the 
3 
 
Yankees in 1937. His skill began to rapidly deteriorate due to ALS in 1938, forcing him 
to retire the next year and ultimately leading to his death in 1941. 
 
Mutations in the Cu, Zn Superoxide Dismutase Cause ALS 
 
A hallmark of ALS, as well as other protein misfolding diseases, is the incidence of 
visible, protein based, inclusions found in tissue sections extracted from the brain and 
spinal cord of patients.8 Approximately 90% of ALS cases have no apparent pattern of 
genetic inheritance and are termed sporadic ALS (sALS). In the remaining ~10% of 
cases, a variety of heritable factors have been determined (Table 1.1)9; 10; 11; 12; 13; 14; 15; 16 
and are collectively termed familial ALS cases (fALS). The most prevalent of these fALS 
cases are caused by mutations in the gene encoding for the Cu, Zn superoxide dismutase 
(SOD1), which were discovered by the Brown lab in 1993,14 and account for ~20% of all 
cases of fALS. Mutant SOD1 mediated neurodegeneration may even be a universal 
phenomenon as presence of mutant SOD1 in mice, the G86R variant,17; 18 and dogs, the 
E40K variant,19 has also been linked with ALS-like symptoms in these animals. 
 
The SOD1 gene is located on chromosome 21 and consists of 5 exons which are spliced 
to produce a single species of SOD1 protein. To date, there are no known natural 
alternative splicing isoforms of SOD1. The mRNA encodes for a 154 amino acid protein, 
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Table 1.1. List of confirmed fALS genes 
  
Gene Protein Inheritance Clinical Features Protein Function
SOD1 Superoxide dismutase I AD Typical ALS Superoxide dismutase
ALS2 Alsin AR Juvenile onset, slowly progressive, predominantly corticospinal Guanine exchange factor for Rab5a
SETX Senataxin AD Adult onset, slowly progressive, early vocal cord paralysis DNA/RNA helicase
VAPB VAMP‐associated protein B AD Typical ALS Vesicle transport regulation
Dynactin Dynactin AD Adult onset, slowly progressive, early vocal cord paralysis
Component of retrograde axonal 
transport motor dynein
TDP‐43 Tar DNA Binding Protein 43 AD Typical ALS Transcription and splicing
FUS/TLS
Fused in 
sarcoma/Translated in 
liposarcoma
AD Typical ALS DNA/RNA metabolism
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Figure 1.1. The sequence, secondary structure and missense mutations in SOD1. 
The sequence, secondary structure and missense mutations found in SOD1. The β-strands 
that form each of the two sheets are separated by color. The five exons which encode for 
the sequence of SOD1 are separated by color. 
 
 Figure 1.1. The sequence, secondary structure and missense mutations in SOD1
7 
. 
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 and 49 occurring at highly conserved residues in mammals.22 The high sequence 
conservation combined with the dispersal of mutations throughout the sequence (Figure 
1.1) suggests that SOD1 is not a protein which is particularly tolerant of mutations. 
Interestingly, even though all aerobically respiring organisms have some version of a 
superoxide dismutase, SOD1 is not an essential gene in humans or mice.23 Humans and 
mice have a complementary manganese superoxide dismutase, SOD2, which is localized 
directly in the innermembrane space of mitochondria where much of the superoxide 
anion is produced. It is likely SOD2 actually performs much of the dismutation activity 
necessary for cellular survival. This idea is supported by the observation that SOD2 
knockout mice suffer early postnatal death,24 whereas SOD1 knockout mice display 
subtle motor neuron dysfunction,25 and  impaired fertility,26 but no symptoms of ALS. 
 
The Structural Features of SOD1 
 
SOD1 is a diffusion-limited enzyme, and several structural characteristics of the protein, 
such as the sterically limited active site channel, the high stability, or the absence of 
easily oxidizable methionine residues, would indicate that evolution has selected for 
features that can withstand dealing with highly reactive species such as superoxide or 
copper. SOD1 is present at high concentrations in the cell, ranging from 10 – 100 μM in 
different tissues.27; 28 However, the inability to isolate only motor neurons from brain and 
spinal cord samples, without contamination from glia, makes an accurate estimate of 
9 
 
SOD1 concentration in motor neurons difficult. SOD1 is primarily located in the cytosol, 
but is also found in the intermembrane space of mitochondria,29; 30 the nucleus and in 
peroxisomes.31  It is also one of the most stable proteins in the human proteome. The 
fully-metalated protein has a melting point over 90 °C and is enzymatically active in 8 M 
urea.32; 33; 34  
 
SOD1 is functional as a 32 kDa homodimer, with one copper and one zinc binding site in 
each 153 amino acid monomer (Figure 1.2).  Each monomer binds a catalytic copper and 
a structural zinc ion and contains eight anti-parallel β-strands, supporting two large, 
structurally important loops. Each chain also contains an intramolecular disulfide bond 
between C57 and C146. The fold of SOD1 is similar to the immunoglobulin-like family 
of proteins, characterized by two anti-parallel β-sheets and a Greek key motif. Each β-
sheet is formed by four anti-parallel β-strands. The first sheet is mostly local in sequence, 
consisting of β1-3 and β6 which is part of the Greek key motif (Figure 1.3). The more C-
terminal β-sheet contains the disulfide bond as well as the two long loops, the Zn-binding 
loop between β4 and β5, and the electrostatic loop between β7 and β8. These loops are 
critical in binding the Zn cation and facilitating the electrostatic guidance of the 
superoxide anion to the active site, respectively. In the absence of metals, especially Zn, 
these loops appear largely disordered by NMR and x-ray crystallography.35; 36  
  
10 
 
Figure 1.2. Crystal structure of SOD1. 
SOD1 is a 153 amino acid, β-sandwich protein with eight anti-parallel β-strands 
organized in two sheets, and supported by two large catalytic loops (PDB: 2C9V). These 
are the Zn binding loop, loop IV shown in cyan, and the electrostatic loop, loop VII 
shown in green. The Cu ion is responsible for catalyzing the disproportionation reaction 
of the superoxide anion, while the Zn serves a structural role. These metals are depicted 
as orange and blue spheres respectively. Primarily a cytosolic enzyme, SOD1 
nevertheless has an intramolecular disulfide bond between C57-C146, shown here in 
yellow. For the studies in this thesis, the free cysteines C6 and C111, shown in red, have 
been mutated to alanine and serine respectively. 
 
 F
 
igure 1.2. Crystal structure of SO
 
D1.  
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Figure 1.3. The topology of SOD1. 
The eight anti-parallel β-strands of SOD1 are organized in two β-sheets formed by β1-
3+β6 and β4+ β5+ β7+ β8. The β-strands β3- β6 form a Greek-key motif, disrupting the 
sequence local structure of the β-sandwich. The seven loops of SOD1 are labeled with 
roman numerals. Both structurally distinct loops of SOD1, the Zn-binding (blue)  and 
electrostatic loops (green), are located in the second β-sheet, as well as the intramolecular 
disulfide bond between C57 and C146, depicted by the orange dotted line. 
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SOD1 Maturation 
 
While the nascent SOD1 chain is able to fold into a stable structure without any post-
translational modifications, a series of maturation steps are required for the protein to 
attain its most stable conformation. Folding of the nascent chain occurs without any metal 
binding and precedes disulfide-bond oxidation. This step is ATP independent, suggesting 
that chaperones do not playing a significant role in the folding of the WT protein.37 The 
resulting metal-free, disulfide-reduced monomer is unable to dimerize prior to either Zn 
binding or disulfide oxidation.38 The unfolded form of this immature species is 
biologically important as it is the only species that can be transported into the 
intermembrane space of mitochondria.39 Further oxidation of the disulfide bond, 
dimerization, and Cu and Zn insertion leads to the formation of the catalytically active 
SOD1. 
 
The Disulfide Bond 
Each monomer of SOD1 contains an intramolecular disulfide bond between C57 and 
C146, which is highly conserved between species. The oxidation of the disulfide bond is 
critical in maintaining the quaternary structure of the protein,40 and may also play a role 
in Cu insertion.41; 42 Reduction of the disulfide bond in the absence of metals leads to the 
dissociation of the dimer38 and consequently a significant reduction in the 
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thermodynamic stability.43; 44 Thus, keeping the disulfide bond oxidized in the reducing 
environment of the cytosol is likely critical in preventing the aggregation of the protein. 
 
In the cell, the order of the maturation steps is not well understood but it is likely that 
disulfide-bond oxidation precedes Zn binding, as the presence of Zn does not accelerate 
the formation of the disulfide bond of human SOD1 expressed in rabbit reticulocyte 
lysates.37 This is surprising because studies of yeast SOD1, which is dependent on the 
copper chaperone of SOD1 (CCS) to oxidize the disulfide bond, have suggested that Zn 
binding was required to mediate the CCS-SOD1 interaction.42 These seemingly 
contradictory results may reflect differences in the maturation pathway of yeast and 
human SOD1, as human SOD1 is not entirely dependent on CCS for disulfide-bond 
oxidation.45 
 
The redox potential of the disulfide bond of budding yeast SOD1 is -0.23 eV,42 and 
human SOD1 expressed in budding yeast can be reduced by cytosolic glutaredoxin.46 
Therefore, the oxidized status of the disulfide bond must be kinetically controlled. This is 
supported by the resistance of mature WT SOD1 against disulfide reduction by TCEP 
over 24 hour incubation47 while unfolded SOD1 can be reduced in a matter of minutes 
(CK, CRM unpublished). Structural evidence provides an explanation for the resistance 
of the SOD1 disulfide bond against reduction. Once formed, the disulfide bond is 
significantly protected from solvent by packing against V118, the aliphatic portion of 
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R143, and the gamma methyl group of T116, as well as by contributions from the C-
terminus of β1. The stability of the disulfide bond is also coupled with metal binding, as 
evidenced by the significantly lower Zn affinity of the disulfide-reduced protein reported 
in this thesis. The stabilization of the disulfide bond by folding, dimerization and metal 
binding likely explains its persistence in the reducing environment of the cytosol. 
 
Zinc Binding 
While the binding of Cu is related to catalytic activity, Zn serves a strictly structural role 
in stabilizing the native fold of the protein. Studies reported in this thesis have 
demonstrated that Zn binds progressively more tightly along the folding reaction 
coordinate of SOD1. Zn binding enhances the stability of SOD1 monomers by 7 kcal 
mol-1 under standard state conditions and further stabilizing the dimer by at least an 
additional 1.7 kcal mol-1.48 These results are consistent with measurements of the 
increased stability of Zn-bound SOD1 reported by differential scanning calorimetry 
experiments33. While apo-SOD1 has a Tm of 52 °C, the binding of Zn increases the 
melting point by ~24 °C, to 76 °C.  
 
This observed stabilization is likely due to a number of structural changes upon Zn 
binding. First and foremost, upon Zn ligation by H63, H71, H80, and D83 (Figure 1.4), 
the Zn-binding and electrostatic loops become well ordered.35; 36; 49 This facilitates the 
formation of a tight channel near the active site, restricting the access of non-native 
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Figure 1.4. The Cu and Zn binding sites of SOD1. 
The Cu2+ and Zn2+ binding sites of SOD1 (PDB: 2C9V) are depicted in orange and blue 
respectively. The shared ligand, H63 has been highlighted with both colors. Parts of the 
protein have been hidden for clarity. 
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substrates to the highly reactive copper cation.50 It also appropriately positions the dimer 
interface contacts of the Zn-binding loop, making Zn-bound monomers dimerization 
competent even in the absence of the disulfide bond. Despite these inter-subunit contacts, 
the metal binding regions in one subunit of SOD1 share very limited contacts with the 
alternate subunit, consistent with a small loss in catalytic activity for monomeric versions 
of the protein.51 The β-strands connected by loop IV and loop VII, β4, β5, and β7 also 
become lengthened upon Zn binding to the extent observed in the holo-SOD1. Most 
significantly, β4 becomes elongated to include two Cu binding residues His46 and His48. 
The packing of H48, V117 and H120 against the disulfide bond may serve to explain the 
coupling between disulfide bond status and Zn affinity (Figure 1.5).  
 
Copper binding 
The final step in SOD1 maturation is thought to be Cu binding. For human SOD1, copper 
binding is largely mediated by the copper chaperone of SOD1 (CCS). However, it can 
also be activated by chaperone independent pathways that may involve copper bound by 
glutathione.52 The pathway for activation can also vary by species. For instance, the yeast 
SOD1 is entirely dependent on the CCS pathway,45 while the C. elegans SOD1 is entirely 
independent of the CCS pathway.53 The requirement for CCS is highly dependent on 
sequence, particularly around the conserved disulfide bond. The yeast and human SOD1 
share 54% sequence identity, yet display significant differences in CCS requirement, and 
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Figure 1.5. The structural connection between Zn and the disulfide bond. 
The coupling between the Zn affinity and the disulfide bond can be explained 
structurally. The Zn binding site is located proximal to the disulfide bond and structurally 
orients the Cu binding histidines to the appropriate final geometry, in the absence of Cu. 
These histidines pack against V118, which directly packs against the disulfide bond. 
Furthermore, Zn binding induces order in loop IV, which contains C57, likely favoring 
disulfide bonding. 
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 strikingly a single point mutation at P144 can confer CCS independence to the yeast 
protein.45 
 
It is thought that the CCS transfers the copper ion to the copper-free SOD1 through direct 
insertion via heterodimerization with a SOD1 monomer and is dependent on the presence 
of oxygen.45; 54; 55 The structural consequences of Cu binding are far less dramatic due to 
the fact that the amino acids that ligate this cation – H46, H48, H63, H120 – are 
predominantly found in the β-strands which are already well structured in the apo-state 
(Figure 1.4).35 The only exception is H63, the shared ligand between the Cu and Zn ions, 
which is found in the Zn-binding loop.  
 
Cu binding, while structurally less significant than Zn, does lead to a further increase in 
thermodynamic32; 56 and kinetic57 stability, and it is likely that Cu and Zn binding to 
SOD1 act synergistically in stabilizing SOD1. This is partially due to the presence of a 
shared ligand, H63, and the secondary hydrogen bonding network formed upon Zn 
binding. This secondary bridge is critically dependent on D124, which forms hydrogen 
bonds between H46, a copper ligand, and H71, a Zn ligand. In the electrostatic loop, 
another important hydrogen bond is formed between the side chains of D125 and S134. 
The combination of these interactions effectively communicates the structural 
organization of the Zn binding loop by Zn binding to the electrostatic loop. Any 
substitutions in these residues will likely result in disorder in the electrostatic loop even 
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in the presence of Zn, as observed for the S134N variant by NMR. While D124V and 
D125H, also ALS variants, have not been characterized structurally, they may be 
expected to exhibit similar structural characteristics.  
 
Mechanisms of Toxicity 
 
While the exact mechanism of how mutant SOD1 leads to motor neuron loss is unclear, it 
is well accepted that this toxicity is due to a gain-of-function that is independent of a loss 
in dismutase activity of SOD1. First, over-expression of the mutant human transgene in 
mice58; 59 and rats60; 61 leads to a disease with symptoms comparable to ALS symptoms in 
humans. Neither the presence of endogenous mouse or rat SOD1, nor co-expression of 
WT human SOD1 prevents disease symptoms.23 In fact, co-expression with WT has been 
shown to increase toxicity in an A4V mouse model with low protein expression.62 Mice 
lacking SOD1 do not develop ALS,63 while loss-of-function mutations in Cu ligands, 
such as H46R or H48Q, have been identified in humans patients. Comparable variants 
lacking two64 or four Cu ligands,65 when expressed in mice, also leads to the disease. 
Loss of catalytic activity can also be induced by knocking out CCS, which is partially 
required for loading copper for mouse and human SOD1. This also has no affect on 
disease66 and co-expression of human CCS actually leads to an exacerbation of the 
disease.67 In mice, the age of onset as well as the time from diagnosis to death is 
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generally coupled with the expression levels of the protein.68 Yet, high expression levels 
are not a strict requirement for recapitulating ALS in mice.69; 70  
 
Though mutant SOD1 expression leads to the death of motor neurons, recent work has 
revealed that mutant SOD1 toxicity is not cell autonomous (reviewed in Glabe, JBC 
200871). The susceptibility of motor neurons to mutant SOD1 expression over dorsal root 
ganglia or hippocampal neurons can be demonstrated in cell culture models of ALS.72 
However, attempts at recapitulating the disease phenotype induced by mutant SOD1 
expression in motor neurons in vivo has either failed,73; 74 or resulted in a mild disease 
phenotype when the protein is expressed in very high levels.75 The involvement of 
specific cell types in ALS was tested by the use Cre-Lox system in mice which allows for 
the tissue specific excision of genes flanked by lox sites upon the expression of Cre 
recombinase. Deletion of mutant SOD1 expression in motor neurons, but not astrocytes, 
delayed the onset of symptoms but did not provide any slowing of disease progression 
after onset.76; 77 Conversely, in the same studies it was found that the excision of SOD1 
from microglia had little effect on disease onset but the duration of the disease after onset 
was significantly increased. These results suggest that disease initiation may be triggered 
by the toxic action of SOD1 in motor neurons, while disease progression may be 
influenced by the response from microglial cells and the inflammatory response. 
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Aberrant Catalytic Activity 
But what is the molecular mechanism for the toxicity of mutant SOD1? Several 
hypotheses have been proposed for the gain-of-function toxicity imparted by SOD1 
mutations and can be divided into two categories: aberrant catalytic functions and 
misfolding/aggregation. The aberrant catalytic function theory suggests that structural 
changes in SOD1 due to mutations may lead to the increased access of non-native 
substrates. In addition to dismutase activity, WT and mutant SOD1 have been shown to 
exhibit some level of superoxide reductase or oxidase activities.78 One potential aberrant 
catalytic activity proposed is the formation of peroxynitrite by the combination of 
superoxide and nitric oxide in the active site of SOD1, which is strongly exacerbated with 
the depletion of zinc from SOD1.79 Alternatively, hydrogen peroxide, the normal end-
product of oxidized SOD1 (Cu2+), could react with the reduced form of SOD1 (Cu+) to 
produce the reactive hydroxyl radical.80 
 
While these mechanisms may play some role in ALS, it is likely that they cannot be the 
definitive underlying cause of the disease. Elevated levels of free nitrotyrosine, a 
byproduct of damage by peroxynitrite, have been reported in patients81 and mouse 
models,82 but no evidence of protein-bound nitrotyrosine was reported.82 Furthermore, 
these mechanisms require some retention of catalytic activity of SOD1, yet SOD1 with 
all four copper binding histidines removed is still capable of causing ALS in mouse 
models.65 As stated earlier, mutations have been found in humans which result in the loss 
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of some or all metal content from the enzyme, and consequently the loss of all catalytic 
activity.83 One alternative Cu binding site was suggested involving C111 but the affinity 
of this site for Cu was determined to be in the micromolar range and is likely too weak to 
bind Cu in vivo.84 Additionally, the G86R mutation in mouse SOD1, which has a serine 
instead of a cysteine at position 111, have also been found to cause an ALS phenotype,18 
effectively ruling out a causative role in Cu binding to C111 as a cause of aberrant 
catalytic activity. 
 
Misfolding and Aggregation 
An alternative possibility lies in the potential for SOD1 to misfold and aggregate, and 
that these aggregates themselves exert some toxic effect. While aggregates are observed 
in many misfolding diseases, the morphology of the aggregates can vary. Unlike the 
amyloid fibrils that are characteristic of Alzheimer’s and Parkinson’s disease, aggregates 
of SOD1 appear more amorphous and dynamic.85 Though the toxic nature of these 
aggregates is not well understood, it is thought that smaller, soluble aggregates are a 
likely source of the toxicity. In the G93A SOD1 mouse model, studies have observed the 
presence of hydrophobic species of SOD1 enriched in spinal cord extract from birth.70 
Additionally, in the G127insTGGG mouse model, nearly 20% of all SOD1 in spinal cord 
extracts was found as a detergent soluble proto-aggregate at all stages of the mouse’s 
life.70 These results, in combination with evidence that larger insoluble aggregates appear 
concomitantly with the onset of disease symptoms86; 87 support the hypothesis that the 
27 
 
toxicity of mutant SOD1 is due to the proto-oligomeric species, rather than end-stage 
aggregates.  
 
It is likely that this enhanced toxicity of proto-aggregate material is a common theme 
underlying many protein misfolding and aggregation diseases. Similar results have been 
observed for both familial amyloid neuropathy,88 which involves the aggregation of 
transthyretin, as well as Parkinson’s disease, which involves the aggregation of α-
synuclein89. Toxicity to motor neurons has also been observed in prefibrillar forms of 
non-disease related HypF-N from E. coli, the SH3 domain from bovine 
phosphotidylinositol 3’ kinase, horse lysozyme and sperm whale apomyoglobin.90; 91; 92 
Furthermore, the existence of conformationally-specific antibodies which can target 
fibrillar and prefibrillar aggregates,93 independent of the sequence of the aggregating 
protein, suggests that the aggregation/toxicity phenotype may be a general phenomenon 
of protein misfolding. 
 
The Molecular Mechanism of SOD1 Aggregation 
 
Aggregation Due to Structural Changes of the Native State 
To date, several hypotheses have emerged as to what the aggregation prone species of 
SOD1 may be. One potential aggregation pathway of SOD1 involves local unfolding of 
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the protein. This sort of behavior has been observed for the ALS variant S134N, where 
the unfolding of the electrostatic loop leads to non-native intermolecular interactions in 
solution94 and novel contacts to form a nanotube like structure in crystals.95 This variant 
partially mimics the metal-free state of SOD1 where both the electrostatic and Zn binding 
loops are disordered. Similar destabilization or de-protection of the electrostatic loop has 
been observed by native state hydrogen exchange experiments for the G85R, D124V and 
D125H variants as well.96 This pathway for aggregation may represent a differentiation 
point between classes of ALS variants as many other variants for which crystal or NMR 
structures have been determined, such as A4V, G37R, G93A, and I113T, show only 
small differences compared to the WT protein.97; 98; 99; 100 
 
Aggregation by Intermolecular Crosslinking 
Alternatively, the aggregation of SOD1 could be facilitated by the intermolecular 
crosslinking of the two free cysteines, C6 and C111. C6 is part of the hydrophobic cluster 
that makes up the interior of the β-sandwich, while C111 is largely solvent exposed near 
the dimer interface (Figure 1.2). While intermolecular crosslinking via these residues is 
an attractive possibility for initiating or propagating aggregation,43; 101; 102 the causative 
role of the free cysteines in aggregation has been highly controversial. Some in vitro 
experiments have demonstrated that the aggregation of SOD1 is highly dependent upon 
the presence of both free cysteines.101; 102 On the other hand, in vitro studies from the 
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Valentine lab, investigating the aggregation of SOD1 into fibril-like aggregates, have 
suggested that neither C6 nor C111 are required to aggregate SOD1.8 
 
A causative role for non-native disulfide formation is cast further into doubt by the 
existance of fALS mutations at each of the four cysteine residues of SOD1. This is 
supported by work from the Borchelt lab investigating mutant SOD1 aggregation in cell 
culture, which has demonstrated that SOD1 mutants lacking all cysteine residues 
(C6F/C57S/C111Y/C146R) or mutants which contain just C6 or C111 but not the other 
cysteines can readily aggregate.103 In this study the choice of the amino acid replacing 
C6, glycine or phenylalanine, greatly altered the aggregation propensity of the mutant 
SOD1. The C6G variant remained soluble while the C6F variant caused significant 
aggregation. Interestingly, the presence of C6 and C111 were observed to enhance the 
aggregation propensity of the G85R variant of SOD1. Collectively, these studies suggest 
that C6 and C111 may play a role in modulating the aggregation propensity of SOD1 and 
may be required for some studies investigating aggregation in vitro. Nevertheless, these 
results suggest that the free cysteines are not necessary to initiate or stabilize mutant 
SOD1 aggregation. 
 
Aggregation from Immature, Partially-Folded Species 
While aggregation may be caused by an altered native structure, another pathway exists 
from immature species of SOD1. Monomeric intermediates have been observed in in 
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vitro aggregation studies104 and are supported by the observation that antibodies targeting 
the dimer interface of SOD1 can stain tissues extracted from the brain and spinal cord of 
ALS mice.105 The species may be populated by the destabilization of the native state 
(Figure 1.6), as well as transiently after synthesis but prior to any post-translational 
modifications. Immature species are efficiently degraded by the proteosome106 and the 
aggregation of mutant SOD1 has been shown to be highly sensitive to proteosome 
activity,107 suggesting that cells have evolved to remove these species of SOD1 from the 
cytoplasm. This effect may be due to the increased hydrophobicity observed for metal-
free and/or disulfide-reduced SOD1.47; 108 It is also known that unstructured regions are 
required for efficient degradation by the proteosome,109 and the dynamic nature of the 
SOD1 loops in the apo-state may provide just such a structural feature. 
 
Not surprisingly, premature species of SOD1 have been consistently linked with 
aggregation. Disulfide-reduced proteins have been found to be enriched in spinal cord 
extracts of mutant SOD1 expressing mice69 and the presence of small amounts of 
disulfide-reduced SOD1 has been shown to greatly enhance aggregation kinetics in in 
vitro studies8. Additional evidence supporting the toxic potential of immature species of 
SOD1 comes from the protective effect of Zn binding, which is known to greatly stabilize 
the native fold of SOD1. The loss of Zn is thought to be a necessary step in the pathway 
to aggregation,110 and it may be an early step in the unfolding pathway of the protein 
under denaturational stress.111; 112 The presence of Zn has consistently slowed aggregation 
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of SOD1 in vitro and Zn-free SOD1 has been shown to be cytotoxic in motor neuron 
cultures.79 
 
Applying Protein Folding to ALS 
 
The Folding Pathway of SOD1 
It is likely that aggregation-prone species are present on the folding free energy surface of 
nearly any protein.2 Mutations in exons can lead to changes in amino acid sequence that 
may destabilize the native structure and predispose these variants to develop increased 
populations of aggregation-prone partially folded or misfolded species. Detailed analyses 
of the folding mechanism of both metal-free113; 114; 115 and metal-bound48; 116 SOD1 have 
revealed a three-state folding mechanism where monomers fold autonomously and then 
rapidly dimerize to form the native structure, 2U ? 2M ? N2.  
 
The thermodynamic consequence of a very slow monomer folding rate, followed by a 
very rapid dimer association step, is a two-state-like equilibrium unfolding reaction, 2U 
? N2.48; 114; 115 The visualization of monomer stability in equilibrium titrations of the 
dimeric protein requires high concentrations of stabilizing salts such as ammonium 
sulfate. The presence of these osmolytes makes comparisons with cellular phenomena 
ambiguous.115 Furthermore, the folding free energy landscape is such that monomer 
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folding is always rate-limiting in refolding experiments. In unfolding, dimer dissociation 
is rate limiting at high denaturant concentrations; however, near the transition region the 
kinetics become protein-concentration dependent, suggesting that the dimer association 
rate is contributing to the observed rate. A detailed global analysis of the kinetic 
unfolding and refolding measurements is required to validate the folding model for 
SOD1, determine the rates of folding and unfolding, and accurately predict the 
populations of species on the folding pathway.114; 117  
 
Because monomer unfolding is never rate-limiting, monomeric constructs of SOD1 were 
created to monitor monomer folding/unfolding reactions that are not perturbed or 
concealed by the dimerization reaction. This monomeric SOD1 was created by the 
replacement of Phe50 and Gly51, near the dimer interface (Figure 1.2), with glutamic 
acid. Variants of this protein with the free cysteines at positions 6 and 111 replaced with 
alanine, mAA-SOD1, or alanine and serine, respectively, mAS-SOD1, have been studied 
extensively. A comparison of the crystallographic and NMR structures of SOD1 reveals 
that mAS-SOD1 is very similar to a monomer subunit in a SOD1 dimer.49; 118 The 
catalytic activity of mAS-SOD1 is reduced ~10-fold relative to WT.51 Considering SOD1 
is a diffusion-limited enzyme, the mAS-SOD1 still retains significant catalytic activity. 
From experiments performed in the Matthews lab, the stability and folding kinetics of 
mAS-SOD1 recapitulate those of the SOD1 monomer without the F50E/G51E 
mutations.117 These results are also supported by the near identical folding kinetics of 
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reduced mAA-SOD1, and reduced AA-SOD1, which is also monomeric.113 Together 
these observations justify a study of the characteristics of the SOD1 monomer to facilitate 
the understanding of the dimer folding reaction. 
 
Thermodynamic destabilization and the effect on populations 
To take the simple perspective of the disulfide-oxidized, dimeric apo-protein, mutations 
could result in the destabilization of the dimer, the monomer or both.119 A destabilization 
of the dimer would result in increased populations of folded monomeric species. 
Conversely, destabilization of the dimer results in an increase in both folded and unfolded 
monomers, while a destabilization of the monomer leads to an increase in unfolded 
monomeric species (Figure 1.6). By characterizing the folding free energy landscape of 
WT SOD1 and the ALS variants, it is possible to determine changes in the populations of 
the species. A consistent increase in one species may reveal the aggregation prone 
species.  
 
The apo-protein is a reasonable model for protein folding studies, but is it a relevant 
system? The issue of whether all mutations in SOD1 result in a destabilized protein has 
been of some debate,43; 120; 121 and the consensus is that not all mutations result in a 
significantly destabilized apo-protein. Nevertheless, the majority of variants with 
stabilities equal or greater than WT are the result of amino acid replacements in metal-
binding ligands. These results suggest that metal-binding affinity must be taken into 
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Figure 1.6. Changes in populations in response to mutations. 
Destabilization of the protein can lead to increased populations of immature species. The 
destabilization of the native dimer (red arrow) can lead to increased folded monomer 
populations (red population plot) compared to the WT protein (blue populations). 
Destabilization of the monomer (green+red arrows) and the dimer can lead to the increase 
of both folded and unfolded monomer populations (green population plot). 
  
 Figure 1.6. Changes in populations in response to mutations.  
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consideration when studying the effects of amino acid replacements on the folding free 
energy surface of SOD1.  
 
Furthermore, variants such as E100K or D101N, which reduce the net charge of SOD1, 
have been reported to leave stability and the metal affinity unaffected. It is possible that 
these mutations in fact do not cause ALS, as a recent report has cast doubt on the 
pathogenic nature of E100K.122 Nevertheless, these mutations can be regarded as 
lowering the activation energy barrier for aggregation by reducing the net charge of a 
protein and decreasing the electrostatic repulsion between identical proteins. This 
phenomenon may be especially relevant to E100K and D101N which are found in the 
edge β-strands of the β-sandwich structure, part of the “negative design” observed  in β-
rich proteins to prevent aggregation.123 These strands often exhibit a large number of 
solvent-exposed charged residues and are thought to serve as gatekeepers for preventing 
aggregation in SOD1.124  
 
Variants Studied 
The work in this thesis concentrates on five specific ALS variants representing a range of 
structural perturbations to SOD1. All five mutations result in amino acid replacements of 
highly conserved residues: A4V, L38V, G93A, L106V and S134N.22 All of these 
mutations are dominant and patients expressing the mutant SOD1 exhibit typical age of 
onset and mean life expectancy for fALS.7 
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Variants have generally been partitioned in two groups based on their catalytic activity: 
wild-type-like (WTL), and metal-binding region (MBR) mutants with reduced dismutase 
activity.125 WTL variants are generally those with amino acid substitutions in the β-
barrel, while MBR mutants are found in the Zn-binding and electrostatic loops. 
Nevertheless, there are notable exceptions such as H46R and H48Q, which are 
replacements of Cu binding residues, but are located in β4. Mutations can exhibit several 
different but not mutually exclusive phenotypes. Some mutations decrease the stability of 
the structure of apo-SOD1, other mutations decrease the metal affinity, and another group 
of mutations increase the intrinsic aggregation propensity of SOD1. These complex 
responses highlight one of the major difficulties in applying protein folding 
methodologies to the problem of SOD1 mediated ALS. The variety of post-translational 
modifications involved in SOD1 maturation result in a complicated folding free energy 
surface with as many as 44 microstates.126 We chose to study the states that would likely 
be the most significantly populated given the current knowledge on SOD1folding and 
maturation. These include all combinations of disulfide-bond status and Zn binding to the 
SOD1 monomer, and the apo and Zn-bound SOD1 dimer. 
 
Mutations that decrease the stability of apo-SOD1 have been extensively studied in the 
literature. Many of these involve hydrophobic residues in the tightly-packed core of the 
β-sandwich of SOD1 and fall into the WTL category. Four such variants were studied in 
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Figure 1.7. Crystal structure showing ALS variants studied. 
The ALS variants studied in this thesis are highlighted in orange on a monomer subunit 
of the crystal structure of holo-SOD1 (PDB 2C9V). The Zn ion and the disulfide bond are 
depicted in blue and yellow respectively. The two residues mutated to glutamic acid to 
make the obligate monomer F50/G51 are shown in red. The image on the right is a 90° 
clockwise rotation, into the page, of the image on the left. 
  
 Figure 1.7. Crystal structure showing ALS variants studied. 
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this thesis: A4V, L38V, G93A and L106V. Of these variants, A4V, and G93A (Figure 
1.7) have been characterized structurally by x-ray crystallography. The crystal structure 
of both A4V and G93A holo-SOD1 are nearly superimposable on the WT protein,97; 98; 100 
implying that the thermodynamic consequences of destabilization, rather than changes to 
the native structure, may be playing a primary role in the pathogenicity of these variants. 
 
The L38 and L106 residues lie on the “top” and “bottom” of the β-sandwich (Figure 1.7) 
and play key roles in capping the hydrophobic interior of the protein. The loss of a 
methyl group when replacing Leu with Val would be expected to cause minimal 
structural perturbations but a significant loss of thermodynamic stability may be 
expected. While the metal affinity for the L106V variant has not been measured, due to 
the structural similarities between these variants, it could be similar to the L38V variant, 
which was found to be reduced 30 fold compared to the WT protein.127 
The S134N variant has significant disruption and disorder in the electrostatic loop when 
compared to the WT holo-enzyme. This variant is thought to possess much lower Zn and 
Cu affinity and was found to bind little or no metals when isolated from insect cells.83 
Because this loop is disordered in the absence of metals, the stability of the apo-protein 
should be unaffected. 
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Summary of Thesis 
 
We propose that the majority of ALS mutations lead to the destabilization of the metal-
bound and/or metal-free species of SOD1, leading to increased populations of partially 
folded or unfolded species. Non-native interactions between these molecules and with 
other proteins found in the cell can lead to the formation of soluble and insoluble 
aggregates, which may explain the gain-of-function toxicity of mutant SOD1. To test this 
hypothesis, we have employed biophysical techniques to characterize the thermodynamic 
and structural properties of the major species in the folding pathway of SOD1, and the 
effect of ALS mutations on these species.  
 
Chapter II. Zinc Binding Modulates the Entire Folding Free Energy Surface of 
Human Cu,Zn Superoxide Dismutase 
To investigate the role of Zn in SOD1 folding, we performed a detailed equilibrium and 
kinetic analysis of SOD1 monomer and dimer in the presence of stoichiometric Zn. The 
results show that Zn binds progressively tighter along the folding free energy surface, 
imparting the greatest stabilization to the native dimer, the net result of which is a 
reduction in monomeric species. Since Zn-binding has been shown to decrease the 
propensity for aggregation, these results suggest that the aggregation prone species may 
be a folded or unfolded monomeric species of SOD1.  
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Chapter III. Disulfide-Reduced ALS Variants of Cu, Zn Superoxide Dismutase 
Exhibit Increased Populations of Unfolded Species 
In order to investigate the thermodynamic and kinetic folding differences between WT 
and ALS variants of SOD1 on the immature species, we probed the coupling between 
folding, disulfide-bond status and amino acid replacements on the stability of monomeric 
SOD1. Surprisingly, only minimal differences were observed in the Zn-binding affinity, 
even for the S134N variant. While the destabilization due to ALS-causing amino acid 
replacements was comparable in the disulfide-oxidized and disulfide-reduced metal-free 
forms, the changes in the unfolded state populations were significantly different. Under 
physiological conditions, the four β-sandwich variants were >50% unfolded when the 
disulfide-bond was reduced. It was also determined that the Zn affinity of the disulfide-
reduced protein was reduced ~750 fold compared to the oxidized SOD1, suggesting that 
disulfide-oxidation may precede Zn binding. The persistence of partially unfolded, 
disulfide-reduced protein after synthesis may explain the increased aggregation 
propensity observed for some ALS variants. 
 
Chapter IV. Enthalpic barriers associated with desolvation dominate the folding 
reaction of SOD1 monomers. 
The slow folding relaxation time of disulfide-oxidized and reduced, apo-SOD1 
monomers motivated a detailed investigation of the nature of the barriers involved in the 
formation of the folding and unfolding transition state ensemble. These studies were 
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performed both to gain insights into the folding pathway of immunoglobulin-like proteins 
and to determine if SOD1 had unique folding properties which may explain the link with 
ALS. Both the folding and unfolding barriers were found to be dominated by enthalpic 
barriers. In combination with the observation that little or no compaction is observed for 
SOD1 prior to the rate-limiting folding step, these results suggest that dehydration of the 
chain is the main source of this energetic barrier. The change in heat capacity upon 
folding, the relative contribution between entropy and enthalpy to the folding free energy, 
and the viscosity dependence of SOD1 folding are all in the expected range of proteins 
with two-state folding mechanisms, suggesting that these characterisitcs are unlikely to 
explain why mutant SOD1 causes ALS. On the other hand, the insights obtained from 
SOD1 folding can be applied to answering the more general question of how amino acid 
sequence defines the folding pathway and final structure of a protein. 
 
Chapter V. Structural characterization of the native and higher energy states of 
SOD1. 
A combination of in solution small angle x-ray scattering (SAXS) and native state 
hydrogen exchange (NS-HX) techniques were utilized to characterize potential structural 
differces between WT and ALS variants of SOD1. The NS-HX studies revealed that 
exchange from the dimeric state may occur in two steps, potentially reflecting differential 
protection in the dimer and monomer. The core of the monomer was highly protected in 
these measurements, suggesting that fraying of the interface and edge strands may be 
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occuring upon dimer dissociation. Puzzlingly, exchange from the monomeric state 
proceeded too slowly to be explained by the global unfolding rate, potentially due to 
some residual protection in the unfolded state. Structural characterization by SAXS 
revealed significant differences in the size and shape of the variants studied in the apo 
disulfide-reduced and disulfide-oxidized forms. Both the addition of Zn and the oxidation 
of the disulfide bond was found to lessen the differences between the ALS variants and 
the WT SOD1.  
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Chapter II. Zinc Binding Modulates the Entire Folding Free Energy 
Surface of Human Cu, Zn Superoxide Dismutase 
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Abstract 
 
Over 100 amino acid replacements in human Cu, Zn superoxide dismutase (SOD1) are 
known to cause amyotrophic lateral sclerosis, a gain-of-function neurodegenerative 
disease that destroys motor neurons. Supposing that aggregates of partially-folded states 
are primarily responsible for toxicity, the role of the structurally-important zinc ion in 
defining the folding free energy surface of dimeric SOD1 was determined by comparing 
the thermodynamic and kinetic folding properties of the zinc-free and zinc-bound forms 
of the protein. The presence of zinc was found to decrease the free energies of a peptide 
model of the unfolded monomer, a stable variant of the folded monomeric intermediate 
and the folded dimeric species. The unfolded state binds zinc weakly with a micromolar 
dissociation constant, and the folded monomeric intermediate and the native dimeric form 
both bind zinc tightly, with sub-nanomolar dissociation constants. Coupled with the 
strong driving force for the subunit association reaction, the shift in the populations 
towards more well-folded states in the presence of zinc decreases the steady-state 
populations of higher-energy states in SOD1 under expected in vivo zinc concentrations 
(~nanomolar). The significant decrease in the population of partially-folded states is 
expected to diminish their potential for aggregation and account for the known protective 
effect of zinc. The ~100-fold increase in the rate of folding of SOD1 in the presence of 
micromolar concentrations of zinc demonstrates a significant role for a pre-organized 
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zinc-binding loop in the transition state ensemble for the rate-limiting monomer folding 
reaction in this β-barrel protein. 
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Introduction 
 
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease, characterized by 
systematic loss of the motor neurons in the brain and spinal cord.128 Though no definitive 
biochemical mechanism has been discovered, a subset of familial ALS (fALS) cases has 
been linked to mutations at the Cu, Zn superoxide dismutase (SOD1) locus.14; 129 Despite 
constituting only 2-5% of all known cases, SOD1 mediated fALS is the most prominent, 
identified, heritable cause of the disease. Moreover, sporadic cases of ALS are clinically 
and pathologically similar to fALS cases,128 suggesting both forms may share a common 
underlying mechanism. 
 
In its native form, SOD is a 153 amino acid, cytosolic protein that catalyzes the 
dismutation of superoxide into hydrogen peroxide and oxygen.21 SOD is catalytically 
active as a homodimer with both a copper and a zinc ion bound to each monomer. The 
fold of an SOD1 monomer is a β-sandwich composed of eight antiparallel β-strands 
supporting a pair of large loops that follow β4 and β7, loops IV and VII, respectively 
(Figure 2.1). Loop IV is covalently linked to β8 by a disulfide bond between Cys57 and 
Cys146.118 Loops IV and VII coordinate the metals and provide the catalytic and 
electrostatic components of the active site.50 The copper redox cycle drives the 
disproportionation reaction, and the zinc ion is thought to play a role in defining the 
structure and stability of SOD1.35; 36; 49 The binding of zinc to dimeric SOD1 is very tight,  
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Figure 2.1. Crystal structure of SOD1. 
(A) The crystal structure of SOD1 (PDB: 2C9V).130 The zinc ion is depicted in yellow, 
with the metal-binding region of the zinc-binding loop (loop IV), as well as the residues 
that bind zinc, shown in dark blue. Proximal to this region, the electrostatic loop is 
colored in teal. The region of loop IV involved in or near the intramolecular disulfide 
bond (in dark orange) between C57-C146 is shown in light yellow, and the dimer 
interface portion of loop IV is highlighted in orange. Shown in blue is the copper ion with 
the histidines to which it binds depicted in green. In red are F50 and G51 that were 
replaced with glutamic acid to create mAS-SOD1. (B) The sequence of the zinc-binding 
loop with the zinc-binding residues indicated in red. The non-native residues are shown 
in teal for the C-terminal tryptophan and yellow for the N-terminal cysteine, which was 
further modified with an EDANS molecule. 
  
 Figure 2.1. Crystal structure of SOD1. 
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with a Kd of <10-8 M by isothermal titration calorimetry131 and a Kd of ~10-14 M by 
competition experiments.127 While the order of the metal-binding and disulfide-bonding 
events in vivo is not definitively known, it is thought that zinc binds first to the disulfide-
reduced protein. This complex then interacts with the copper chaperone of SOD1, which 
loads the copper and oxidizes the intramolecular disulfide bond.126 
 
Although several hypotheses have been proposed to explain the toxic gain of function of 
SOD1 variants,5; 132; 133; 134 a prevailing view holds that amino acid replacements increase 
populations of partially-folded states and induce subsequent aggregation.132; 135; 136 The 
rationale for the unfolding/aggregation hypothesis is based on the fact that well over 100 
replacements and C-terminal truncations (see http://alsod.iop.kcl.ac.uk/Als/ for a 
complete list), covering nearly 50% of the sequence, can cause ALS.137 Many of these 
variants lead to the deposition of amorphous aggregates in and around the motor neurons 
of patients afflicted with ALS, and a debate has ensued about whether small oligomers or 
macroscopic aggregates are the toxic agents.138 It has been demonstrated that loss of zinc 
may result in aggregation, reinforcing the structural importance of zinc.110 Candidates for 
aggregation have focused on zinc-free partially-folded monomeric states of SOD1, 
including those with the disulfide bond intact and those in which the disulfide bond has 
been reduced.139 More recently, the unfolded state, extruded from the ribosome and prior 
to disulfide bond formation or folding, has also been proposed as a candidate for 
aggregation and toxicity.140 
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The unfolding/aggregation hypothesis has been tested by comparative biophysical 
analysis of the thermodynamic folding properties of wild-type and ALS-inducing SOD1 
variants in both their disulfide-oxidized119 and disulfide-reduced113; 141 forms. Detailed 
analyses of the folding mechanisms of disulfide-intact SOD1 have shown that both apo-
SOD1113; 114; 115 and Cu, Zn-SOD1116 fold by a three-state mechanism involving a folded 
monomeric intermediate. Left unanswered in these studies were several questions on the 
specific role of zinc on the folding and stability of SOD1 that pertain to its influence on 
nonnative states that might be responsible for aggregation. Pertinent to the argument that 
newly-synthesized chains might be the source of toxicity, at what stage of folding does 
zinc become bound to SOD1? Once the native state is reached, what are the quantitative 
ramifications of zinc binding to diminish the propensity of the disulfide-bonded native 
dimer and the folded monomer to populate less structured, aggregation-prone states? In 
the event that the folded monomer is a source of aggregation, does zinc binding alter the 
relative populations of monomeric and dimeric forms of SOD1 at equilibrium to favor the 
fully-folded form? A comparative analysis of the thermodynamic and kinetic folding 
properties of disulfide-bonded AS-SOD1 in the presence and absence of zinc 
demonstrated that zinc binding modulates its entire folding free energy surface. The 
results provide a benchmark for future studies on metal-binding ALS-inducing variants 
containing disulfide bonds and on disulfide-reduced SOD1. 
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Results 
 
Quantitative information on the effect of zinc binding on high energy states in SOD1 was 
obtained by chemical denaturation analysis of both the thermodynamic and kinetic 
properties of the reversible folding reaction. The C6A/C111S variant, AS-SOD1, was 
used in place of the wild-type SOD1 because it has been shown to fold reversibly with 
wild-type like stability.142 The elimination of the free cysteines precludes intermolecular 
disulfide bond formation and intramolecular disulfide bond interchange. The results 
obtained can be compared with those from a previous study of metal-free apo-AS-
SOD1114 to determine the decrease in the free energy, i.e. the increase in stabilization 
relative to the unfolded state, of the zinc-bound states in the absence of denaturant.  
 
Thermodynamic analysis 
 
Chemical denaturation of dimeric AS-SOD1.  
The effects of zinc binding on the thermodynamic properties of disulfide-intact 
AS-SOD1 were determined by chemical denaturation experiments in the presence and 
absence of zinc and monitored by circular dichroism spectroscopy. It has been previously 
shown that the ellipticity at 230 nm is a sensitive probe of global structure in AS-
SOD1114 and provides optimal signal to noise compared to measurements at the typical 
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minimum for β-rich structures, 218 nm. Although urea is a sufficiently potent denaturant 
to unfold apo-SOD1,114; 120 guanidine hydrochloride (Gdn-HCl) was required to unfold 
zinc-bound AS-SOD1. The Gdn-HCl unfolding titration curves at 230 nm, pH 7.2 and 20 
ºC, for apo- and stoichiometric zinc-bound Zn-AS-SOD1 (2 zinc ions per dimer) are 
shown in Figure 2.2. The native dimeric form of apo-AS-SOD1 is stable up to ~1 M Gdn-
HCl, where it experiences a cooperative unfolding transition that is complete by ~2 M 
Gdn-HCl. In the presence of stoichiometric zinc, Zn-AS-SOD1 is stable up to ~2 M Gdn-
HCl, where it also undergoes a cooperative unfolding transition that is complete by ~3 M 
Gdn-HCl. The reversibility of the Zn-AS-SOD1 unfolding reaction was demonstrated by 
the coincidence of a refolding transition curve beginning with denatured AS-SOD1 (data 
not shown). As has been observed previously with Cu, Zn SOD1,116 the full equilibration 
of the Zn-AS-SOD1 samples at pH 7.2 for both unfolding and refolding curves was 
exceedingly slow, requiring 7 days at room temperature.  
 
Chemical denaturation of monomeric AS-SOD1.  
Previous analyses of the chemical denaturation of apo-SOD1114 and Cu, Zn SOD1116 
have implicated an essential role for a folded monomeric species that subsequently 
undergoes a diffusion-limited association reaction to produce the native dimer.  Insight 
into the effect of zinc binding on the stability of the monomeric folding intermediate was 
obtained by examining the enhancement of stability for a stable monomeric version of 
AS-SOD1, mAS-SOD1, upon zinc binding. The mAS-SOD1 variant was created by 
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Figure 2.2. Equilibrium titrations of Zn-bound and apo-SOD1. 
Equilibrium Gdn-HCl titrations measured by the ellipticity in 20 mM HEPES, pH 7.2, at 
20 oC. Representative data at 230 nm are shown with fits to a two-state model for the 
metal-free apo-AS-SOD1 (open squares) and apo-mAS-SOD1 (open circles) and with fits 
to a three-state model for stoichiometric Zn-AS-SOD1 (filled squares) and Zn-mAS-
SOD1 (filled circles).  Protein and zinc concentrations were 10 µM for AS-SOD1 and 5 
µM for mAS-SOD1. 
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Figure 2.2. Equilibrium titrations of Zn-bound and apo-SOD1. 
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replacing two subunit interface residues, F50 and G51, with glutamic acid.143 In the 
absence of zinc, the native mAS-SOD1 is stable up to ~0.7 M Gdn-HCl where it 
undergoes a cooperative unfolding transition that is complete by ~1 M Gdn-HCl. Similar 
to AS-SOD1, the addition of stoichiometric zinc to mAS-SOD1 (1 zinc per chain) 
significantly stabilizes the protein. The Zn-mAS-SOD1 is stable up to ~1.5 M Gdn-HCl, 
where it undergoes a cooperative unfolding transition that is complete by ~2.8 M Gdn-
HCl. 
 
Stoichiometry and location of zinc binding to AS-SOD1.   
Inspection of the titration curves in Figure 2.2 reveal a distinctly more positive ellipticity 
at 230 nm under native conditions for the stoichiometric Zn-AS-SOD1, and possibly Zn-
mAS-SOD1, compared to their metal-free counterparts. Realizing that this signal could 
be used to monitor zinc binding to the folded dimeric form of AS-SOD1, the ellipticity at 
230 nm was monitored as a function of zinc concentration. The ellipticity increased 
linearly with increasing concentration of zinc up to the level at which the stoichiometric 
zinc concentration was reached (Figure 2.3). Further addition of zinc led to a decrease in 
the ellipticity that is complete when an equivalent of 6 zinc ions per dimer has been 
added. The data imply that zinc binds to at least two different sites on apo-AS-SOD1, 
possibly the zinc and copper sites nested in loops IV and VII (Figure 2.1).  
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Figure 2.3. Zn titration of AS-SOD1. 
Titration of AS-SOD1 in buffer monitoring the change in ellipticity at 230 nm as a 
function of the zinc concentration.  The titration was performed in 20 mM HEPES, pH 
7.2, at 20 oC. Protein concentration was 10 µM. 
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Figure 2.3. Zn titration of AS-SOD1. 
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The assumption that the initial increase in ellipticity upon addition of zinc corresponds to 
zinc binding at the zinc site was tested using the cobalt ion as an optical probe. Cobalt is 
an excellent mimic for zinc because its divalent form has an ionic radius and geometric 
preferences that are similar to zinc. Although zinc is spectroscopically silent, cobalt gives 
a strong absorbance in the visible region when bound to the zinc site in SOD1. Addition 
of stoichiometric cobalt to apo-AS-SOD1 yielded strong absorption bands between 500 
and 650 nm, very similar to the previously determined spectra of cobalt ion bound to the 
zinc site (Figure 2.4).144 By contrast, the addition of stoichiometric cobalt after apo-AS-
SOD1 was pre-incubated with stoichiometric zinc results in dramatically reduced 
absorption bands (Figure 2.4); further addition of zinc eliminates the small residual 
absorption band. These data show that zinc binds preferentially to the zinc site on AS-
SOD1. Excess zinc binds to one or more additional sites, possibly the copper site, on each 
subunit. Crystallographic studies of SOD1 in the presence of excess zinc show zinc 
binding in the copper site,130 and cobalt binding to the copper site produces absorption 
band in this same region.144  This conclusion is also consistent with the findings of an 
extensive dialysis against buffer of a sample of AS-SOD1 pre-incubated with 10-fold 
excess zinc. Atomic absorption analysis revealed an average of 2.5 zinc ions per dimer, 
implying a second weaker binding site for zinc in AS-SOD1. 
 
Zinc binding to unfolded AS-SOD1. 
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Figure 2.4. Cobalt binding to AS-SOD1. 
Visible absorbance spectra of AS-SOD1 in 20mM HEPES, pH 7.2, at room temperature. 
Traces shown are protein with (A) no metal added, (B) after addition of 1 cobalt ion per 
monomer, (C) after pre-incubation of protein with 1 zinc ion per monomer followed by 
the addition of 1 cobalt ion per monomer, and (D) after pre-incubation with 6 zinc ions 
per monomer followed by the addition of 1 cobalt ion per monomer. The protein 
concentration for all four traces was 123 µM. 
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Figure 2.4. Cobalt binding to AS-SOD1. 
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Although it is not surprising that the folded state of AS-SOD1 binds zinc in the zinc site 
with high affinity, it is possible that the unfolded state may also bind zinc. Previous 
studies on azurin145; 146 have found that zinc can bind to the chemically-denatured protein, 
complicating estimates of stability by denaturation experiments. Binding to the unfolded 
state of AS-SOD1 was tested by synthesizing a 27-residue peptide that corresponds to the 
sequence containing all four zinc-binding side chains, H63, H71, H80 and D83 (Figure 
2.1B). The potential acquisition of structure upon zinc binding to the peptide was 
monitored by Förster resonance energy transfer (FRET) from a tryptophan added at the 
C-terminus to an EDANS acceptor covalently attached to an additional cysteine at the N-
terminus.  
 
As shown in Figure 2.5A, the fluorescence intensity of the tryptophan emission at 360 nm 
decreased and the EDANS emission at 500 nm increased with increasing zinc 
concentration. The quenching of the tryptophan donor by the EDANS acceptor implies 
that zinc induces structure in the peptide in the micromolar concentration range. The 
affinity of this peptide for zinc was calculated by fitting the data in buffer to a simple 
binding isotherm (Figure 2.5B). The dissociation constant of the zinc/peptide complex is 
1.1±0.1 µM, and the free energy of binding is -8.0±0.3 kcal (mol monomer)-1 at the 
standard state (1 M in each component). Relevant to the denaturation analysis of AS-
SOD1, the binding becomes progressively weaker in the presence of increasing Gdn-HCl 
concentrations to over 60 µM at 4 M Gdn-HCl. Significant zinc binding to the peptide is 
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Figure 2.5. Zn affinity of the peptide model of the unfolded state. 
Zinc binding affinity of a peptide model of the unfolded state of SOD1. The change in 
fluorescence intensity of a FRET pair at the termini of a peptide encompassing the four 
zinc binding residues of SOD1 was monitored at various zinc concentrations and in the 
presence of varying amounts of Gdn-HCl. (A) The addition of zinc causes a decrease in 
the tryptophan fluorescence (λmax= 360 nm) and a proportional increase in EDANS 
fluorescence (λmax= 500 nm). Traces shown are at 1 M Gdn-HCl and represent zinc 
concentrations of 1 µM (solid line), 7 µM (dotted line), 20 µM (dashed line) and 60 µM 
(dashed and dotted line). (B) Quenching of the tryptophan emission at 360 nm by 
EDANS as zinc induces structure in the peptide of the zinc-binding loop. The isotherms 
shown are for 0 M Gdn-HCl (filled circles), 0.5 M Gdn-HCl (open circles), 1 M Gdn-HCl 
(filled upside-down triangles), 2 M Gdn-HCl (open triangles), 4 M Gdn-HCl (filled 
squares) and 5 M Gdn-HCl (open squares). These data represent two different 
preparations of the peptide with different labeling efficiencies so the intensities were 
normalized to the zinc-free value to show relative differences. The peptide concentration 
for all experiments was 4 µM in 20 mM HEPES, pH 7.2, and 20 oC. 
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Figure 2.5. Zn affinity of the peptide model of the unfolded state. 
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not detected above 5 M Gdn-HCl (Figure 2.5B). A plot of –RT ln(Kd), i.e., the free 
energy of the dissociation reaction at the standard state, ΔGdo, vs. the concentration of 
Gdn-HCl is linear (Figure 2.6).  This behavior is typical of protein folding reactions when 
the free energy of folding is plotted vs. the concentration of denaturant.  The free energy 
of the dissociation reaction in the absence of denaturant, ΔGdo, obtained by extrapolation, 
-7.6 kcal (mol monomer)-1 agrees well with the value obtained by direct measurement, -
8.0 kcal (mol monomer)-1, and the denaturant dependence of ΔGdo, the m-value, is 0.42 
kcal (mol monomer)-1 M-1 (Table 2.1).  Thus, under equilibrium conditions, there is a 
significant perturbation of the free energy of the unfolded state of SOD1 from zinc 
binding to the zinc-binding loop peptide. This behavior influences the Gdn-HCl 
unfolding reaction of SOD1 and must be accounted for in the extraction of accurate 
thermodynamic parameters (see below). 
 
Thermodynamic parameters for AS-SOD1 and Zn-AS-SOD1.  
The evident cooperativity of the Gdn-HCl unfolding reaction and the results of previous 
studies on apo-AS-SOD1 denatured in urea114 motivated the test of a simple two-state 
equilibrium model for the unfolding of apo-AS-SOD1, 2U ? N2, and a three-state 
equilibrium model for Zn-AS-SOD1 with Gdn-HCl, 2U + 2Zn ? 2(U•Zn) ? (N•Zn)2. 
The latter fits were done by fixing the change in free energy in the absence of denaturant 
and the m-value for the 2(U•Zn) ? 2U + 2Zn step to twice the values obtained from the 
Zn/peptide complex described above. The accuracy of the parameters was enhanced by
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Table 2.1. Equilibrium thermodynamic parameters. 
Thermodynamic parameters measured at 20 oC and pH 7.2 for the Gdn-HCl induced 
equilibrium unfolding reactions of dimeric and monomeric apo and zinc-bound AS-
SOD1 and the zinc titration of the peptide of the zinc-binding region of SOD1. 
 ∆G° Kinetic 
∆G° 
Equilibrium 
m-value 
Kinetic 
m-value 
Equilibrium Kd 
Apo-
mAS-
SOD1a 
-3.6±0.1 -4.3±0.1 4.9±0.3 5.1±0.5 NAd 
Apo-
AS-
SOD1b 
-20.6±0.3 -18.6±0.3 NDc 9.3±0.2 NAd 
Zn-
mAS-
SOD1a 
-17.0±0.7 13.4±0.6 4.6±0.3 2.6±0.2 100±122 pMe 
Zn-AS-
SOD1b -49.4±1.5 -33.0±1.4 ND
c 4.2±0.3 22±35 pMe 
Peptidea NA -8.0±0.3 NA 0.42±0.08 1.1±0.1 µM 
aUnits for ∆Gº are kcal (mol monomer)-1; units for m are kcal (mol monomer)-1 M-1. 
bUnits for ∆G° are in kcal (mol dimer)-1; units for m are kcal (mol dimer)-1 M-1. 
cThe m-value could not be calculated because the protein concentration-dependent kinetic 
data in the transition region were inaccessible in Gdn-HCl. 
dNot applicable. 
eCalculated from kinetic parameters. 
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Figure 2.6. Gdn-HCl dependence of Zn binding to the unfolded state. 
The Gdn-HCl dependence of the zinc-binding free energy of the peptide of the zinc 
binding loop. The values were obtained by simultaneously fitting the zinc titration at each 
wavelength of the tryptophan and EDANS emission spectra to a single binding site 
isotherm model. The error of reproducibility between two data sets taken on two different 
preparations of the peptide is ±0.65 kcal (mol monomer)-1.
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Figure 2.6. Gdn-HCl dependence of Zn binding to the unfolded state. 
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simultaneously fitting all of the CD data between 220 and 240 nm to the models for both 
forms (see Materials and Methods for a more detailed description of the analysis).  
 
The stability of the apo-AS-SOD1 at standard state concentrations (1 M in each of the 
components), at 20 ºC and pH 7.2 is -18.6±0.3 kcal (mol dimer)-1 (Figure 2.2 and Table 
2.1), in good agreement with the previously determined value by Gdn-HCl denaturation 
monitored by CD, -17±2 kcal (mol dimer)-1,115 as well as with the value determined by 
urea denaturation monitored by CD, -20.4±1.0 kcal (mol dimer)-1.114 The denaturant-
dependence of the free energy difference between the folded dimer and the unfolded 
monomer, the m-value, is 9.3±0.2 kcal (mol dimer)-1 M-1.  
 
The binding of zinc increases the stability of AS-SOD1, as evidenced by the increase in 
the apparent midpoint of the unfolding transition from ~1.3 to ~2.6 M Gdn-HCl (Figure 
2.2).  Fitting the titration data to the 3-state model, 2U + 2Zn ? 2(U•Zn) ? (N•Zn)2, the 
free energy change and the m-value for the 2(U•Zn) ? (N•Zn)2  reaction were found to be 
-17.0±0.2 kcal (mol dimer)-1 and 3.4±0.1 kcal (mol dimer)-1 M-1. When the free energy 
change for this reaction is added to that for the 2U + 2Zn ?  2(U•Zn) reaction, -16.0±1.2 
kcal (mol dimer)-1 and 0.84 kcal (mol dimer)-1 M-1, the total free energy difference 
between the (N•Zn)2  and the 2U + 2Zn states is -33.0±1.4 kcal (mol dimer)-1 at the 
standard state. 
71 
 
 
Surprisingly, the sum of the m-values for the folding/subunit dissociation step, 3.4±0.1 
kcal (mol dimer)-1 M-1, and twice the m-value for the zinc dissociation step, 0.84 kcal 
(mol dimer)-1 M-1, 4.2±0.2 kcal (mol dimer)-1 M-1, is significantly lower than the m-value 
for apo-SOD1, 9.3±0.2 kcal (mol dimer)-1. The magnitude of the m-value has been shown 
to correlate with the exposure of buried surface area during unfolding147. Therefore, if 
zinc binding induces structure in native SOD1, one might expect that the total m-value 
for the dimer unfolding and zinc dissociation steps would be at least equal to if not 
exceed the m-value for the unfolding of apo-SOD1. As will be shown below, the aberrant 
m-value for the unfolding of AS-SOD1 in the presence of stoichiometric zinc has another 
explanation. 
 
Thermodynamic parameters for mAS-SOD1 and Zn-mAS-SOD1. 
The stability enhancement for zinc binding to mAS-SOD1 was obtained by similar two-
state and three-state fits of the unfolding titration data (Figure 2.2) for the apo and zinc-
bound stable monomeric form (see Materials and Methods). The stability of apo-mAS-
SOD1, -4.3±0.1 kcal (mol monomer)-1 (Table 1) is in good agreement with the value 
previously determined by urea denaturation, -4.27±0.48 kcal (mol monomer)-1. The 
m-value for the monomer unfolding reaction is 5.1±0.5 kcal (mol monomer)-1 M-1. The 
free energy change for the (U•Zn) ?  (M•Zn) reaction is -5.8±0.3 kcal (mol monomer)-1, 
and the m-value is 2.3±0.1 kcal (mol monomer)-1.  When zinc binding to the unfolded 
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state is considered, the total free energy change for the (M•Zn) ? U + Zn reaction 
is -13.8±0.9 kcal (mol monomer)-1 and the total m-value is 2.6±0.2 kcal (mol monomer)-1 
M-1. Similar to Zn-AS-SOD1, the m-value for the unfolding of the zinc-bound stable 
monomeric form is significantly less than its apo-mAS-SOD1 counterpart.   
 
There are two possibilities for the discrepancies in the m-values for the apo- and zinc-
bound forms of AS-SOD1 and mAS-SOD1. First, the reduced m-values in the presence 
of zinc could reflect the population of additional species in the transition region. Obvious 
candidates are the metal-free N state and zinc bound to non-zinc sites – possibly the 
copper site - evident at super-stoichiometric zinc concentrations (Figure 2.3). The 
possibility that zinc-bound monomers are populated is unlikely since both AS-SOD1 and 
mAS-SOD1 exhibit the same behavior. Kinetic analysis of the AS-SOD1 folding reaction 
resolves the discrepancies between the m-values and provides reliable estimates of the 
thermodynamic parameters sought in this study. 
 
Kinetic analysis 
The thermodynamic analysis of the equilibrium unfolding reactions of AS-SOD1, mAS-
SOD1 and a peptide model for the zinc-binding loop has shown that zinc can bind to all 
three species in the kinetic folding mechanism.  Kinetic folding studies are required to 
determine the effects of zinc binding on the intervening transition states. Importantly, 
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kinetic analysis also provides an alternative approach towards determining the magnitude 
of the stabilizing effect of zinc on the monomeric and dimeric forms of AS-SOD1.  
 
Folding kinetics of AS-SOD1 and Zn-AS-SOD1. 
Semi-log plots of the relaxation times as a function of the final denaturant concentration, 
chevron plots,148 for apo-AS-SOD1 and Zn-AS-SOD1 are shown in Figure 2.7A. The 
single unfolding relaxation time for dimeric apo-AS-SOD1 decreases exponentially 
above 3 M Gdn-HCl, and the single refolding relaxation time decreases exponentially 
below 1 M Gdn-HCl.  Neither phase depends upon the protein concentration under 
strongly unfolding or refolding conditions (data not shown).  Previous studies of the urea 
denaturation reaction for apo-AS-SOD1,114 have shown that the unfolding phase at high 
denaturant concentration corresponds to the unimolecular dissociation of the dimer. The 
single refolding phase observed by CD at 230 nm corresponds to the rate-limiting folding 
of the monomer. The non-exponential dependence in the unfolding leg of the chevron 
between 1.5 and 3 M Gdn-HCl reflects the coupling of the monomer refolding/unfolding 
and the dimer association/dissociation reactions in the transition zone.114 
 
The presence of zinc has a significant effect on both the unfolding and refolding reactions 
of AS-SOD1 (Figure 2.7A, Table 2.2). Unfolding is slowed by 5-fold at 6 M Gdn-HCl, 
and refolding is accelerated by a factor of ~100-fold at 0.6 M Gdn-HCl. The denaturant  
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Figure 2.7. Zn-bound AS-SOD1 and mAS-SOD1 kinetics. 
Observed refolding (open symbols) and unfolding (filled symbols) relaxation times for 
(A) AS-SOD1 and (B) mAS-SOD1 as a function of final Gdn-HCl concentration in the 
presence (squares) and absence (circles) of zinc as monitored by CD at 230 nm.  In panel 
A, the dashed and dotted lines represent the linear extrapolations used to determine the 
relaxation times for the rate-limiting folding reactions, and the dashed lines represent the 
extrapolations used to determine the dimer dissociation reaction in the absence of 
denaturant.  In panel B, the lines represent the fits of the data to simple two-state 
chevrons.  The results yield the unfolding and refolding relaxation times and their 
reciprocal rate constants in the absence of denaturant. The two observed relaxation times 
of the unfolding of 1 zinc per dimer AS-SOD1 is shown by the open star symbols in 
panel A. The filled upside-down triangle in panel B is the observed relaxation time for 
the unfolding double-jump experiment at stoichiometric zinc concentration.  Protein 
concentrations were 10 µM for both AS-SOD1 and mAS-SOD1, and the buffer contained 
20 mM HEPES, pH 7.2, 20 oC. 
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Figure 2.7. Zn-bound AS-SOD1 and mAS-SOD1 kinetics. 
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Table 2.2. Microscopic rate constants, kinetic m‡ values and the effect of zinc 
binding on the activation free energy of the transition state ensembles of AS-SOD1 
measured at 20 oC and pH 7.2.  
 Apo-AS-SOD1a Zn-AS-SOD1a ΔG
‡ b 
Apo-AS-SOD1 
ΔG‡ b 
Zn-AS-SOD1 ΔΔG
‡ b 
kf c 0.012±0.002 1.19±0.05 5.2±0.2 0.2±0.08 -5.0±0.1 
‡
fm c 3.17±0.53 3.13±0.01 NA
h NA NA 
ku d (3.1±1.5)×10-5 (2.0±1)×10-7 -12.0±0.6 -18.0±0.6 6.0±0.7 
‡
um d -1.39±0.07 -1.45±0.11 NA NA NA 
kae (6.9±8.3)×106 (6.9±8.3)×106 18.2±1.2 18.2±1.2 0 
‡
am  ND
g ND NA NA NA 
kd f (38.1±0.9)×10-5 (2.1±0.4)×10-5 -4.6±0.1 -6.3±0.1 1.7±0.1 
‡
dm f -0.67±0.03 -0.95±0.06 NA NA NA 
 
aUnits for the monomer folding rate constants (kf), unfolding rate constants (ku), dimer association rate 
constants (ka) and dimer dissociation rate constants (kd) are s-1; units of the denaturant dependence of 
monomer folding ( ‡fm ) and unfolding ( ‡um ) rate constants are kcal (mol monomer)-1 M-1, and units for the 
denaturant dependence of the dimer dissociation rate constant ( ‡dm ) are kcal (mol dimer)-1 M-1. 
bUnits for the activation free energy barrier (ΔG‡) and the change in the free energy barrier upon zinc 
binding to the transition state ensemble (ΔΔG‡) are kcal (mol dimer)-1. 
cCalculated from the linear extrapolation of the refolding leg of the AS-SOD1 chevron (Figure 6A). 
dCalculated from the 2-state fit of the mAS-SOD1 chevron (Figure 6B). 
eThe dimer association rate constant was taken from Svensson et al. (Manuscript in preparation) 
fCalculated from the linear extrapolation of the >5.5 M Gdn-HCl region of the unfolding leg of the zinc-
bound AS-SOD1 chevron and the >3.8 M Gdn-HCl region of the unfolding leg of the apo-AS-SOD1 
chevron (Figure 2.7A). 
gNot determined. 
hNot applicable. 
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dependence of the dimer dissociation relaxation time in the presence of zinc between 5.5 
and 6.8 M Gdn-HCl, -0.95±0.06 kcal (mol dimer)-1 M-1, is larger than that for apo-AS-
SOD1 between 3.8 M and 6.0 M Gdn-HCl, -0.67±0.03 kcal (mol dimer)-1 M-1. As a 
result, the dimer dissociation relaxation time in the absence of denaturant, estimated by 
linear extrapolation, is ~20-fold longer in the presence of zinc. The small increase in the 
denaturant dependence of the relaxation time implies an enhancement of structure as the 
zinc-binding and electrostatic loops are organized by zinc binding. Given the quite 
similar denaturant dependence of the refolding relaxation times for apo- and Zn-AS-
SOD1, the kinetic refolding data yield a 100-fold acceleration of the refolding rate by 
zinc in the absence of Gdn-HCl. Although the linear extrapolations in Gdn-HCl may be 
questioned,149 the differences between the extrapolated relaxation times in the presence 
and absence of zinc should be minimal.  
 
Valentine and her colleagues,131 on the basis of isothermal titration calorimetry 
experiments, have proposed that the binding of the first zinc ion to the SOD1 dimer may 
contribute the majority of the stability induced by zinc binding. By implication, the 1 zinc 
per dimer species should comprise the entire population at half saturation. This 
conclusion was investigated by incubating AS-SOD1 with 1 zinc ion per dimer and 
monitoring the unfolding reaction. The observed unfolding reaction could not be fit to a 
single exponential expected for a homogeneous population. When fit to two exponentials, 
the observed relaxation times corresponded well with the unfolding relaxation times of 
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the apo-protein and the zinc-bound protein (Figure 2.7). This result is better explained by 
a binomial distribution of zinc in the two zinc sites per dimer, reflecting the metal-free 
protein, the half-saturated protein and the fully-saturated protein. The absence of a third 
phase suggests that the unfolding relaxation time of the 1 zinc per dimer species is similar 
to that for the 2 zinc per dimer species. As noted above, the unfolding of AS-SOD1 
incubated with 2 zinc per dimer is well described by a single exponential at the same 
concentration of Gdn-HCl (Figure 2.7). The discrepancies between these results and 
those from the Valentine laboratory may reflect the different pH values at which the two 
studies were performed.  It is likely that the histidines that ligate zinc are protonated at 
pH 5.5, where the isothermal titration calorimetry studies were done.  The zinc binding 
properties would undoubtedly be altered from those at pH 7.2, perhaps to include a 
preferential binding of the first zinc ion to the dimeric protein. 
  
Attempts to visualize the protein concentration dependence in the transition region, 1.5 to 
3.0 M Gdn-HCl, as previously observed for the urea denaturation reaction113; 114 and 
required for the determination of the association rate constant, were not successful.  The 
relaxation times in this Gdn-HCl concentration range exceed experimental limitations, 
>105 s, precluding accurate measurements.  
 
Folding kinetics for mAS-SOD1. 
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In the absence of direct information on the association reaction, the effect of zinc binding 
on refolding/unfolding reactions of the stable monomer, mAS-SOD1, was examined. 
Oliveberg and his colleagues119 have previously used this approach towards partitioning 
the global free energy change for the unfolding of AA-SOD1 into its monomer folding 
reaction and monomer/dimer association reaction components. In the absence of zinc, 
apo-mAS-SOD1 unfolds via a simple exponential reaction whose relaxation time 
decreases linearly with increasing denaturant concentration from ~1 to ~ 3.5 M Gdn-HCl 
(Figure 2.4B).  The single refolding relaxation time decreases linearly with decreasing 
Gdn-HCl below ~1 M denaturant, and the two legs of the chevron intersect at ~ 1 M Gdn-
HCl.  The maximum in the relaxation time corresponds closely with the mid-point in the 
equilibrium titration for apo-mAS-SOD1 (Figure 2.2), as expected for a simple two-state 
folding reaction148. Extrapolation of both relaxation times, τ, to the absence of denaturant 
yields rate constants, k (k = 1/ τ) of ku = 3.05×10-5 s-1 for unfolding and kf = 0.015 s-1 for 
refolding.  The denaturant dependence of the rate constants, the m‡ values, are -1.4 and 
3.5 kcal (mol monomer)-1 M-1, respectively.  The free energy of folding of apo-mAS-
SOD1, estimated from ΔG0= -RT ln(ku/kf), is -3.6±0.1 kcal (mol monomer)-1, in 
reasonable agreement with the stability estimated from the equilibrium titration, 4.3±0.1 
kcal (mol monomer)-1 (Table 2.1).  
 
The kinetic consequences of unfolding and refolding mAS-SOD1 in the presence of 
stoichiometric zinc are to increase the unfolding relaxation time by ~110-fold at 3 M 
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Gdn-HCl and to decrease the refolding relaxation time by ~100-fold at 0.6 M Gdn-HCl 
(Figure 2.4B).  As in the case of the dimeric AS-SOD1, the refolding relaxation time is 
independent of the zinc concentration at and above stoichiometric zinc concentrations 
(data not shown).  Below stoichiometric zinc concentrations, a small faster phase with a 
relaxation time equal to that for apo-mAS-SOD1 appears (data not shown).  The two 
phases reflect the independent folding of the zinc-bound unfolded and zinc-free unfolded 
AS-SOD1.  The m‡u and m‡f values in the presence of zinc are similar to those in the 
absence of zinc, insuring that the differences in the relaxation times observed in Gdn-HCl 
are maintained in the absence of denaturant.   
 
Preferential binding of zinc to the zinc site in refolding was tested by a double-jump 
experiment.  Metal-free mAS-SOD1 was unfolded in 3.9 M Gdn-HCl, and then refolded 
by a 10-fold dilution to 0.4 M Gdn-HCl containing stoichiometric zinc. After 30 s of 
refolding, approximately three times the refolding relaxation time under these conditions 
(Figure 2.4A), the protein was unfolded in 4.2 M Gdn-HCl and the unfolding reaction 
was monitored by CD. The observed unfolding relaxation time is within error to the 
observed relaxation time for a single-jump unfolding reaction to the same final conditions 
when the protein is incubated with stoichiometric zinc in the native state (Figure 2.7B). 
Given the preferential binding of zinc to the zinc site in native AS-SOD1 (Figure 2.4), 
zinc must also bind preferentially to the zinc site during the refolding reaction. 
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The obvious perturbations of the unfolding and refolding relaxation times for mAS-
SOD1 at stoichiometric concentrations of monomer and zinc (Figure 2.7B) and the 
knowledge that zinc binds to both folded and unfolded protein in low concentrations of 
denaturant allows a simple two-state analysis of the U•Zn ? M•Zn reaction from the 
chevron.  The free energy difference between these states, ΔG = -RT ln(ku/kf), is -9.0±0.1 
kcal (mol monomer)-1 in the absence of denaturant.  When this value is added to the free 
energy of binding of zinc to the peptide model of the unfolded state, -8.0±0.3 kcal (mol 
monomer)-1, the free energy of the zinc-bound folded monomeric form relative to the 
zinc-free unfolded state is found to be -17.0±0.4 kcal (mol monomer)-1.   
 
The kinetic chevrons for apo-mAS-SOD1 and Zn-mAS-SOD1 also provide a resolution 
to the anomalously low m-value for the equilibrium titration of Zn-mAS-SOD1.  For two-
state reactions, the sum of the absolute values of the kinetic m‡-values is equal to the m-
value for the equilibrium titration.  The equilibrium m-value for apo-mAS-SOD1, 
5.1±0.5 kcal (mol monomer)-1 M-1, is in good agreement with the value determined from 
the rate constants for folding and unfolding, 4.9±0.1 kcal (mol monomer)-1 M-1.  By 
contrast, the equilibrium m-value for Zn-mAS-SOD1, 2.6±0.2 kcal (mol monomer)-1 M-1 
is about half that of the value determined from the chevron for this system, 4.6±0.1 kcal 
(mol monomer)-1 M-1. These contradictory estimates for the equilibrium m-value reflect 
the complexity of the equilibrium Zn-mAS-SOD1 folding reaction. At equilibrium in the 
transition zone, the m-value is sensitive to the presence of all of the states that bind zinc 
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and are significantly populated under these conditions. The kinetic experiment, by 
contrast, reveals the rate constants for specific steps in the mechanism, U•Zn → M•Zn, 
and M•Zn → U•Zn, that pass through a common transition state ensemble. The sum of 
the absolute values of the denaturant dependences of these rate constants provides an 
accurate measure of the equilibrium m-value and, with the extrapolated intercepts of the 
rate constants, an accurate estimate of the stability of the Zn-mAS-SOD1 not available 
from the equilibrium titration experiment. 
 
The good agreement between the m-values for apo-mAS-SOD1 and Zn-mAS-SOD1 
obtained from the kinetic analysis (Table 2.2) implies that the buried surface induced by 
zinc binding is similar for the M•Zn, the U•Zn and the intervening TSE compared to their 
respective apo-states. If zinc were binding to non-zinc sites in unfolded AS-SOD1 so as 
to reduce the equilibrium m-value by a factor of two, one might expect to observe a 
significant decrease in the m‡f-value for the folding reaction. The very similar m‡f -values 
for apo- and Zn-mAS-SOD1 (Figure 2.7 and Table 2.2) argue against this possibility. 
 
Reaction coordinate diagram for Zn-AS-SOD1. 
The folding data for the apo- and zinc-bound forms of AS-SOD1 and mAS-SOD1 and the 
thermodynamic data for the binding of zinc to the peptide model of the zinc binding loop 
can be combined to determine the effect of zinc on the folding reaction coordinate 
diagram of AS-SOD1 under standard state conditions. The free energies are those for the 
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dimeric systems: 2U ? 2M ? N2 for apo-AS-SOD1 and 2(U•Zn) ? 2(M•Zn) ? (N•Zn)2 
for Zn-AS-SOD1. Although the conversion of the kinetic data to transition state energies 
depends upon the formalism adopted,150 the perturbations in the free energies of the 
transition states induced by zinc binding should, to a first-approximation, be independent 
of the formalism because the same kinetic mechanisms are operative.   
 
The procedure by which the thermodynamic and kinetic data on the folding of Zn-AS-
SOD1 were converted into a reaction coordinate diagram was as follows: 
 
The unfolded apo-monomer, 2U, was chosen as the reference state for both the apo-AS-
SOD1 and Zn-AS-SOD1 diagrams (Figure 2.8). 
 
The energy of the unfolded zinc-bound monomer, U•Zn, relative to the U state was 
determined by converting the dissociation constant for the zinc-peptide complex using 
ΔG = -RT ln(Kd)= -8.0 kcal (mol monomer)-1 (Table 2.1). For the dimeric system, the 
free energy of the 2(U•Zn) state is -16.0 kcal (mol dimer)-1 lower than that of the 2U 
state.   
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Figure 2.8. The folding free energy surface of Zn-AS-SOD1 
Reaction coordinate diagrams of apo-AS-SOD1 and Zn-AS-SOD1 in the dimer reference 
frame and at the standard state, 1 M in each of the components. Apo-states are depicted in 
gray, while zinc-bound states are shown in black. Solid lines are thermodynamic states, 
where 2U is the unfolded state, 2M is the folded monomer and N2 is the native dimer. 
Dotted lines represent the energies of the transition states, where 2TSEM is the transition 
state ensemble of monomer folding and TSED is the transition state ensemble of dimer 
formation.  The absolute values of the TSE energies depend upon the formalism chosen 
to determine these energies. All changes in free energy induced by zinc binding, reported 
under the bar representing the zinc-bound states, are given in units of kcal (mol dimer)-1. 
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igure 2.8. The folding free energy 
 
surface of Zn-AS-SOD1. 
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The chevron analysis of apo-mAS-SOD1 (Figure 2.7B) revealed that the folded 
monomeric state, 2M, is -7.2 kcal (mol dimer)-1 lower than the 2U state.114  The 
thermodynamic stability of Zn-mAS-SOD1 was calculated by fitting its kinetic chevron 
to a two-state model, and the free energy difference between the U•Zn ? N•Zn states was 
determined from ΔGo = -RTln(ku/kf) to be -9.0 kcal (mol monomer)-1. The binding free 
energy of zinc to the unfolded state, U+Zn ? U•Zn, -8.0 kcal (mol monomer)-1, was 
added to yield a total free energy for the U+Zn ? U•Zn ? N•Zn reaction of -17.0 kcal 
(mol monomer)-1. The energy of the 2(M•Zn) state is -34.0 kcal (mol dimer)-1 lower than 
the 2U state and -26.8 kcal (mol dimer)-1 less than that of the 2M state. Therefore Zn-
mAS-SOD1 is 13.4 kcal (mol monomer)-1 more stable than apo-mAS-SOD1 (Table 2.1). 
 
The free energy of the (N•Zn)2 state was calculated by the sum of twice the free energy of 
the Zn-mAS-SOD1 and the free energy change for the dimerization reaction. The latter 
free energy change was calculated from the dissociation rate constant, kd = 2.1×10-5 s-1, 
obtained by linear extrapolation of the unfolding relaxation time at high denaturant 
concentration (Figure 2.7A) and the association rate constant, ka = 6.9×106  M-1 s-1, 
determined by global kinetic analysis of the urea-denaturation reaction.117 These rate 
constants yield a ΔGo2U/N2 = 2(ΔGoU/M) – RT ln(ka/kd) = -49.4 kcal (mol dimer)-1 for the 
(N•Zn)2  state relative to the 2U + 2Zn state. The same calculation performed for the 
metal-free AS-SOD1 yields a free energy difference of -20.9 kcal (mol dimer)-1 for the 
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N2 state relative to the 2U state. Therefore, the free energy of the (N•Zn)2 state is 28.5 
kcal (mol dimer)-1 less than the N2 state. 
 
The activation free energy of the transition state ensemble for the 2M ? N2 reaction, 
TSED, was placed relative to the M state using the Eyring formalism, ΔG‡ = -RT 
ln[(kah)/kBT)], where ka is the association rate constant in the absence of denaturant, 6.9 
× 106 M-1 s-1, h is the Planck constant, kB is the Boltzmann constant and T is the absolute 
temperature; ΔG‡ =18.2 kcal (mol dimer)-1.  The TSED for the 2(M•Zn) ? (N•Zn)2  
reaction, relative to the (M•Zn) state, is identical to that for the metal-free M state 
because the association reaction is near diffusion-limited and, therefore, will not be 
affected by zinc binding. 
 
The activation free energy for the transition state ensemble for the 2U ? 2M reaction, 
2TSEM, can be placed with the rate constant for folding in the absence of denaturant, 
0.008 s-1, and the Erying formalism as described above. Similarly, the 2TSEM for the 
2(U•Zn) ? 2(M•Zn) reaction can be placed relative to the 2(U•Zn) state, recognizing that 
the 100-fold acceleration in folding due to zinc binding corresponds to a decrease in the 
barrier of 5.0 kcal (mol dimer)-1 (Table 2.2).   
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It is evident that zinc binding perturbs the entire folding reaction coordinate for 
AS-SOD1. The implications of this observation for the unfolding/aggregation hypothesis 
for ALS are discussed below. 
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Discussion 
 
Modulation of the folding free energy surface 
The thermodynamic and kinetic data for the effects of zinc binding on the folding and 
stability of AS-SOD1 (Tables 2.1 and 2.2) provide quantitative answers to the following 
questions about the role of zinc in protecting cells against the aggregation of partially-
folded states of SOD1.  
 
At what stage of the folding reaction does zinc become bound to SOD1 and potentially 
offer protection against aggregation? Zinc binds rapidly to the zinc site in the unfolded 
state with micromolar affinity in vitro and remains bound throughout the reaction. The 
binding of zinc to the peptide model for unfolded SOD1 provides a ready explanation for 
its dramatic acceleration of the monomer folding reaction in vitro and offers insights into 
the source of the very slow folding reaction for apo-AS-SOD1 (see below). The 
nanomolar concentration of free zinc in cells,151 however, is not sufficient to saturate the 
zinc-binding loop segment, and the lifetime of unfolded SOD1 would be that of the 
metal-free protein following synthesis on the ribosome. 
 
What are the quantitative ramifications of zinc binding on the propensity of the native 
dimer and the folded monomer to populate, at equilibrium, less well structured states that 
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may be prone to aggregate? Zinc binding significantly stabilizes the native dimer and 
folded monomer relative to the unfolded state by comparable amounts, -28.5±1.8 and -
26.8±0.8 kcal (mol dimer)-1 respectively, at the standard state of 1 M in each component. 
The calculated zinc dissociation constants (Table 2.2) are within the range, 10-8 and 10-14 
M-1, which have been reported previously.127; 131 The wide range of affinities are likely 
the result of different buffer conditions used. Correcting to a 10 µM standard state, 
subtracting –RT ln[protein] = +6.7 kcal (mol monomer)-1 for mAS-SOD1 and –3RT 
ln[protein] = +20.1 kcal (mol dimer)-1 for AS-SOD1, the zinc-bound monomer is 
stabilized 6.7 kcal (mol monomer)-1 relative to the metal-free monomer state and the 
relative population of the metal-free monomer would decrease by 105-fold. Zinc 
stabilizes dimeric AS-SOD1 by 14.8 kcal (mol dimer)-1, corresponding to a decrease in 
the relative population of the metal-free dimer of 1011. Thus, the effects of zinc binding 
on all of the species in the reaction coordinate diagram are dramatic.  
 
Chakrabartty and coworkers have recently demonstrated that the major unfolding 
pathway of SOD1 at high concentrations of Gdn-HCl involves the initial dissociation of 
the dimer coupled with zinc release. Subsequently, the monomer unfolds and copper is 
released.111 The results of this study may appear surprising given the very high affinity of 
SOD1 for zinc at neutral pH. However, as acknowledged by the authors, zinc dissociation 
could occur either during dimer dissociation or subsequently via a rapid reaction. The 
results of the present study support the latter possibility in that zinc dissociation from the 
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unfolded state, U, follows the rate-limiting dimer dissociation reaction and the faster 
monomer unfolding reaction.  
 
Does zinc binding alter the relative populations of monomeric and dimeric forms of 
SOD1 at equilibrium? Although the propagation of error analysis finds the stabilities of 
monomeric and dimeric AS-SOD1 to be comparable (Table 2.1), the 20-fold slower 
dissociation of Zn-AS-SOD1 vs. AS-SOD1 shows that zinc actually stabilizes dimeric 
AS-SOD1, relative to monomeric AS-SOD1, by 1.7 kcal (mol dimer)-1. The lower free 
energy for the (N•Zn)2 state relative to the 2(M•Zn) state means that the equilibrium 
between the monomeric and dimeric zinc-bound states will shift  to favor the native 
dimer of AS-SOD1 in the presence of zinc. Although the major protective effect of zinc 
binding on SOD1 would be to decrease the relative populations of metal-free forms, the 
decrease in the population of the zinc-bound folded monomeric form might also be a 
factor. 
 
Implications for aggregation 
The capacity of all of the components in the folding mechanism of wild-type SOD1, 
including the TSEs, to bind zinc has significant implications for the aggregation 
propensity of ALS-inducing variants. It has been shown that zinc-bound SOD1 is very 
resistant to aggregation, reinforcing the structural and protective role of zinc.101 Two 
distinct scenarios for aggregation can be envisioned, an equilibrium scenario and a 
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kinetic scenario. The equilibrium scenario involves fully-folded disulfide-bonded protein 
occasionally sampling partially-folded or unfolded aggregation-prone states, whereas the 
kinetic scenario involves the aggregation of transient folding intermediates that are highly 
populated during the folding reaction following synthesis on the ribosome.   
 
Equilibrium scenario.  
The sub-nanomolar binding of zinc to native dimeric SOD1, coupled with the intrinsic 
affinity of the metal-free subunits for each other,114 means that the coupled equilibria will 
flow towards the dimeric state for the wild-type protein. As a result, the populations of all 
zinc-free states will decrease. Conversely, ALS variants containing mutations that lead to 
the loss of metal binding83 will shift their populations toward zinc-free monomeric states.  
For example, the population of the monomeric metal-free form of AS-SOD1 would 
increase by 20-fold relative to its metal-bound wild-type counterpart for a 10 µM 
concentration of the metal-binding variants. Due to the higher order nature of aggregation 
reactions, even small changes in the concentration of these aggregation prone species can 
be amplified into a large change in the rate of aggregation. 
 
One possible scenario is partial unfolding of the monomeric intermediate state, leaving 
the protein susceptible to aggregation. Oliveberg and his colleagues have argued that β5 
and β6, edge strands in the β-sandwich (Figure 2.1), serve as gate keepers for the β-
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sandwich by preventing the aggregation of the monomeric species.123; 124 The boundary 
position of these two β-strands would make them logical candidates for spontaneous 
dissociation in a rapidly-interconverting ensemble of conformers in a manifold of states 
representing the folded monomer of SOD1. Supporting this model are molecular 
dynamics simulations which have predicted that mutations and dimer destabilization have 
the effect of partially unfolding β5 and β6.152 The disorder induced in the zinc-binding 
and electrostatic loops in the absence of zinc could propagate to the adjacent β5 strand 
(Figure 2.1) and, thereby, enhance the propensity for aggregation of monomeric SOD1 in 
the absence of zinc. The increased tendency for metal-free ALS variants to bind 
hydrophobic dyes may be a manifestation of this phenomenon.47 
 
Alternatively, the unfolded state could provide a platform for aggregation. The 
micromolar affinity of the unfolded state for zinc and the sub-nanomolar affinities (Table 
2.1) of the folded monomeric and dimeric states of AS-SOD1 means that the unfolded 
state will not bind zinc, but the folded monomeric intermediate and the dimeric native 
state will be saturated at nanomolar concentrations of zinc in vivo151 for the wild-type 
protein. The folded states of metal-binding variants, which would not be stabilized by 
metal binding, will not benefit from this shift in equilibrium for the wild-type protein 
towards more folded states in the presence of zinc. Once again, this effect will be 
amplified in the rate of aggregation by the higher order kinetics that characterize multi-
component reactions. 
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Kinetic scenario.  
Arguments have also been made for a kinetic pathway for aggregation, where 
polypeptide chains misfold and aggregate after synthesis.153 The micromolar dissociation 
constant for zinc binding to a peptide model for unfolded SOD1 means that the folding 
reaction cannot be accelerated and the lifetime of the unfolded state decreased by 
nanomolar zinc concentrations in vivo. The increased temperature in motor neurons, 37 
ºC vs. 20 ºC in vitro, would only serve to decrease the affinity of zinc for the unfolded 
state because zinc binding is exothermic.131 As a result, immediately following synthesis 
on the ribosome, zinc would not be expected to offer protection against aggregation of 
unfolded, disulfide-reduced ALS-inducing variants of SOD1. 
 
Implications for the folding mechanism of SOD1. 
The significant acceleration of the monomer folding rate by the binding of zinc to 
unfolded AS-SOD1 provides insights into the structure of the TSEM. A previous 
mutational analysis of monomeric SOD1 revealed that β1-β4 and β7, representing 
contributions from both sides of the β-sandwich (β1/β2/β3 and β4/β7; Figure 2.1), are 
integral components of the TSEM.124 A surprising property of the zinc-free monomer 
folding reaction is its very small rate constant, 0.012 s-1 (Table 2.2).  This value is ~104 
less than the rate constant predicted by the relative contact order, a measure of the 
sequence separation between contacting residues in the native structure, of the fully-
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folded SOD1 monomer.154 This significant discrepancy shows an important aspect of the 
rate-limiting folding reaction is not captured by this topological metric. The 100-fold 
acceleration of this reaction by zinc suggests that disorder in the zinc-binding loop might 
be partially responsible. Application of an algorithm to assess the propensity for disorder, 
PONDR,155 to the SOD1 sequence reveals that the zinc-binding loop and, to a lesser 
extent, the electrostatic loop as well as β5 and β6 are expected to be natively disordered. 
The prediction for disorder in the loops and in β5 is in accord with experimental 
observations on monomeric SOD1.35; 36 Both of these loops follow β-strands that are 
adjacent and integral to the β-sheet on one side of the β-sandwich, β4 and β7, and these 
loops pack on each other in the fully-folded structure (Figure 2.1). Thus, the pre-
organization of the zinc-binding loop in the presence of zinc and its potential recruitment 
of the electrostatic loop might be expected to enhance the probability of accessing the 
crucial β4/β7 pair of strands in the TSEM. The significance of C-terminal organization is 
also consistent with slower refolding kinetics observed for disulfide-reduced SOD1,113 in 
which the crosslink between C57 and C146 near the C-terminus is absent.  It would be 
interesting to test the proposed involvement of the zinc and electrostatic loops in the 
TSEM by performing a mutational analysis on side chains in these loops in the presence 
and absence of zinc.  
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Overview on ALS-inducing variants of SOD1. 
The biophysical analyses presented previously104; 115; 124; 156 support a general mechanism 
for the gain-of-function via aggregation of partially-folded states whose populations are 
enhanced in ALS-inducing variants of SOD1. As would be expected for a highly 
cooperative system, the contributions of the inherent protein stability, the disulfide bond 
and the affinity for metal binding are strongly coupled.37; 141 This coupling is evident in 
the present study by the enhanced binding of zinc along the reaction coordinate. It is also 
evident in previous studies by the loss of affinity for zinc of aggregation-prone ALS 
variants.83 and by the increased susceptibility of ALS variants for disulfide bond 
reduction.157 Although chaperones and proteosomes may mitigate the potential for 
aggregation, the diminished potency of these house-keeping systems in aging cells4; 158; 
159 may eventually lead to the formation of toxic aggregates by either the thermodynamic 
or kinetic scenario. Detailed analyses on the stability and folding of ALS-inducing 
variants of SOD1 would provide quantitative metrics on the properties of the unfolded 
and monomeric intermediate states for comparisons with biological measures of 
aggregation and toxicity. These experiments are currently in progress. 
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Materials and Methods 
 
Protein purification. 
 Human C6A/C111S SOD1 and the monomeric variant C6A/C111S/G50E/F51E SOD1 
recombinant proteins were expressed in pET3d/BL21-Gold(DE3) Escherichia coli cells 
(Stratagene®, Inc., Cedar Creek, TX) induced with 1 mM IPTG. All centrifugation steps 
were done using a Beckman JA 25.50 rotor and performed for 45 min at 4 °C unless 
otherwise specified. The cells were pelleted by centrifugation at 9000 RPM for 15 min 
and resuspended in lysis buffer (100 mM HEPES, pH 7.2, 150 mM NaCl, 1 mM ZnSO4, 
1 mM DTE, 1 mg mL-1 lysozyme and one protease inhibitor tablet (F. Hoffmann-La 
Roche Ltd, Switzerland) per 50 mL lysate. After stirring for 30 min at room temperature, 
the cells were sonicated (30 s on, 90 s off) and centrifuged at 20,000 RPM. The resulting 
pellet was then resuspended in lysis buffer lacking lysozyme, 0.6 mL per gram of pellet, 
and the sonication and centrifugation steps were repeated. The combined supernatants 
were placed in a 47 °C water bath and incubated for 45 min and then centrifuged at 
20,000 RPM (this step was not performed for mAS-SOD1). The supernatant from the 
heat incubation was allowed to cool to room temperature, mixed with an equal volume of 
4 M (NH4)2SO4, stirred at room temperature for 30 min, and centrifuged at 20,000 RPM. 
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The resulting supernatant was dialyzed extensively against standard buffer (20 mM 
HEPES, pH 7.2) and loaded onto a Q Sepharose column and eluted with a linear gradient 
to 40% high salt buffer (300 mM KCl, 20 mM HEPES, pH 7.2) over 10 column volumes. 
The presence of AS-SOD1 in the fractions was determined by SDS-PAGE. The pooled 
fractions were concentrated to <10 mL using a YM-10 membrane on an Amicon® 
concentrator and dialyzed against standard buffer. The protein was demetalated and 
tested for purity as previously described.114 The concentration of protein was calculated 
using a molar extinction coefficient at 280 nm of 5400 M-1 cm-1 for the monomer of AS-
SOD1, and, unless otherwise specified, all protein concentrations are given in terms of 
moles of monomer of AS-SOD1 per liter of solution. 
 
Peptide labeling and purification. 
The peptide fragment representing the metal binding region of loop IV, amino acids 61-
86, was purchased from Sigma-Aldrich and modified by adding an N-terminal tryptophan 
and a C-terminal cysteine. Purity was assessed by a single high pressure liquid 
chromatography peak and by mass spectroscopy provided by the manufacturer. The 
covalent modification of the cysteine with the FRET acceptor N-(iodoacetaminoethyl)-1-
naphthylamine-5-sulfonic acid (IAEDANS) was performed at peptide concentrations of 1 
mg mL-1 in 20 mM HEPES buffer pH 7.2, with the addition of 1 mM TCEP. Initially, 10-
fold excess free IAEDANS was incubated with the peptide at room temperature for 2 
hours. Another 10-fold excess of label was then added and the reaction mixture was 
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incubated for another 2 hours at 4 oC. The labeled peptide was separated from free dye by 
running the reaction mixture on two sequential 5 mL HiTrapTM desalting column (GE 
Healthcare Life Sciences). Labeling efficiency was determined by comparing the ratios of 
the absorbance peaks for EDANS and Trp, 340 nm and 280 nm respectively. The 
extinction coefficients of 5700 M-1 cm-1 at 340 nm and 6400 M-1 cm-1 at 280 nm were 
used to calculate the concentration of peptide and dye. 
 
 Fluorescence data were collected on a Spex fluorolog fluorometer with an 
excitation frequency of 280 nm. The concentration of peptide, a mixture of labeled and 
unlabeled, was 4 μM. Emission from the donor and acceptor were collected over 320 nm 
to 570 nm with a collection time of 1 s/nm. The excitation and both emission slits were 
set to 3 nm. It should be noted that this lead to significant photobleaching of the peptide 
and a smaller excitation slit width is recommended for future experiments. 
 
Equilibrium folding experiments. 
All circular dichroism (CD) spectroscopy was performed on a Jasco-810 
spectropolarimeter (Jasco Inc., Easton, MD) equipped with a water-cooled Peltier 
temperature control system. The Gdn-HCl induced unfolding curves were monitored 
from 220-240 nm in a 0.5 cm path length quartz cuvette using a scan rate of 20 nm min-1 
and a response time of 8 s. Gdn-HCl concentrations were determined by refractive index 
160 on a Leica Mark II refractometer. Unless otherwise stated, titration samples were 
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made from concentration matched stocks of folded protein in buffer and unfolded protein 
at 7 M Gdn-HCl and incubated at room temperature for 1 day for apo-protein and 7 days 
for zinc-bound protein.  Coincident unfolding and refolding curves from companion 
experiments in which denaturant was added to native protein and buffer was added to 
unfolded protein insured that the samples were fully equilibrated in this time frame. The 
stocks were mixed precisely using a Hamilton Microlab 500 titrator interfaced with in-
house software to calculate the mixing ratios, and the index of refraction of each sample 
was measured after the experiment was completed. The protein concentrations, given in 
monomer units, were 10 µM for AS-SOD1 and 5 µM for mAS-SOD1 for the equilibrium 
unfolding experiments. 
 
Kinetic experiments. 
The unfolding and refolding kinetics of AS-SOD1, initiated by manual mixing, were 
monitored by CD. Data were collected at 230 nm in a 1 cm2 cuvette under continuous 
mixing with a solution volume of 1.8-2.0 mL. Unfolding jumps were initiated from 
protein in 0 M Gdn-HCl and refolding jumps were initiated from protein denatured 
overnight in 5-6 M Gdn-HCl to various final concentrations. For zinc-loaded samples, the 
protein was incubated in stoichiometric zinc prior to dilution in the buffer. The final 
concentration of Gdn-HCl was measured by index of refraction.  Protein concentrations 
were 10 µM for both AS-SOD1 and mAS-SOD1 for the kinetic folding experiments. 
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Analysis of equilibrium folding data. 
To determine the folding free energy of metal-free AS-SOD1 and mAS-SOD1 from the 
equilibrium unfolding titrations, the data were fit to a simple two-state mechanism. While 
it is known that SOD1 folds via a monomeric intermediate,113; 114; 116 it is not populated 
significantly at these protein concentrations,115 making a 2-state folding model an 
adequate approximation. For all thermodynamic analyses, the free energy of folding in 
the absence of denaturant was calculated assuming a linear dependence of the apparent 
free energy on the denaturant concentration. Equilibrium data were analyzed by globally 
fitting the CD signal at 20 different wavelengths (220-240 nm) to the same 
thermodynamic parameters. All data were fit using Savuka 6.2, an in-house non-linear 
least squares program using the Marquardt-Levenberg algorithm.161 In the absence of 
zinc, equilibrium folding data were fit to a two-state model, U ? N for mAS-SOD1 and 
2U ? N2 for AS-SOD1 as previously described.114 
For equilibrium titrations in the presence of zinc, the data were modeled as a three state 
reaction.  
U+Zn ? U•Zn ? N•Zn 
2U+2Zn ? 2(U•Zn) ? (N•Zn)2 
The Gdn-HCl induced unfolding transition for these titrations involves the native zinc-
bound monomer (N•Zn),or dimer (N•Zn)2, state, the zinc-bound unfolded state U•Zn or 
2(U•Zn) and the zinc-free unfolded chains, U+Zn and 2U+2Zn,  respectively. The 
equilibrium constants can be defined for the stable monomeric form, Zn-mAS-SOD1, as: 
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An equation for total protein concentration may be written as a function of KU, the 
equilibrium constant of unfolding, KD, the dissociation constant for zinc, total protein 
concentration (Pt), total zinc concentration (Zt), and the concentration of unfolded protein 
([U]) (See supplemental for a more detailed derivation).  
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The titration data were fit by numerically solving the equations for the concentration of 
unfolded protein at each Gdn-HCl concentration. The value for KD and its denaturant 
dependence were held fixed to the values obtained from an independent assessment of the 
zinc-peptide complex, and the value for KU was optimized across the denaturant 
concentration and the wavelength range, 220 to 240 nm. The free energy differences 
between thermodynamic states were assumed to depend linearly on the Gdn-HCl 
concentration. 
 
Analysis of kinetic folding data. 
The unfolding and refolding relaxation times were obtained by jumping from 0 or 6 M 
Gdn-HCl to various final concentrations of denaturant and fitting the traces to 
exponentials as described previously.114 The monomer folding and unfolding rates, for 
both apo- and Zn-mAS-SOD1 in the absence of denaturant, were calculated by fitting the 
chevron to a two-state folding model 
)/][()/][( RTDm
u
RTDm
f
uf ekekk −− +=
 
Where k is the observed rate constant, kf and ku are the folding and unfolding rate 
constants in the absence of denaturant respectively, mf and mu are the denaturant 
dependence of the folding and unfolding rates respectively, [D] is the denaturant 
concentration, R is the gas constant and T is the absolute temperature. Knowing the 
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folding and unfolding rate constants in the absence of denaturant, the folding free energy 
can be calculated: 
)ln(
f
u
u k
kRTG −=Δ
 
The dimer dissociation rate constants in the absence of denaturant were calculated from 
linear extrapolations to 0 M Gdn-HCl of the >5.5 M Gdn-HCl region of the unfolding leg 
of the Zn-AS-SOD1 chevron and the >3.8 M Gdn-HCl region of the unfolding leg of the 
apo-AS-SOD1 chevron. 
 
Analysis of zinc binding to the zinc-binding loop peptide. 
All fluorescence spectroscopy was done on a T-format Spex Fluorolog-3 (Instruments S. 
A. Inc, Edison, NJ) at room temperature. The donor tryptophan was excited at 280 nm 
and the emission spectra were monitored from 320 to 540 nm to encompass both the 
tryptophan and EDANS fluorescence. The peptide was incubated at various 
concentrations of Gdn-HCl ranging from 0-6 M in standard buffer. Zinc was added in a 
stepwise manner, from a high concentration stock solution to minimize changes to the 
volume, to samples at each denaturant concentration.  The fluorescence spectra were 
obtained at various zinc and denaturant concentrations and corrected for background 
fluorescence and the small change in volume accompanying the addition of zinc. The 
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fluorescence was measured as a function of zinc concentration, and all wavelengths were 
simultaneously fit to a binding isotherm with one binding site per peptide: 
][
][max
ZnK
ZnBy
D +
×=
 
where y is the fluorescence intensity, Bmax is the signal at saturating concentrations of 
zinc, KD is the dissociation equilibrium constant and [Zn] is the concentration of zinc.  
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Chapter III. Disulfide-Reduced ALS Variants of Cu, Zn Superoxide 
Dismutase Exhibit Increased Populations of Unfolded Species 
108 
 
Abstract 
 
Cu, Zn superoxide dismutase (SOD1) is a dimeric metal binding enzyme responsible for 
the dismutation of toxic superoxide to hydrogen peroxide and oxygen in cells. Mutations 
at dozens of sites in SOD1 induce amyotrophic lateral sclerosis (ALS), a fatal gain-of-
function neurodegenerative disease whose molecular basis is unknown. To obtain 
insights into effects of the mutations on the folded and unfolded populations of immature 
monomeric forms whose aggregation or self-association may be responsible for ALS, the 
thermodynamic and kinetic folding properties of a set of disulfide-reduced and disulfide-
oxidized Zn-free and Zn-bound stable monomeric SOD1 variants were compared to the 
wild-type (WT) protein. The most striking effect of the mutations on the monomer 
stability was observed for the disulfide-reduced metal-free variants. Whereas the WT and 
S134N monomers are >95% folded at neutral pH and 37 ºC, A4V, L38V, G93A, and 
L106V ranged from 50% to ~90% unfolded. The reduction of the disulfide-bond was also 
found to reduce the apparent Zn affinity of the WT monomer by 750-fold, into the 
nanomolar range where it may be unable to compete for free Zn in the cell. With the 
exception of the S134N metal-binding variant, the Zn affinity of disulfide-oxidized SOD1 
monomers showed little sensitivity to amino acid replacements. These results suggest a 
model for SOD1 aggregation where the constant synthesis of ALS-variants of SOD1 on 
ribosomes provides a pool of species in which the increased population of the unfolded 
state may favor aggregation over productive folding to the stable native dimeric state.  
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Introduction 
 
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease that results in 
the death of motor neurons.128 An inherited form of ALS has been linked to mutations in 
the gene encoding for the Cu, Zn superoxide dismutase (SOD1).14; 129 To date, over 150 
amino acid replacements, insertions, deletions and truncations throughout the sequence 
have been discovered that give rise to this deleterious gain-of-function disease 
(http://alsod.iop.kcl.ac.uk/Als/Index.aspx).23 Although a number of mechanisms have 
been proposed for toxicity,137 ALS variants of SOD1 often lead to the formation of 
macroscopic aggregates in the motor neurons of afflicted individuals. Recognizing that 
these types of sequence alterations typically destabilize proteins, it is reasonable to 
hypothesize that marginally soluble forms of SOD1 self-associate to produce toxic small 
oligomers or larger aggregates.138 Nevertheless, the conformations of SOD1 responsible 
for aggregation are unclear, and a common molecular explanation for the formation of 
these aggregates has not been discovered.  
 
SOD1 is a cytosolic protein responsible for the dismutation of superoxide, a toxic 
byproduct of metabolism, into hydrogen peroxide and oxygen through the cyclical 
oxidation and reduction of its catalytic Cu ion.21 In its mature form, SOD1 is a 
homodimer with one Zn and one Cu ion bound to each subunit. The fold of each 
monomer can be described as a β-sandwich composed of eight β-strands supporting two 
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large loops. The Zn-binding loop binds the structurally-important Zn ion, and the 
electrostatic loop plays a role in guiding the superoxide anion to the active site. In 
addition, each monomer contains an intramolecular disulfide bond between C57 in the 
Zn-binding loop and C146 in β8 (Figure 3.1). 
 
There has been growing interest in the role of immature monomeric species, i.e. metal-
free and/or disulfide-reduced, in aggregation.162 Monomeric species of SOD1 may be 
more prone to aggregation98; 104; 105 because they are likely to be partially folded and 
marginally soluble.70; 135; 136; 163 This hypothesis is consistent with the three-state folding 
mechanism of SOD1, 2U?2M?N2, in which the rate-limiting monomer folding reaction 
from the unfolded state, U, to the folded state, M, is followed by the rapid association of 
the monomers to form the dimeric native state, N2.113; 114 As a consequence, the folded 
monomer population is minimized during the folding reaction of the WT protein. Also 
supporting this view is the observation that several ALS variants destabilize the native 
state, leading to increased populations of folded and unfolded monomeric species at 
equilibrium.115; 117; 120 These studies focused on forms of SOD1 and its variants that 
contain the intramolecular disulfide bond, in essence, the mature species closely 
connected with the native conformation. 
 
It has previously been shown that the reduction of the disulfide bond leads to the 
dissociation of the dimer in the absence of metal ions; zinc binding reverses this 
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process.40 The reduction of the disulfide bond in several ALS-inducing variants decreases 
the apparent melting point below physiological temperature.43 However the irreversibility 
of the thermal unfolding reaction and the requirement for a stabilizing osmolyte render 
this conclusion ambiguous. To obtain unambiguous quantitative insight into the 
thermodynamic coupling between disulfide bond, Zn binding and amino acid 
replacements on immature SOD1, a combined thermodynamic and kinetic analysis of the 
reversible folding reactions of a monomeric version of SOD1 (mAS-SOD1), 
C6A/F50E/G51E/C111S, and five ALS variants introduced into this background (Figure 
3.1) was performed. The A4V mutation increases the side chain volume in a tightly 
packed hydrophobic cluster inside the β-sandwich. Both L38 and L106 serve as 
hydrophobic capping residues for the β-sandwich, and replacement with valine at these 
positions decreases the side chain volume and replaces a γ-branched side chain with a β-
branched side chain. The main chain of G93 is in a tight loop, and the dihedral angles are 
disfavored for all but glycine at this position. Finally, S134 is involved in the hydrogen 
bonding network that links the electrostatic loop to the Zn-binding loop, and its 
replacement with asparagine leads to decreased metalation (For a general review see 
Valentine et al.137).   
 
With the exception of S134N, both oxidized and reduced monomeric forms of the 
remaining variants exhibited a significant loss of thermodynamic stability for their metal-
free forms. By contrast, S134N was the only variant studied which exhibited a  
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Figure 3.1. Crystal structure highlighting ALS variants studied. 
Crystal structure of holo-SOD1 (PDB: 2C9V). The Cu ion and the other monomer have 
been omitted. The disulfide bond is highlighted in yellow, and the Zn ion in blue. The 
sites of ALS mutations studied are highlighted by the green side chains for the native 
amino acids. The two residues replaced by glutamic acid to create the monomer model, 
F50 and G51, are shown in red. The ALS-inducing variants studied are A4V, L38V, 
G93A, L106V and S134N. 
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Figure 3.1. Crystal structure highlighting ALS variants studied. 
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significantly weakened apparent Zn affinity. Surprisingly, the reduction of the disulfide 
bond decreased the affinity of mAS-SOD1 for Zn by ~750-fold. The substantially 
increased populations of the unfolded forms in four of the five disulfide-reduced ALS-
variants of SOD1 at physiological temperature may provide the common link between 
mutations at many positions and protein aggregation. The reduction in the apparent Zn 
affinity of the S134N variant would allow this variant to more readily sample the metal-
free folding free energy surface whose folded and/or unfolded monomeric populations 
might be sufficient to induce aggregation even for WT SOD1. 
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Results 
 
The thermodynamic stability of the Zn-bound and/or disulfide-reduced states of 
monomeric WT, A4V, L38V, G93A, L106V and S134N SOD1 variants was determined 
by chemical denaturation experiments on the C6A/F50E/G51E/C111S model of SOD1 
(Figure 3.1).143 In this pseudo-WT model, the free cysteines, C6 and C111, have been 
replaced with non-oxidizable side chains to eliminate intramolecular disulfide-
interchange in the unfolded state and intermolecular disulfide crosslinking in the native 
state. The F50 and G51 residues at the dimer interface have been replaced with glutamic 
acid to prevent dimerization.49; 142 The structure of this stable monomer is very similar to 
that for the monomer in the context of the dimer,36; 49 as is the thermodynamic stability.113 
This system enables measurements of highly reversible folding reactions solely for the 
monomeric forms of these ALS variants, in the absence of their self-association to 
dimeric species. Although the C6A/C111S and F50E/G51E mutations might themselves 
perturb the aggregation propensity of SOD1 (C6F, C6G and C111Y are ALS variants162), 
the introduction of ALS-inducing mutations into the same background allows for a direct 
comparison of their perturbations on the thermodynamic properties and populations of 
the SOD1 system. 
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Stabilities of disulfide-reduced apo-mAS-SOD1.  
The role of the disulfide bond in stabilizing ApoSOD1-mAS was determined by reducing 
the disulfide bond and monitoring the ellipticity at pH 7.2 and 20 ºC as a function of the 
urea concentration. The choice of urea as the denaturant was necessitated by the expected 
low thermodynamic stability of these proteins. The far-UV circular dichroism (CD) 
spectra of the disulfide-reduced monomers can be seen in Figure 3.2A. WT and S134N
2SH
ApoSOD1-mAS  exhibit a minimum at ~208 nm and a slight shoulder at 230 nm, 
consistent with a significant degree of folding. In contrast, A4V, L38V, G93A and 
L106V 2SHApoSOD1-mAS exhibit unfolded-like CD spectra with the minimum shifted to 
~200 nm, and they lack the shoulder at 230 nm characteristic of the native fold. 
   
The equilibrium urea denaturation curves for 2SHApoSOD1-mAS  variants are shown in 
Figure 3.2C. WT 2SHApoSOD-mAS  is stable to ~1.2 M urea, where it undergoes a cooperative 
unfolding reaction that is complete by ~2.6 M urea. The S134N variant is nearly 
coincident with WT with the exception of a slightly negatively sloped native baseline 
prior to the cooperative unfolding transition. The A4V, L38V, G93A and L106V variants 
are all completely denatured by 1 M urea and lack native baselines. These equilibrium 
data were fit to a two-state model, U?M, assuming a linear dependence of the apparent 
free energy of folding, ΔGº, on the denaturant concentration: ΔGº (urea) = ΔGº (H2O) – 
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Figure 3.2. Equilibrium studies. 
CD spectra and urea titrations reveal that A4V, L38V, G93A and L106V 2SHApoSOD1-mAS  
are partially unfolded. The CD spectra of WT (solid gray), A4V (dash-dot black), L38V 
(dotted black), G93A (dashed black), L106V (solid black), S134N (dashed gray) (A) 
2SH
ApoSOD1-mAS  and (B) SSApoSOD1-mAS at 20 ºC and pH 7.2. Equilibrium unfolding 
curves at 20 ºC and pH 7.2 for (C) 2SHApoSOD1-mAS  and (D) SSApoSOD1-mAS variants and 
the calculated fraction unfolded plots for (E) 2SHApoSOD1-mAS  and (F) SSApoSOD1-mAS
variants measured by CD at 230 nm: WT (filled circle), A4V (triangle), L38V 
(hexagon), G93A (diamond), L106V (square), S134N (upside-down triangle). Best fit 
curves to a two-state U?M folding model are shown in solid lines. The thermodynamic 
data are presented in Table 3.1. The protein concentration for these experiments was 10 
μM. 
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Figure 3.2. Equilibrium studies. 
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 m[urea] (Table 3.1). All data were fit using Savuka 6.2, an in-house non-linear least 
squares program using the Marquardt-Levenberg algorithm. The fits were performed by 
globally analyzing the ellipticity at 20 different wavelengths between 220 and 240 nm. 
 
Both WT and S134N 2SHApoSOD1-mAS  exhibit well defined baselines and were fit without 
constraining the parameters. From the determined thermodynamic stability (Table 3.1), it 
is evident that both of these proteins are >99% folded under these conditions (Figure 
3.2E). For the highly-destabilized ALS variants where no native baseline was observed, 
the m-value and the slope and intercept of the native baseline were fixed to the same 
values as WT. The constraint on several variables, required to fit these titrations, likely 
results in an underestimated error of the fit, suggesting caution in the accuracy of these 
estimates for stability. Nevertheless, the lack of native baselines and the reduced CD 
signal in the absence of denaturant (Figure 3.2B) make it clear that substantial fractions 
of A4V, L38V, G93A and L106V 2SHApoSOD1-mAS  are unfolded at 20 ºC and pH 7.2 
(Figure 3.2E).  
The large fraction of unfolded protein for the A4V, L38V, G93A and L106V variants at 
20 ºC and the known endothermic unfolding reaction for SOD156 prompted a comparison 
of the urea denaturation reactions for WT and A4V 2SHApoSOD1-mAS  over the temperature 
range from 4 – 37 °C to determine the extent of unfolding at physiological temperature, 
37 ºC. While the stability of WT protein can be measured reliably at 37 °C, A4V is too 
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Table 3.1.  Thermodynamic parameters, microscopic rate constants and kinetic m‡-
values for monomeric variants.* 
 
 
 
 
 
 WT A4V L38V G93A L106V S134N
Apo reduceda       
o
)M/U(GΔ b -3.95±0.10 -1.09c -0.22c +0.12c -0.40c -3.97±0.16 
)M/U(m  2.23±0.11 2.23
d 2.23d 2.23d 2.23d 2.08±0.08 
Apo oxidizeda, e      
o
)M/U(GΔ  b
 
-4.48±0.07 -2.83±0.07 -2.32±0.15 -1.87±0.07 -2.52±0.08 -4.54±0.10 
)M/U(m 1.65±0.02 1.88±0.04 1.91±0.08 1.89±0.04 2.09±0.05 1.73±0.03 
Apo oxidizeda, e      
kf 0.056±0.002 0.15±0.02 0.033±0.006
0.029±0.00
4 0.030±0.003 
0.039±0.00
4
‡
fm  1.20±0.05 1.5±0.1 1.36±0.20 1.37±0.18 1.33±0.13 1.13±0.04 
ku (2.0±0.40)×10-5 
(1.0±0.1)× 
10-3 
(3.5±1.5)×
10-4
(1.2±0.2)×
10-3 
(5.0±1.0)× 
10-4 
(1.2±0.1)×
10-5
‡
um  -0.58±0.01 -0.64±0.03 -0.78±0.09 -0.74±0.03 -0.74±0.05 -0.65±0.01 o
)/( MUGΔ
 
-4.61±0.12 -2.92±0.2 -2.65±0.28 -1.85±0.13 -2.37±0.13 -4.70±0.08 
)M/U(m f 1.79±0.05 2.14±0.1 2.14±0.22 2.11±0.18 2.07±0.14 1.78±0.04 
Zn oxidizedg      
kf 0.74±0.01 0.87±0.15 0.27±0.05 0.19±0.05 0.34±0.05 0.64±0.01
‡
fm  2.93±0.07 3.0±0.1 2.89±0.09 2.48±0.17 3.39±0.10 2.95±0.10 
ku (0.23±0.08)×10-7 
(1.77±0.39)×
10-7 
(2.8±0.8)×
10-7
(4.1±1.2)×
10-7 
(13.3±3.9)×
10-7 
(2.8±1.2)×
10-7
‡
um  -1.76±0.05 -1.85±0.03 -2.01±0.06 -1.88±0.06 -1.68±0.06 -1.47±0.13 o
)/( MUGΔ h -18.0±0.2 -17.0±0.2 -15.3±0.5 -15.6±0.2 -15.2±0.2 -16.5±0.3 
)M/U(m f 4.69±0.09 4.85±0.1 4.90±0.11 4.36±0.18 5.07±0.12 4.42±0.13 
o
ZnGΔΔ  -13.4±0.2 -14.1±0.2 -12.7±0.5 -13.8±0.2 -12.8±0.2 -11.8±0.3 
Kdh 100±39 pM 31±15 pM 
360±350 
pM 55±23 pM 
270±110 
pM 
1600±840 
pM
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*Units for the U ? M reaction: kf and ku, s-1; ‡fm , ‡um , and m(U/M), kcal mol-1 M-1; o )M/U(GΔ
, oZnGΔΔ , kcal mol-1.  
a Denaturation was performed with urea. 
b Equilibrium data were fit to a two-state model, U?M, by globally analyzing the CD 
signal at 20 different wavelengths between 220 and 240 nm. 
c Due to the constraints required to fit these titrations, the error in the free energy of 
folding is approximated to be ±0.3 kcal mol-1. 
d Parameter was fixed to the WT value. 
e WT values adapted from Svensson et al.114 
f Calculated according to mtot = ׀m‡u׀ + ׀m‡f.׀ 
g Denaturation was performed with Gdn-HCl. 
h The free energy difference between U+Zn ? N•Zn and the Zn affinity was calculated as 
described in Kayatekin et al. 48 
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destabilized at these temperatures to allow accurate fitting of the data. For both A4V and 
WT, the thermodynamic stability was determined by an singular value decomposition 
(SVD) analysis of CD spectra from 220-240 nm.164 The SVD vectors were normalized to 
the unfolded baseline and fit by holding the slope and y-intercept of the native baseline 
fixed to the 4 ºC data set. A van’t Hoff plot of the results is shown in Figure 3.3. The data 
are well-described by a simple linear dependence whose calculated enthalpy changes, 
23.8±2.8 kcal mol-1 for WT and 20.3±2.2 kcal mol-1 for A4V, allow for the prediction of 
the stabilities at 37 °C. 
 
The stability of WT 2SHApoSOD1-mAS  is 2.0 kcal mol
-1 at pH 7.2 and 37 °C, meaning that 
~97% of the protein is folded under these conditions. By contrast, the stability of A4V
2SH
ApoSOD1-mAS , which could be measured reliably up to 27 ºC, falls from 2.1 kcal mol
-1 
at 4 oC to 0.8 kcal mol-1 at 27 ºC. Linear extrapolation to 37 ºC reveals that the stability is 
reduced to ~0 kcal mol-1, indicating that A4V is half unfolded under physiological 
conditions. These results are consistent with previous native-state hydrogen exchange 
experiments that showed WT 2SHApoSOD1  retained some protection against amide hydrogen 
exchange at 37 °C while A4V 2SHApoSOD1 did not.
165 Urea titrations at 37 ºC for all variants 
can be seen in Figure 3.4. For the highly destabilized variants, these titration curves 
entirely lack native baselines and display a very small portion of the unfolding transition, 
consistent with the conclusion that these proteins are largely unfolded at 37 ºC.  On the 
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Figure 3.3. Temperature dependence of WT and A4V stability. 
The van’t Hoff plot of WT (circle) and A4V (triangle) 2SHApoSOD1-mAS . The stability at 
each temperature was determined from a urea titration. Linear extrapolations to 
physiological temperature are shown by the solid black lines. The black, dashed, vertical 
line indicates 37 oC while the dashed line represents a folding free energy of zero, where 
the protein is half unfolded. The buffer used was 20 mM HEPES, 1 mM EDTA, 1 mM 
TCEP pH 7.2. 
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Figure 3.3. Temperature dependence of WT and A4V stability. 
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 other hand, the S134N and WT variants are nearly indistinguishable and appear 
reasonably well folded under these conditions. 
 
Stabilities of disulfide-oxidized apo-mAS-SOD1.  
The far-UV CD spectra of the disulfide-oxidized monomers can be seen in Figure 3.2B. 
In contrast with disulfide-reduced proteins, all variants exhibit well folded CD spectra 
similar to WT SSApoSOD1-mAS . Nevertheless, the characteristic shoulder at 230 nm is 
diminished for A4V, L38V, L106V and G93A, suggesting some structural differences 
may exist between these variants and WT SSApoSOD1-mAS . 
 
The stabilities of the disulfide-oxidized and metal-free variants were measured by both 
kinetic and equilibrium methods. These complementary approaches towards stability 
measurement are possible because both kinetic and equilibrium mechanisms are well-
described by two-state processes. The equilibrium urea denaturation curves for 
SS
ApoSOD1-mAS variants at 20 
oC and pH 7.2, and the fraction unfolded plots for these 
titrations are shown in Figure 3.2D and Figure 3.2F, respectively. WT and S134N 
SS
ApoSOD1-mAS  are stable to ~1.8 M urea, where both proteins undergo a cooperative 
unfolding reaction that is complete by ~3.8 M urea. The next most stable variant, A4V 
undergoes a cooperative unfolding reaction beginning around 0.8 M urea and is complete 
by 2.8 M urea. L38V, G93A and L106V variants exhibit sloped native baselines and are 
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completely unfolded by 2 M urea. These equilibrium data were fit to a two-state model as 
described for the SSApoSOD1-mAS  titrations, except no were constraints imposed on the 
thermodynamic parameters or baselines and CD spectra between 215 and 245 nm were 
fit. From the calculated stabilities (Table 3.1) and the fraction unfolded plots (Figure 
3.2F), it is evident that all disulfide-oxidized variants are at least 95% folded at 20 oC and 
pH 7.2. 
 
The stabilities of the SSApoSOD1-mAS variants were also measured kinetically in order to 
facilitate an appropriate comparison with the Zn-bound data (see below). The kinetic 
unfolding and refolding reactions of the SSApoSOD1-mAS  ALS-variants at 20 
oC and pH 
7.2 were monitored by far-UV CD at 230 nm. Both reactions were well described by 
single exponentials. Semi-log plots of the relaxation times as a function of the final 
denaturant concentration, i.e., chevron plots, are shown in Figure 3.5. The rate constants 
for the global unfolding and refolding reactions in the absence of denaturant were 
obtained by linear extrapolation of the exponentially-dependent regions of the chevron 
plots and calculated by the reciprocal of the relaxation times, k = 1/τ. The refolding rates 
only vary by a factor of 5 from the slowest, G93A, with a rate constant of 0.029 s-1, to the 
fastest, A4V, with a rate constant of 0.15 s-1. The largest perturbations are observed in the 
unfolding rates, ranging from 168-fold faster for G93A to 1.7-fold faster for S134N 
(Table 3.1), closely paralleling the perturbation in stability for each variant. 
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Figure 3.4. Equilibrium titrations at 37 °C. 
Equilibrium unfolding curves at 37 ºC and pH 7.2 for WT 2SHApoSOD1-mAS and ALS 
variants as measured by CD at 230 nm: WT (filled circle),  A4V (triangle), L38V 
(hexagon), G93A (diamond), L106V (square), S134N (upside-down triangle). The buffer 
used was 20 mM HEPES, 1 mM EDTA, 1 mM TCEP pH 7.2. 
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Figure 3.4. Equilibrium titrations at 37 °C. 
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The free energy of folding for each variant, determined from the extrapolated rates, 
ΔG°=-RTln(kf/ku), is in very good agreement with the free energy of folding determined 
from the equilibrium titrations (Table 3.1). The observed change in stability range from 
no significant difference for S134N to as large as a 2.76 kcal mol-1 destabilization for 
G93A by the kinetic measurement (Table 3.1). 
 
The effect of ALS mutations on the apparent Zn affinity of mAS-SOD1. 
 The apparent Zn affinity of SSSOD1-mAS variants was determined from the difference in 
the free energies of their Zn-bound and Zn-free forms relative to the Zn-free unfolded 
state. Accurate estimates of the stability of the SSZnSOD1-mAS  species cannot be obtained 
from equilibrium titrations because Zn appears to scramble to the Cu site in the unfolding 
transition zone.48 Alternatively, the equilibrium constant for the reversible unfolding 
reaction can be calculated from the ratio of the rate constants of unfolding and refolding 
reactions for zinc-bound unfolded state and the zinc-bound folded state. When combined 
with the affinity of Zn for the unfolded protein, estimated from a peptide model of the 
Zn-binding loop,48 the free energy of Zn binding (ΔΔG°Zn), and the corresponding 
apparent Zn affinity, can be obtained from the difference in the metal-bound (ΔG°Zn) and 
the metal-free stability(ΔG°Apo): ΔΔG°Zn = ΔG°Zn(Gdn-HCl) - ΔG°Apo(Urea) , where 
ΔΔG°Zn=-RTln(Kd) (see Kayatekin et al.48 for a detailed explanation of the analysis). 
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Figure 3.5. Chevron plots of disulfide-oxidized variants. 
Observed refolding (open symbols) and unfolding (filled symbols) relaxation times of 
SS
ApoSOD1-mAS variants monitored by CD at 230 nm, at pH 7.2 and 20 ºC, and plotted 
as a function of final denaturant concentration. The data for A4V (triangle), L38V 
(hexagon), G93A (diamond), L106V (square), S134N (upside-down triangle) are shown 
with the best fit line two a two-state folding reaction (solid lines). The fit to the 
disulfide-oxidized WT data (dashed-line) was adapted from Svensson et al.114 The buffer 
used was 10 mM KPi, 1 mM EDTA pH 7.2. 
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Figure 3.5. Chevron plots of disulfide-oxidized variants. 
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The unfolding and refolding reactions of 10 µM protein loaded with stoichiometric Zn at 
20 oC and pH 7.2 were monitored by far-UV CD at 230 nm. Guanidine hydrochloride 
(Gdn-HCl) rather than urea was used as a denaturant to sample the entire folding reaction 
coordinate because Zn greatly enhances the stability of SOD1 and requires a more potent 
denaturant to access the unfolded state. The presence of Zn also required a HEPES buffer 
because Zn3(PO4)2 precipitates at mM buffer concentrations. The requirement to change 
both the denaturant and the buffer to make this comparison means that the dissociation 
constants should be considered apparent and not absolute. However, because the WT and 
ALS-variants were subjected to the same procedures, the differences in the Zn binding 
free energies are expected to reflect the inherent differences in affinities induced by the 
mutations. 
 
Above stoichiometric Zn:protein concentrations for all variants, the refolding reactions 
were well described by a single exponential phase, corresponding to the faster of the two 
observed relaxation times at stoichiometric or lower Zn concentrations. The slower 
reaction corresponds to the folding of SSApoSOD1-mAS .48 The unfolding reactions displayed 
a second, faster exponential in the transition zone that has previously been attributed to 
the scrambling of the Zn ion to the Cu site.48 The chevron plots for A4V, L38V and WT 
SS
ZnSOD1-mAS are shown in Figure 3.6A, and the chevron plots for G93A and L106V and 
S134N are shown in Figure 3.6B. 
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Figure 3.6. Chevron plots of Zn-bound, disulfide-oxidized variants. 
Observed refolding (open symbols) and unfolding (filled symbols) relaxation times 
monitored by CD at 230 nm, at pH 7.2 and 20 ºC, and plotted as a function of final 
denaturant concentration. (A) The data for SSZnSOD1-mAS  WT (circle), A4V (triangle), 
L38V (hexagon) and (B) the data for SSZnSOD1-mAS G93A (diamond), L106V (square) 
and S134N (upside-down triangle) are shown with the best fit line two a two-state folding 
reaction. The WT SSZnSOD1-mAS data were adapted from Kayatekin et al.
48 The 
concentration of protein and Zn for all ALS variants was 10 µM and the buffer used was 
20 mM HEPES pH 7.2. 
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Figure 3.6. Chevron plots of Zn-bound, disulfide-oxidized variants. 
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The refolding relaxation times increase exponentially with increasing denaturant 
concentration to a maximum around 1.8-2.2 M Gdn-HCl. At higher denaturant 
concentrations the unfolding reaction is favored and the observed unfolding relaxation 
times decrease exponentially with increasing denaturant concentration. Above 4-5 M 
Gdn-HCl, the unfolding relaxation times in the presence of Zn for WT SSZnSOD1-mAS and 
all of the variants except for L38V rollover to become nearly independent of the 
denaturant concentration. The L38V variant may roll over at fast unfolding rates which 
are within the dead time of a manual-mixing experiment. These data suggest either that 
Zn has introduced a rate-limiting rearrangement reaction in the native conformation or 
that Zn has slowed a rearrangement reaction that was previously undetectable for the apo-
protein with manual-mixing techniques. Because this reaction is not kinetically coupled 
to the major unfolding reaction that controls unfolding above 4-5 M Gdn-HCl, its 
presence does not interfere with the kinetic measurement of stability 
.  
The refolding rate constants of all the proteins are within a factor of ~5 of each other, 
ranging from 0.19±0.05 s-1 for G93A, to 0.74±0.01 s-1 for WT to 0.87±0.15 s-1 for A4V 
SS
ZnSOD-mAS  (Table 3.1). The effects of the mutations are substantially greater on the 
unfolding rate constants, which parallel the effects on stability. WT SSZnSOD-mAS is the 
slowest to unfold, with a rate constant of 0.23±0.08×10-7 s-1, while L106V unfolds the 
most rapidly, roughly 60-fold faster, with a rate constant of 13.3±3.9×10-7 s-1. 
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These data can be compared with the stabilities of the Zn-free forms of these proteins to 
yield an apparent Zn affinity for the ALS variants (Table 3.1). A4V and G93A variants 
bind Zn slightly tighter than WT mAS-SOD1SS, while L38V, L106V and S134N bind Zn 
more weakly than the WT protein. The corresponding dissociation constants, Kd, for 
A4V, L38V, G93A and L106V are within a factor of three of the Kd for WT, 100 pM, 
and, with the exception of S134N, are nearly within the estimated errors of the 
measurement. The apparent Zn affinity of S134N is reduced by roughly an order-of-
magnitude compared to WT. Contrasting with the dramatic effects on stability with the 
loss of the disulfide bond, Zn has little differential effect on the standard state stability of 
the A4V, L38V, G93A and L106V variants. Only the apparent Zn affinity of S134N is 
significantly reduced from WT mAS-SOD1SS. 
 
The apparent Zn affinity of the disulfide-reduced protein is greatly decreased. 
 The thermodynamic coupling between the disulfide bond and Zn binding was assessed 
by measuring the Zn affinity of WT and S134N 2SHSOD1-mAS with the kinetic assay 
described above for the SSSOD-mAS species. The chevron plot of WT and S134N 
2SH
ApoSOD1-mAS  are shown in Figure 3.7A. In both refolding and unfolding, only a single 
exponential phase was observed. Neither the denaturant dependence of the refolding rate 
nor the unfolding rate is significantly affected by the loss of the disulfide-bond. Both  
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Figure 3.7. Chevron plots of disulfide-reduced WT and S134N. 
Observed refolding (open symbols) and unfolding (filled symbols) relaxation times of 
WT (circles) and S134N (upside-down triangle) (A) 2SHApoSOD1-mAS  and (B) 
2SH
ZnSOD1-mAS  monitored by CD at 230 nm, at pH 7.2 and 20 ºC, and plotted as a 
function of final denaturant concentration. The data are shown with the best fit line to a 
two-state folding reaction for WT(solid line) and S134N (dashed line). The protein and 
Zn concentrations were 10 µM and the buffer used was 20 mM HEPES, 1 mM TCEP pH 
7.2. 
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Figure 3.6. Chevron plots of Zn-bound, disulfide-oxidized variants. 
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variants exhibit an identical response to disulfide-bond reduction, where the refolding 
rates are slowed ~3 fold compared to the disulfide-oxidized protein and the unfolding rate 
is accelerated ~5 fold (Table 3.2).  
 
When Zn was introduced, two phases were observed in refolding and unfolding, 
comparable to the disulfide-oxidized protein. The slower phase in refolding matched the 
refolding rate of the metal-free protein. The chevron plot of the slow exponential phase in 
unfolding and the fast phase in refolding at stoichiometric Zn concentrations for WT and 
S134N 2SHSOD1-mAS Zn  are shown in Figure 3.7B and the associated thermodynamic and 
kinetics parameters are reported in Table 3.2. Although the status of the disulfide bond 
does not alter the denaturant-dependence of the refolding reaction, the denaturant-
dependence of the unfolding reaction is substantially decreased when the disulfide-bond 
is reduced. This change presumably reflects a less structured native state for 
2SHSOD1-mAS Zn compared to
SS
ZnSOD1-mAS . The refolding rate in the absence of 
denaturant for WT 2SHZnSOD1-mAS is nearly 10-fold slower than for 
SS
ZnSOD1-mAS , while 
the unfolding rate constant is nearly 1000-fold faster.  
 
Surprisingly, the disulfide-reduced S134N variant clearly exhibits a ~3-fold slower 
unfolding rate than the WT protein in the presence of Zn, while the refolding rates for 
both proteins are comparable. This result suggests that the replacement of serine with 
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asparagine in the electrostatic loop may actually lead to interactions which stabilize Zn 
binding compared to the WT protein when the disulfide-bond is reduced and the protein 
relaxes (see Discussion).  
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Table 3.2.  Thermodynamic parameters, microscopic rate constants and kinetic m‡-
values for disulfide-reduced WT and S134N.* 
*Units for the U ? M reaction: kf and ku, s-1; ‡fm , ‡um , and m(U/M), kcal mol-1 M-1; o )M/U(GΔ
, oZnGΔΔ , kcal mol-1. 
a Denaturation was performed with urea. 
b Denaturation was performed with Gdn-HCl. 
c Calculated according to mtot = ׀m‡u׀ + ׀m‡f׀ 
d The free energy difference between U+Zn ? N•Zn and the Zn affinity was calculated as 
described in Kayatekin et al. 48 
 
 
 WTapoa S134Napoa WTZnb S134NZnb 
kf 0.027±0.006 0.019±0.003 0.099±0.005 0.064±0.014 
‡
fm  1.43±0.23 1.19±0.12 3.6±0.1 2.87±0.17 
ku (1.0±0.3)×10-4 (6.6±1.7)×10-5 (2.7±0.5)×10-5 (5.2±0.6)×10-6 
‡
um  -0.57±0.03 -0.65±0.03 -0.92±0.03 -1.04±0.02 
o
)/( MUGΔ  3.26±0.22 3.30±0.18 4.78±0.11 5.48±0.14 
)M/U(m c 2.00±0.23 1.84±0.12 4.52±0.1 3.91±0.17 
o
ZnGΔΔ  - - 9.52±0.25 10.2±0.2 
Kdd - - 75±33 nM 25±10 nM 
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Discussion 
 
Patients with the five ALS-variants of SOD1 examined in this study, A4V, L38V, G93A, 
L106V and S134N, exhibit an average life expectancy of less than three years after the 
onset of disease.7 Our approach towards testing the potential role of monomeric species 
in the aggregation hypothesis for toxicity in SOD1-mediated fALS has been to employ 
classical thermodynamic and kinetic folding experiments to define the folding free 
energy surface of stable monomeric versions of these variants. The coupling between 
mutations, disulfide-bond status and Zn binding can be related to the changes in the 
relative populations of the folded and unfolded states (Figure 3.8). Enhanced populations 
of marginally-soluble monomeric forms would be expected to increase the propensity for 
aggregation and, possibly, promote toxicity. 
 
Disulfide-reduced ALS variants are very unstable.  
The reduction of the disulfide bond in the stable monomeric models of the A4V, L38V, 
G93A and L106V variants causes a significant reduction in their stability (Table 3.1) and 
a corresponding increase in the population of their unfolded states (Figure 3.8). For 
example G93A SSApoSOD1-mAS , the least stable variant, is only 5% unfolded at 20 ºC. 
Upon reduction of the disulfide bond, the population of unfolded protein increases to 
55%. The effect is exacerbated at 37 ºC, where the unfolded populations of A4V, L38V, 
G93A and L106V exceed 50%, while only 3% of the WT protein is unfolded under these  
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Figure 3.8. Unfolded state populations. 
The fraction of unfolded species populated at equilibrium for each variant, SSZnSOD1-mAS
(black), SSApoSOD1-mAS (light gray), 2SHApoSOD1-mAS  (dark gray) at 10 µM protein 
concentration, 20 oC and pH 7.2. The errors for A4V, L38V, G93A and L106V 
2SH
ApoSOD1-mAS  were approximated at 20%. All other errors were determined from the 
error in the ΔG°. 
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Figure 3.6. Chevron plots of Zn-bound, disulfide-oxidized variants. 
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conditions. These results demonstrate that unfolded 2SHApoSOD1-mAS  is prevalent in these 
ALS variants under physiological conditions and, therefore, could play a critical role in 
aggregation. A recent report has demonstrated that even WT-SOD1Apo can aggregate 
under conditions that enhance the unfolded state, such as the addition of reducing agent 
or the presence of 1M Gdn-HCl, when agitated at 37 ºC.8 Given that the unfolded 
thermodynamic state represents a manifold of rapidly-interconverting conformations, it is 
also possible that a transient population of sub-structure might be more aggregation-
prone and, therefore, responsible for the initiation of the aggregation reaction.  
 
Implications for mitochondrial damage.  
The dramatic destabilization of the disulfide-reduced forms of the A4V, L38V, G93A and 
L106V variants may also play a role in mitochondrial damage observed in mouse models 
of ALS.166 The transport of SOD1 into yeast mitochondria is greatly favored for the 
reduced metal-free monomeric form,30 presumably reflecting the ease of access to an 
unstructured unfolded state required to traverse the outer membrane. Once inside the 
intermembrane space, a resident disulfide relay system oxidizes the intra-molecular 
disulfide bond, which, along with Zn binding and dimer formation, would effectively trap 
SOD1 inside the mitochondria.167 The dominant population of the unfolded state for the 
disulfide-reduced form of the four WT-like variants, A4V, L38V, G93A and L106V, at 
pH 7.2 and 37 ºC and the unusually slow folding reaction to the disulfide-competent 
folded state could provide an opportunity for the unfolded state to aggregate or to 
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associate with other components in the intermembrane space. The observed increased 
localization of G93A and other ALS variants of SOD1 in mitochondria,168 especially in 
the spinal cord of transgenic mice,169 and their capacity to damage this essential organelle 
may, therefore, be a manifestation of their thermodynamic and kinetic folding properties. 
 
Zn binding is marginally affected in WT-like ALS variants.  
NMR and crystallographic studies have shown that Zn binding has an important role in 
defining the structure of SOD1 by organizing the Zn binding and electrostatic loops of 
the WT protein.35; 36; 49 As shown in the present study, Zn binding to mAS-SOD1SS 
significantly stabilizes the folded state for all of the variants (Table 3.1). However, the 
apparent dissociation constants for the WT-like variants, A4V, L38V, G93A and L106V, 
vary by less than an order of magnitude from the 100 pM apparent Kd for the WT protein 
and are not consistently decreased. Despite the small differences in the measured Zn 
affinity, these results correlate well with the observed metal content of the mutant protein 
when isolated from insect cells.32 
 
These results may appear to contradict the findings by Crow et al., 127 who found that the 
dimeric A4V and L38V SOD1 variants had a 30-fold and 18-fold weakening of the Zn 
affinity relative to WT protein in 2 M urea; the contradiction can be understood in terms 
of the increased population of the folded monomeric forms for these variants and their 
lower zinc affinity relative to the dimeric state.48 The 66 hours required to extract zinc 
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from these variants in the Crow et al. study would provide ample opportunity for the 
monomeric form to serve as the conduit for zinc loss. 
 
S134N, a metal-binding variant of SOD1, differs from the β-sandwich variants in that the 
apparent Zn affinity is significantly reduced. While the S134N variant is not destabilized 
significantly in its metal-free forms, the weakening in the apparent Kd for Zn binding 
from 100 pM for WT mAS-SOD1SS to 1.6 nM for S134N mAS-SOD1SS offers the 
possibility that aggregation of the monomeric forms may still be the source of toxicity. 
Although this variant can be loaded with Zn and Cu in vitro,94; 95 Hayward and 
coworkers83 have observed decreased Zn and Cu content in as-isolated samples of S134N 
SOD1 expressed in insect cells. The replacement of serine with asparagine in the 
electrostatic loop may similarly impede full metalation in motor neurons. The potential 
for aggregation might be further compounded by the spontaneous reduction of the 
disulfide bond of the metal-free species in the cytoplasm. Thus, even the small fraction of 
unfolded mAS-SOD12SH observed for S134N may be sufficient to cause aggregation. 
Because the predicted metal-free unfolded and folded populations for S134N are nearly 
identical to WT, the intriguing possibility arises that the loss of Zn even from the WT 
protein may be sufficient to trigger aggregation. 
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Zn binding is dramatically decreased by reduction of the disulfide bond.  
In contrast to the response to mutations, the reduction of the disulfide bond has a 
dramatic effect on the Zn affinity of mAS-SOD1, resulting in a ~750-fold weakening in 
the apparent Kd from 100 pM to 75 nM for the WT protein and a 16-fold weakening in 
the apparent Kd for the S134N variant from 1.6nM to 25 nM. The 3-fold tighter Kd for 
disulfide-reduced S134N vs. WT protein contrasts with a 16-fold weaker apparent Kd in 
the presence of the disulfide bond. This behavior demonstrates thermodynamic coupling 
between the disulfide bond and Zn binding. Inspection of the crystal structure of SOD1 
shows that the disulfide bond is proximal to the Cu site, which shares a ligand with the 
Zn site. Apparently, the constraints on the structure introduced by the disulfide bond are 
transmitted to the Zn binding site in a way that reduces the affinity of S134N for Zn. This 
may be due to the inability of the S134N variant to induce compactness in the 
electrostatic loop by the formation of the S134 - D125 hydrogen bond.94 When the 
protein relaxes in the absence of the disulfide bond, the electrostatic loop may be able to 
access conformers that form stabilizing electrostatic interactions absent in the WT 
protein. 
 
 These results suggest that disulfide bond oxidation may be the key step in the 
maturation of SOD1. Because 2SHApoSOD1  would not compete effectively for free Zn at ~1 
nM concentration in vivo, Zn would be expected to bind after the oxidation of the 
disulfide bond when the apparent Kd decreases to 100 pM. This hypothesis is supported 
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by the discovery that the presence of Zn does not accelerate the formation of the disulfide 
bond in SOD1 expressed in rabbit reticulocyte assays 37. 
 
Aggregation following synthesis on the ribosome?  
The analysis presented above presumes that the populations of species in vivo dictated by 
the equilibrium free energy surface of SOD1 are those responsible for aggregation and 
toxicity. Alternately, the aggregation of SOD1 may occur soon after synthesis on the 
ribosome, prior to its several maturation steps including disulfide bond formation, 
dimerization and Zn and Cu loading.37 Disulfide-reduced SOD1 folds surprisingly slowly 
in vitro, requiring ~40 seconds at 20 oC, nearly four orders of magnitude slower than 
predicted by its topology.154 Although the time required for folding is comparable to the 
length of time required to translate a 153 residue eukaryotic protein, ~30-50 s,170 co-
translational folding of SOD1 is unlikely since the rate-limiting step of folding involves 
the docking of the first four N-terminal β-strands with the β7 strand near the C-
terminus.124 The observation that the four ALS variants in the β-sandwich structure, A4V, 
L38V, G93A and L106V, have substantially increased unfolded populations of their 
disulfide-reduced forms implies an enhanced opportunity for the aggregation of these 
species prior to their ultimate maturation to their native dimeric forms. The subsequent 
formation of the disulfide bond increases the stability of the folded monomeric form and 
drives the dimerization reaction.40 The high concentration of SOD1 in motor neurons, 
>10 µM,104 and its half-life of ~1 day,171 requires a constant and significant rate of 
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synthesis on ribosomes. Thus, the aggregation of SOD1 may involve both kinetic, i.e., 
following synthesis and prior to maturation, and thermodynamic, i.e., at steady-state after 
maturation,117 mechanisms.  
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Materials and Methods 
 
Protein purification. 
Recombinant proteins were expressed in and purified from BL21-Gold(DE3) PLysS cells 
(Stratagene®, Inc. Cedar Creek, TX).  The protein was purified using the procedure 
previously described in Kayatekin et al.48 Protein identity and purity was determined by 
measuring the molecular weight with LC-ESI mass spectrometry. The protein 
concentrations were calculated using an extinction coefficient of 5,400 M-1 cm-1.  
 
Disulfide-bond reduction. 
 All variants of mAS-SOD1 were reduced by 24 hour incubation in 1 mM TCEP. The 
reduction of the disulfide-bond and absence of re-oxidation after the incubation in 
reducing agent was confirmed by kinetic unfolding or refolding experiments for 
ApoSOD1-mAS . Fully reduced protein exhibited a single exponential phase with a 
relaxation time 5-fold faster than the disulfide-oxidized protein in unfolding. 
 
Equilibrium experiments. 
All circular dichroism spectroscopy was performed on a Jasco-810 spectropolarimeter 
(Jasco Inc., Easton, MD) equipped with a water-cooled Peltier temperature control 
system. The CD spectra of disulfide-reduced protein were an average of 6 spectra 
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obtained using a 1 mm path length quartz cuvette, a scan rate of 20 nm min-1 and a 
response time of 4 s. The buffer used was 10 mM potassium phosphate, 1 mM ETDA, 1 
mM TCEP, pH 7.2. The urea induced unfolding curves were monitored from 220-240 nm 
in a 0.5 cm path length quartz cuvette using a scan rate of 20 nm min-1 and a response 
time of 8 s. The buffer used was 20 mM HEPES, 1 mM EDTA, 1 mM TCEP for 
disulfide-reduced and 10 mM KPi, 1 mM EDTA for disulfide-oxidized samples, pH 7.2. 
Urea concentrations were determined by refractive index on a Leica Mark II 
refractometer. Titration samples were made from concentration matched stocks of folded 
protein in standard buffer and unfolded protein at 8 M urea and incubated at the 
experimental temperature overnight.  
 
Kinetic experiments. 
The unfolding and refolding kinetics, initiated by manual mixing, were monitored by CD. 
For metal-free protein, 10 mM potassium phosphate, 1 mM EDTA, pH 7.2 was used as 
the buffer. For metal-bound protein the potassium phosphate was replaced with 20 mM 
HEPES and the 1 mM EDTA was omitted. Data were collected at 230 nm in a 1 cm2 
cuvette under continuous mixing with a solution volume of 1.9 mL. Unfolding jumps 
were initiated from protein in 0 M urea or Gdn-HCl and refolding jumps were initiated 
from protein denatured in 4-6 M Gdn-HCl or 8 M urea to various final concentrations. 
For Zn-loaded samples, the protein was incubated with stoichiometric Zn prior to dilution 
153 
 
in the unfolding/refolding buffer. The final concentration of Gdn-HCl was measured by 
index of refraction. Protein concentrations were 10 µM for all kinetic experiments.  
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Chapter IV. Enthalpic barriers associated with desolvation dominate 
the folding reaction of SOD1 monomers. 
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Introduction 
 
Amyotrophic lateral sclerosis is a neurodegenerative disease which results in the death of 
motor neurons. Mutations in the gene encoding for the Cu, Zn superoxide dismutase 
(SOD1) have been found to cause ALS through a gain-of-function mechanism. To date, 
over 150 mutations have been discovered in human patients. The overwhelming majority 
of these are missense mutations, but some deletion mutations and C-terminal truncations 
also exist (http://alsod.iop.kcl.ac.uk/). These mutations lead to the formation of 
oligomeric species of SOD1, which, in later stages of the disease, leads to the formation 
of large aggregates. A variety of mechanisms have been suggested for the toxicity of 
misfolded and aggregated SOD1,71 but the exact nature of the toxic species remains 
unknown.  
 
SOD1 is primarily a cytosolic protein responsible for the dismutation of the highly 
reactive superoxide anion (O2-). The protein is a homodimer with one catalytic copper ion 
and one structurally important zinc ion bound to each subunit (Figure 4.1). The fold of 
the protein can be described as a β-sandwich, with eight anti-parallel β-strands supporting 
two large, catalytically important loops. These loops, the Zn binding loop and the 
electrostatic loop, are important structurally and for guiding the substrate to the active 
site, respectively. In the absence of the metals, as in this study, these loops have been 
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Figure 4.1. Crystal structure and topology of SOD1. 
(A)  SOD1 is a dimeric β-sandwich protein consisting of eight anti-parallel β-stands 
supporting two catalytic loops (PDB: 2C9V). The electrostatic loop is depicted in green, 
while the Zn-binding loop is depicted in cyan. Each monomeric subunit also contains a 
Zn and Cu ion, which were not present for this study, as well as an intramolecular 
disulfide bond. The free cysteines, C6/C111 (red), were replaced with alanine and serine 
respectively. Additionally, a pair of glutamic acid residues was introduced at the dimer 
interface, replacing F50/G51 (violet), in order to obtain the obligate monomer, mAS-
SOD1. (B) The topology of SOD1 immunoglobulin-like. It is made up of two β-sheets, 
the first consisting of strands 1-3+6 and the second consisting of 4+5+7+8, and contains a 
Greek-key motif. 
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shown to be intrinsically disordered by NMR35 and x-ray crystallography.36 Each subunit 
also features an intramolecular disulfide bond between C57 and C146.  
 
The folding mechanism of SOD1 can be best described as a three-state reaction,113; 114 
2U?2M?N2, in which the rate-limiting monomer folding reaction from the unfolded 
state, U, to the folded state, M, is followed by their rapid association, contingent upon 
disulfide-bond oxidation or Zn binding,40 to form the dimeric native state, N2. The 
monomer folding reaction of metal-free SOD1 is of particular interest because the 
surprisingly slow folding rate constant in the absence of denaturant, kf = 0.079 s-1,117 is 3-
4 orders of magnitude slower than predictions derived from the complexity of the 
topology, such as relative contact order154 or long-range order.172 The topology of SOD1 
is in the family of immunoglobulin-like folds, characterized by two anti-parallel β-sheets 
with a greek key motif (Figure 4.1B). The formation of long range contacts between 
hydrophobic residues in the core β-strands are likely the critical step in the formation of 
the folding transition state.173 For SOD1, according to the phi analysis performed by 
Nordlund and co-workers, these residues consist of at least C6, I18, L117, forming a 
tightly-packed hydrophobic ring similar to those observed for Tnf3 and CAfn2.174   
 
Characterization of the transition state between the folded and unfolded forms of the 
SOD1 monomer can provide insight into the roles of sequence and topology in governing 
the folding of this molecule. By monitoring the temperature and viscosity dependence of 
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folding and unfolding reactions, key insights may be obtained on the role of entropy and 
enthalpy in defining the barriers to folding. These results show that the barriers to folding 
and unfolding are both enthalpically dominated with large energetic barriers, consistent 
with slow folding and unfolding reactions. The folding reaction shows unitary 
dependence with the solvent viscosity, suggesting that chain diffusion and the search for 
the critical folding nucleus are still contributing to the slow folding reactions. These 
results combined with the lack of significant global collapse preceding monomer 
folding,114 suggest that dehydration of the chain, rather than the breakup of pre-existing 
structure, is the likely contributor to the enthalpic barrier in refolding.  
 
Materials and methods. 
 
Protein purification. 
Recombinant mAS-SOD1 was expressed in BL21-Gold(DE3) cells (Stratagene®, Inc. 
Cedar Creek, TX) and purified according to the procedure previously described (ref 
kayatekin 2008). Protein mass and purity were determined by LC-ESI mass spectrometry. 
Protein concentrations were determined by absorbance measurements performed on a 
Jasco UV-580 UV/Vis spectrophotometer (Jasco Inc., Easton, MD) using an extinction 
coefficient of 5,400 M-1 cm-1 at 280 nm. 
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Kinetics.  
The unfolding and refolding kinetics were all initiated by manual mixing with a dead 
time of ~3 seconds and monitored by CD utilizing a Jasco J-810 CD spectrophotometer 
(Jasco Inc., Easton, MD). The data were collected at 230 nm in a 1 cm2 cuvette with 
continual mixing and a total volume of 1.9 mL. The standard buffer for all experiments 
was 20 mM HEPES, 1 mM EDTA, pH 7.2. Refolding jumps were initiated from 5 M 
Urea for the temperature dependence studies and 4 M Gdn-HCl for the viscosity 
dependence studies. Unfolding jumps were initiated from the absence of denaturant. The 
final denaturant concentration for each kinetic point was determined by index of 
refraction measurements. The final concentration of protein for all experiments was 5-10 
μM. 
 
Data analysis. 
Individual kinetic traces were fit independently using Savuka 6.2, utilizing the 
Marquardt-Levenberg non-linear least squares algorithm. The relaxation kinetics were 
well described by a single exponential: 
 
ktAeFtF −∞ +=)(  (1) 
Where ∞F is the CD signal at infinite time and A is the amplitude of the signal change 
associated with the kinetic phase described by the rate constant, k. 
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The folding and unfolding data as a function of final denaturant concentration were 
extrapolated to the absence of denaturant assuming an exponential dependence on the 
urea concentration: 
 
RTuream
u
RTuream
fobs
uf ekekk /][*0/][0 −− +=
 (2) 
Where kobs is the observed rate at a given denaturant concentration, [urea], 0fk and 
0
uk are 
the folding and unfolding rates in the absence of denaturant, respectively, and mf and mu 
are the denaturant dependence of the folding and unfolding rates, respectively. 
Using the rates in the absence of denaturant, the entropic and enthalpic contributions to 
the activation free energy can be calculated from transition state theory: 
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However, due to the fact that there is a large change in surface area in protein folding and 
unfolding reactions, the change in heat capacity must also be considered:
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Substituting into equation 3, the rate constants in the absence of denaturant at the 
temperatures studied were then parameterized according to: 
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Where ka is the prefactor, T0 is 298.15 K, R is the gas constant and 
‡0SΔ , ‡0HΔ , and 
‡0
pCΔ are the change in entropy, enthalpy and heat capacity, respectively, at standard 
state. The choice of the prefactor, ka, depends on the choice of the Eyring or Kramers 
formalisms. For the Eyring formalism, ka=kbT/h = 6.2 × 1012 s-1, where kb is the 
Boltzmann constant, T is the temperature in Kelvin, and h is Plank’s constant. For the 
Kramers formalism, ka = κ0/η, where κ0 is the rate constant in the absence of a free energy 
barrier and η is the solvent viscosity. The appropriate value, ka = 5 × 108 s-1, was chosen 
based on experiments performed on peptide models.175; 176 
 
Results. 
Monomer model. 
While the dimer dissociation reaction is rate limiting, and therefore the only observable in 
unfolding reactions, the association reaction proceeds with a rate >106 s-1 and is difficult 
to measure directly because it follows the rate-limiting monomer folding reaction117. 
Alternatively, both the monomer folding and unfolding reactions are amenable to manual 
mixing techniques in a monomeric variant of SOD1, mAS-SOD1. This variant was 
created by the replacement of F50 and G51 near the dimer interface with glutamic acid 
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residues (Figure 4.1).143 SOD1 with an intact intramolecular disulfide bond was studied 
specifically to determine whether loop closure plays a significant role in guiding the 
search process to the native structure. The free cysteines, C6 and C111, were replaced 
with alanine and serine in order to improve folding reversibility by preventing disulfide 
interchange in the unfolded state and intermolecular disulfide crosslinking in the native 
state. Additionally, the removal of the free cysteines, combined with the natural absence 
of methionine residues, greatly reduces the possibility of oxidative damage associated 
with experiments performed at higher temperatures.  
 
Temperature dependence of the disulfide-oxidized mAS-SOD1. 
The kinetic folding and unfolding reactions for disulfide-oxidized mAS-SOD1 were 
monitored by circular dichroism spectroscopy at 230 nm and initiated by manual mixing 
with a dead time of ~2 s. The refolding and unfolding rates were measured as a function 
of temperature between 10 °C and 40 °C at 2.5 °C intervals. The raw folding and 
unfolding kinetics were well described by single exponential relaxation kinetics. The 
chevron plots at every 5 °C are shown in Figure 4.2.  
The kinetic data were extrapolated to the absence of denaturant assuming an exponential 
dependence of the observed rate on the concentration of denaturant (Eq. 2). The free 
energy of folding, )/ln(0 fu kkRTG −=Δ  , and m‡-values as a function of temperature 
can be seen in Figure 4.3. The free energy increases non-linearly approaching a 
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Figure 4.2. Temperature dependence of mAS-SOD1 folding kinetics 
The folding and unfolding kinetics of disulfide-oxidized mAS-SOD1 are shown as a 
function of temperature at every 5 °C, ranging from 10 °C (top) to 40 °C (bottom). The 
solid lines represent the fit to a two-state folding model, N↔U. 
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Figure 4.2. Temperature dependence of mAS-SOD1 folding kinetics.  
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Figure 4.3. Temperature dependence of the ΔG° and the m‡-values. 
The free energy of folding (A) and the m‡-values (B) of folding (open circles) and 
unfolding (filled circles) are shown as a function of temperature. The solid line in (A) 
represents to the best fit to the Gibbs-Helmholtz equation (Eq. 8). The error bars 
represent the error of the fit. 
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Figure 4.3. Temperature dependence of the ΔG° and the m‡-values. 
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maximum around 10-15 °C. The change in the free energy of folding as a function of 
temperature, for a two-state process, can be described by the modified Gibbs-Helmholtz 
equation:177; 178 
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where ΔHm, Tm, and ΔCp correspond to the enthalpic change at the midpoint of the 
transition, the temperature of the midpoint of the transition and the heat capacity change 
upon unfolding respectively. By this analysis, the unfolding of mAS-SOD1 results in a 
heat capacity change of 1.93±0.27 kcal mol-1 K-1, a change in enthalpy of 28.0±2.2 kcal 
mol-1, and a change in entropy of 78±7 cal mol-1 K-1 at 298 K.  
 
Unlike the free energy, the m‡-values exhibit a linear dependence on the temperature. The 
refolding m‡-value is relatively unchanged while the unfolding m‡-value slightly 
decreases as a temperature is increased, ranging from -0.67±0.02 kcal mol-1 M-1 at 10 °C 
to -0.48±0.03 kcal mol-1 M-1 at 40 °C. These results suggest that the native state may 
become less structured at higher temperatures, while the transition state ensemble and the 
unfolded state are unchanged. 
 
In order to discriminate between the entropic and enthalpic contributions to the free 
energy of forming the transition state ensemble, the temperature dependence of the rates 
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Figure 4.4. Eyring plots of the folding and unfolding reactions. 
The log of the (A) folding (open circles) and (B) unfolding (filled circles) rates divided 
by the temperature were plotted as a function of the inverse of the temperature and fit to 
an Eyring or Kramers model as described in Materials and Methods to obtain the 
thermodynamic parameters of the transition state, 
‡0SΔ , ‡0HΔ , and ‡0pCΔ . 
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Figure 4.4 Eyring plots of the folding and unfolding reactions. 
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extrapolated to the absence of denaturant (Eq. 3) was evaluated according to equation 6. 
An Eyring plot of the data can be seen in Figure 4.4. The activation energy parameters for 
refolding and unfolding, at 298 K, for evaluated with both the Eyring and Kramers 
formalisms are reported in Table 4.1. This analysis shows that the contribution to the 
activation energy barrier at 298 K is entirely enthalpic for both unfolding and refolding 
reactions.. With the exception of the Eyring formalism for the refolding reaction, the 
entropic contribution is favorable for both the folding and unfolding reactions. 
 
The change in heat capacity and the height of the enthalpic barriers are not unusual for 
small, single domain proteins characterized as two-state folders,179 and can be related to 
the extent of accessible surface area exposure.147 The change in accessible surface area 
between the native and unfolded states evaluated by the m-value is 12045±364 Å2, while 
the change in the surface area estimated from the ΔCp value is 10742±2263 Å2. The good 
agreement between these numbers instills confidence in the results and further reinforces 
the two-state nature of mAS-SOD1 folding. 
 
The apparent linear decrease in the activation free energy and activation enthalpy with 
increasing concentration of denaturant (Figure 4.5) resembles the N→I transition in the 
α-subunit of tryptophan synthase.180 A quantitative comparison can be made by fitting the 
transition state parameters to a denaturant binding model:180; 181; 182 
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Figure 4.5. Urea dependence of the activation energy and enthalpy of unfolding. 
The unfolding energy of activation (A) and the enthalpy of activation (B) are shown as a 
function of urea. The values at each urea concentration were calculated from an 
interpolation of the measured relaxation times. Solid lines are the best fit to a Tanford 
urea binding model.182 
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Figure 4.5. Urea dependence of the activation energy and enthalpy of unfolding. 
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Table 4.1. Thermodynamic parameters of the transition state ensemble of disulfide-
oxidized mAS-SOD1.* 
 ΔH°‡ 
(kcal mol-1) 
ΔS°‡
(cal mol-1) 
ΔCp°‡
(kcal mol-1 K-1)
ΔG°‡ 
(kcal mol-1) 
Folding     
Eyring 16.1±0.6 -9±2 -0.85±0.12 18.8±0.9 
Kramers 16.7±0.6 12±2 -0.85±0.12 13.1±0.6 
Unfolding     
Eyring 45.0±1.7 72±6 1.06±0.37 23.5±2.5 
Kramers 45.6±1.7 93±6 1.06±0.37 17.9±2.5 
* The thermodynamic parameters were calculated by fitting the observed folding rate in 
the absence of denaturant and are reported at standard temperature, To=298 K. The choice 
of prefactor depends on the formalism employed, where ka = 6.2×1012 s-1 for the Eyring 
formalism and ka = 5×108 s-1 for the Kramers formalism.   
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where Δn‡ represents the number of additional urea binding sites in the TSE compared to 
the native state, K is the binding constant of urea to independent and identical sites on the 
protein, a is the activity of urea, and ‡0BHΔ is the enthalpy change upon binding urea. The 
average value of K was assumed to resembled values determined for ribonuclease, 
lysozyme and cytochrome c, 0.061 M-1.181 The activity of urea was determined using the 
equation proposed by Pace: a = 0.9815(urea) - 0.02978(urea)2 + 0.00308(urea)3. 183 
 
The activation energy as a function of urea was calculated from an interpolation of the fit 
to the observed relaxation times, τ = 1/k. As seen in Figure 4.5, equation 8 provides an 
excellent fit to the observed denaturant dependence of the activation free energy and 
yields values of )OH( 2
‡0GΔ  =24.2±0.1 kcal mol-1, ‡nΔ = 26.1±0.8. These values are held 
constant to fit the urea dependence of the activation enthalpy (Eq. 9), yielding values: 
)OH( 2
‡0HΔ = 47.3±0.6 kcal mol-1, ‡0BHΔ = -2.69±0.10 kcal mol-1 M-1. The activation 
entropy of binding urea to the revealed sites, ‡0BSΔ , can be determined from Equation 10, 
and has a value of -14.7±0.5 cal mol-1 K-1 M-1. These values are in good agreement with 
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those determined urea binding to unfolded proteins obtained from calorimetric 
experiments: ‡0BHΔ = -2.2±0.5 kcal mol-1 M-1, ‡0BSΔ =-12.7±1.9 cal mol-1 K-1 M-1.181 
 
Viscosity dependence for the unfolding and refolding rates.  
A theoretical explanation for the effect of solvent viscosity on protein folding is provided 
by the Kramers theory which suggests that the rate of folding should be inversely 
proportional to the friction.184 Put in experimental terms, the relaxation time can be 
interpreted as a function dependent on an adjustable prefactor (C), the internal friction of 
a system (σ), the height of the energy barrier (ΔG‡) and the viscosity of the solvent (η): 
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For systems in which the internal friction of the protein is negligible relative to the 
solvent viscosity, the relaxation time should vary linearly with the solvent viscosity with 
a slope of unity.  
 
We investigated whether internal friction is playing a role in the folding of SOD1 by 
measuring the folding kinetics of mAS-SOD1 over a range of solvent viscosities. The 
increased stability of mAS-SOD1 upon the addition of co-solvents led to the choice of 
guanidine hydrochloride, a more potent denaturant, for these experiments. The chevron 
plots for mAS-SOD1 folding in the presence of increasing concentrations of glycerol are 
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shown in Figure 4.6A. The addition of glycerol increases the stability of mAS-SOD1 by 
both accelerating refolding and slowing unfolding, As a result, glycerol shifts the 
midpoint of the N↔U reaction from 0.8 M in the absence of glycerol to 1.25 M at 16%, 
to 1.46 M at 24% and, 1.76 M at 32%. Because neither the unfolding or refolding m‡-
values are affected by glycerol, the exposure of surface areas of the native, transition state 
ensemble and the unfolded state do not change in response to the viscogens. 
 
In order to ensure that these results were not the result of some property specific to 
glycerol but of increased bulk viscosity of the solvent, four concentrations of glucose, 
one concentration of sucrose, and two concentrations of PEG 8000 were also tested 
(Figure 4.6A and 4.6B). Both glucose and sucrose exhibit similar behavior to glycerol in 
that they stabilize mAS-SOD1 by accelerating refolding and slowing unfolding. On the 
other hand, neither concentration of PEG 8000 shows any effect on the folding kinetics of 
mAS-SOD1 despite a significant increase in the bulk solvent viscosity.  
 
It may seem counterintuitive that the refolding rates accelerate in a more viscous solvent, 
but this is a consequence of the increased stability of the protein in the presence of 
osmolytes.185; 186; 187 In order to separate the effect on stability from the effect on the 
folding and unfolding rates, an isostability approach was used.185 Instead of measuring 
the rates of folding and unfolding for each viscogens at identical Gdn-HCl 
concentrations, the rate constants were determined at concentrations of Gdn-HCl where kf  
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Figure 4.6. Viscosity dependence of mAS-SOD1 folding and unfolding relaxation 
times. 
The folding and unfolding relaxation times as a function of final denaturant concentration 
are shown for increasing concentrations of (A) glycerol: 0% (open circles), 16% (light 
gray), 24% (dark gray), 32% (black); PEG8000: 3% (open diamonds), 6% (gray 
diamonds); (B) Glucose: 11% (white triangles), 17% (light gray triangles), 20% (dark 
gray triangles), 26% (black triangles); Sucrose: 18% (white squares). All experiments 
were performed at 20 °C, in buffer containing 20 mM HEPES, 1 mM EDTA pH 7.2. 
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Figure 4.6. Viscosity dependence of mAS-SOD1 folding and unfolding relaxation 
times. 
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= 1000 ku and ku = 1000 kf respectively. A plot of the observed relaxation time in the 
presence of a viscogen under isostability conditions relative to the relaxation time in 
buffer versus the relative viscosity of the solvent is shown in Figure 4.7. For a protein 
with little or no internal friction, a unitary dependence on the solvent viscosity is 
expected. The best-fit line to relative relaxation time versus relative viscosity for folding 
and unfolding yields a slope of 1.34±0.26 and 1.32±0.27 respectively. Within the 
uncertainly of these data, the results suggest a diffusion-limited process for both 
unfolding and refolding.  
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Figure 4.7. The increase in the relative relaxation time of mAS-SOD1 folding and 
unfolding reactions with increasing solvent viscosity. 
The relative relaxation time (τ/τo) for mAS-SOD1 in the presence of glycerol (circle), 
glucose (diamond), sucrose (triangle) and PEG 8000 (square) are plotted as a function of 
the solvent viscosity. Open circles represent refolding data while the closed circles 
represent unfolding. The solid line represents a linear relationship between the relaxation 
time and solvent viscosity with a slope of unity. The dotted line represents a viscosity 
independent relative relaxation time, the behavior exhibited in the presence of PEG 8000. 
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Figure 4.7. The increase in the relative relaxation time of mAS-SOD1 folding and 
unfolding reactions with increasing solvent viscosity. 
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Discussion 
 
The slow folding reaction of SOD1 monomers and its potential relationship to 
aggregation motivated the study of the temperature and viscosity dependence of the 
folding and unfolding rates of disulfide-oxidized mAS-SOD1. The refolding relaxation 
time of SOD1 under physiological conditions, τ ~ 1 s, is much slower than folding 
reactions observed for α-helical proteins, which can fold in milliseconds or even 
microseconds.188; 189 This 4-5 orders of magnitude difference in timescales may partially 
explain the aggregation propensity of this protein. Both the unfolding and refolding 
activation energy barriers were found to be dominated by unfavorable enthalpic 
contributions. Depending on the choice of formalism, all or all but the refolding reaction 
are partially offset by favorable entropic contributions. SOD1 exhibited the expected 
slowing of the folding and unfolding rates with solvent viscosity, consistent with a 
diffusive process, suggesting that internal friction is not playing a role in the slow folding 
reaction. 
 
The nature of the transition state. 
Insights into the relative position of the transition state ensemble with respect to the 
native and unfolded states can be obtained by comparing the ratio of the refolding m‡-
value and 
‡0
pCΔ  values to the total m-value and 0pCΔ . This parameter, designated α, can 
be related to the surface area buried upon formation of the transition state: 
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where X‡ is either the m‡ or 
‡0
pCΔ  value. An α-value near 1 suggests a very native-like 
transition state, whereas an α-value near 0 suggests an unfolded-like transition state. 
While the net value of both the m-value and 0pCΔ  are dominated by the exposure of 
hydrophobic residues, the value of 0pCΔ  reflects the nature of the exposed surface. The 
contributions to the m-value, which is a measurement of the exposure of the polypeptide 
backbone, are positive regardless of the nature of the side chain. In contrast, the exposure 
of hydrophobic residues contributes positively to 0pCΔ , whereas the exposure of 
hydrophilic or polar residues results in a slight negative contribution.181; 190 
 
The α-value obtained from 
‡0
pCΔ  is 0.44±0.11, whereas the α-value obtained from the 
m‡-values is considerably higher, 0.65±0.02. These results suggest that for the disulfide-
oxidized protein, the burial of hydrophobic residues does not entirely dominate the 
refolding reaction. This is supported by evidence obtained from the phi analysis which 
shows that many hydrophobic residues in the core of the protein were found to have phi 
values of less than 0.3.124 While the TSE is not entirely hydrophobic in character, the 
amino acids with the highest phi values, with the exception of C6 are branched aliphatic 
amino acids - specifically I18, I35, L117. The combination of a few residues with very 
high phi values (>0.5) surrounded by many residues with much lower phi values (<0.3) 
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implies a TSE with a very tightly packed core, surrounded by loosely packed residues. It 
is interesting to note that the A4V substitution has an accelerating effect on the refolding 
rate.44; 117 The additional van der Waals interactions provided by the larger valine side 
chain compared to alanine may stabilize the loosely formed region of the transition state 
ensemble. Beyond the transition state, due to the increased packing density in the native 
state, this and other bulkier substitutions, such as C6F, are severely destabilizing.  
 
This model is also supported by the interpretation of the urea dependence of the 
activation energy and activation enthalpy of the barrier to unfolding.180 These 
thermodynamic parameters represent the nature of the urea binding sites revealed upon 
unfolding to the TSE from the native state. Since the energetics of urea binding to the 
exposed sites in the TSE of mAS-SOD1 resembles the energetics of urea binding to the 
unfolded state,181 it is reasonable to postulate that the formation of the TSE involves the 
complete unfolding of parts of the protein, rather than loose packing of the entire 
structure, and may reflect the unfolding of the loosely packed secondary shell of residues 
around the tight core formed by C6, I18, I35, and L117. 
 
Comparisons with contact order predictions. 
Baker and co-workers, studying proteins which exhibit two-state folding behavior have 
demonstrated a correlation between the rate constant of folding and the topological 
complexity of the protein.154 One metric by which the complexity is quantified, absolute 
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contact order (ACO), is the average sequence distance between all pairs of contacting 
residues.191 Apo-SOD1 was determined to have a ACO of 20.6 (using PDB: 1RK7) and is 
shown in relation to other studied proteins in Figure 4.8. 
 
When considering the entire set of proteins used to determine the correlation of rate 
constant and ACO, much variation in the data is observed. Istomin and colleagues have 
shown that separating the proteins by secondary structure content, all α, all β, and mixed 
α/β, leads to much improved correlations.192 Indeed, when considering only all-β 
proteins, SOD1 seems to lie well within the expected refolding rate constant range 
(Figure 4.8).  
 
An enthalpic barrier associated with desolvation. 
Important energetic and structural information about the TSE for SOD1 can be obtained 
by the analysis of the change in heat capacity, enthalpy, and entropy for the folding and 
unfolding reactions. The entropic contributions to the energy barriers, the quantification 
of the net gain or loss of degrees of freedom in the system, represent the sum of 
contributions from the chain entropy and the solvent entropy. The loss of chain entropy 
upon folding is counterbalanced by the increase in solvent entropy by the desolvation of 
side chains, freeing water molecules into the bulk water.  
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Figure 4.8. Correlations of folding rate constants and a measure of topological 
complexity. 
The log of the refolding rate is plotted as a function of the absolute contact order 
determined from the structure of the protein. Circles represent a combination of all-β, all-
α, and mixtures of α/β topologies, while filled circles represent solely the all-β. The open 
square represents mAS-SOD1. The data for proteins other than SOD1 were adapted from 
Istomin et al.192 
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Figure 4.8. Correlations of folding rate constants and a measure of topological 
complexity. 
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In unfolding, the increase in chain entropy is often compensated by a comparable and 
unfavorable contribution from the solvent entropy. The entropic contribution to the 
formation of the TSE is favorable regardless of the choice of formalism, consistent with a 
partial unfolding of the native state which remains desolvated. Because the activation 
enthalpy is independent of the entropic effects of the conformational search, it provides a 
more direct structural reflection of the intermolecular interactions in the amino acid 
chain. Furthermore, unlike the activation entropy, it is not convoluted by the uncertainties 
in the choice of appropriate prefactor to accurately measure the value. The large enthalpic 
barrier to unfolding implies a loss of hydrogen bonding and packing in the TSE, 
consistent with the analysis of the α-values above. The combination of these results 
suggests the TSE becomes loosely packed relative to the native state in unfolding but 
likely remains desolvated. 
 
In refolding, the barrier is once again dominated by the enthalpic term. The entropic 
contribution to ΔG‡ is very slightly unfavorable according to the Eyring formalism or 
contributes favorably to the energy barrier according to the Kramers formalism. These 
results suggest that the loss of chain entropy is almost entirely, or entirely compensated 
by the increase in solvent entropy, consistent with a highly desolvated TSE. Furthermore, 
mAS-SOD1 folds highly cooperatively by a two-state mechanism, as evidenced by the 
lack of curvature in the chevron plots,44; 113; 117; 119 and an absence of collapse prior to the 
rate-limiting folding reaction as measured by small angle x-ray scattering.114 These 
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observations indicate that breakup of existing structure prior to the formation of the TSE 
cannot contribute to the enthalpic barrier observed in refolding and further reinforces the 
role of desolvation. 
 
It has been suggested that desolvation may play a critical role in the formation of large 
enthalpic barriers in folding. The requirement for a desolvated TSE may also explain 
different correlations of the ln(kf) and the ACO for all-α, all-β, and mixed α/β proteins. 
All-β proteins show a much steeper dependence on the ACO, perhaps due to the non-
local interactions required to form the extensive β-sheets. This would lead to the 
requirement of the cooperative desolvation of many water molecules, which may give 
rise to this high enthalpic barrier, as opposed to the desolvation of a few water molecules, 
such as in the formation of an α-helix, which may be overcome by thermal fluctuations. 
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Chapter V. Structural characterization of the native and higher energy 
states of SOD1. 
  
192 
 
Section I. Native State Hydrogen Exchange. 
 
Background and Rationale 
Though the presence of SOD1 containing aggregates has been a hallmark of SOD1 
mediated ALS, the nature of the aggregation prone species of SOD1 is not well 
understood. One potential pathway is through higher energy species of the dimeric state, 
as observed for S134N.95 Furthermore, the detection of higher energy species accessible 
to the apo-SOD1 monomer suggest that these species may also be potential candidates for 
aggregation.163 Native state hydrogen exchange techniques provide a structural probe to 
map the differences in the features of these hypothesized higher energy states and the 
native structure of SOD1. 
 
Hydrogen exchange is a powerful tool for obtaining insights into the extent of secondary 
structure formation in a protein or an ensemble of proteins. These methods exploit the 
fact that amide protons engaged in secondary structure formation, either by the formation 
of hydrogen bonds or by burial in the core of the protein, are less accessible to exchange 
with protons from the solvent. Hydrogen exchange methods, coupled with either NMR or 
mass spectroscopy, have been used ubiquitously to probe the secondary structure and 
dynamics of proteins and more recently in efforts to obtain structural information on 
aggregate formation.193; 194 In mass spectroscopy, the exchange is monitored by either a 
gain or loss of mass, as the exchange of hydrogen with deuterium leads to a change in 
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mass. In NMR, the loss of peaks arising from hydrogen atoms are monitored because 
deuterium has no net nuclear spin. 
 
Shaw and colleagues165 have used this approach to analyze the effects of the A4V 
mutation, finding protection throughout the sequence for both the WT and A4V proteins. 
The only differences in exchange kinetics were observed for the sequence near the 
disulfide bond, where A4V showed enhanced exchange. Additionally, for the disulfide-
reduced protein, little or no protection from exchange was observed for the A4V variant, 
consistent with the thermodynamic results presented in Chapter III, demonstrating that 
this variant is partially unfolded at 37 °C when disulfide reduced. Furthermore, studies in 
the Agar lab on as-isolated SOD1 variants have suggested that the destabilization of the 
electrostatic loop may be a common feature of ALS variants.96 Nevertheless, the partial 
metalation of the samples in this particular study makes the results difficult to interpret as 
the exchange may be arising from a sub-population of metal-free species.  
 
Native state hydrogen exchange experiments were performed on the monomeric and 
dimeric SOD1 in an effort to elucidate the structural determinants of SOD1 aggregation. 
Considering the implication of monomeric species in the aggregation pathway, structural 
or dynamic differences should be evident between the monomeric and dimeric constructs. 
The common regions of protection against hydrogen exchange should reveal the core of 
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SOD1 stability. The regions of missing protection in the monomer, if any, could reveal 
protective structural features which must be unfolded to allow aggregation. 
  
Materials and Methods 
 
Native state hydrogen exchange. 
 Hydrogen exchange of all samples was initiated by a 10:1 dilution of protonated protein 
into deuterated buffer consisting of 20 mM HEPES, 1 mM EDTA, pD 7.2. The fully 
deuterated sample was prepared by incubating the protein in deuterated buffer containing 
6 M urea. Aliquots for each time point were quenched by another 10:1 dilution into 
quench buffer consisting of 1 mM TCEP, 0.025% TFA, 5% acetonitrile, pH 2.4.  Samples 
were frozen in liquid nitrogen immediately following the quench and stored at −80 °C.  
 
Preparation of peptides.  
Pepsin digestion of AS-SOD1 was performed with immobilized pepsin at an enzyme to 
substrate ratio of 1:1 w/w. Deuterated mAS-SOD1 was diluted 10:1 into 100 μL of 
prewashed immobilized pepsin incubated in 100 μL of quench buffer. Digestion was 
carried out for 4 minutes on ice with occasional mixing. The digested samples were then 
centrifuged for <10 s at 14,000 g and frozen in liquid nitrogen for storage at −80 °C. 
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Liquid chromatography-Electrospray ionization mass spectrometry (ESI-MS).  
The extent of hydrogen/deuterium exchange of full length mAS-SOD1 variants was 
determined by HPLC ESI-MS. 20μL of protein was loaded on to a reverse phase Vydac 
C4 column, 1 mm x 10 mm, and eluted with a 10 minute gradient of 2% - 98% 
acetonitrile, 0.05% TFA, with a flow rate of 20 μL/min. The column and the tubing 
leading into the HPLC were all kept on ice to minimize back exchange. The mass 
spectrometry was performed on an ion trap LCQ ESI mass spectrometer. 
 
Matrix-assisted laser desorption ionization mass spectroscopy (MALDI-MS). 
Samples for MALDI-MS analysis were prepared in a 4°C cold room to limit back 
exchange. Samples were thawed and run through a C18 ZipTip™ according to the 
standard procedure provided by Millipore. 0.2-0.5 μL of samples was plated with 0.5 μL 
of 10 mg ml-1 α-cyano-4-hydroxycinnamic acid, which served as the matrix. Spots were 
dried at room temperature in 1-2 min under a vacuum. MALDI time-of-flight (MALDI-
TOF) mass spectra were obtained with a Micromass MALDI-LR instrument in reflectron 
mode. An average of 50-100 laser shots were used to generate each mass spectrum. 
Peptides were identified using the software package PAWS with a maximum error of 
±100 ppm. 
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Results and discussion 
 
Full length hydrogen exchange of SOD1 monomers.  
The hydrogen exchange kinetics of full length WT and A4V mAS-SOD1 were measured 
in an effort to ascertain the presence of intermediate species which may exist in the 
folding free energy surface of SOD1 monomers but are otherwise not observed by 
traditional kinetic and equilibrium studies. The number of exchanged protons as a 
function of time can be seen in Figure 5.1. It should be noted that the back exchange 
control was not performed for these experiments, and the number of exchanged protons 
represents a number smaller than the actual number of exchanged protons. Similar 
experiments performed in the lab on other proteins have found that a minimum of 20-
25% back exchange occurs in these LC-MS experiments.195 
 
The evidence for exchange from partially folded intermediates would be revealed by 
multiple exponential phases of hydrogen deuterium exchange. The characteristic 
signature of multiphasic exchange in a plot of the number of exchanged protons as a 
function of the log of the time of exchange is the presence of plateaus in the curve. 
Neither WT nor A4V exhibit any such plateaus until the proteins appear fully exchanged 
after a more than 105 s for A4V and 6×106 s for WT. These results are consistent with a 
two-state model for mAS-SOD1 folding between the folded and the unfolded state. 
Previous HX studies on the full length protein were performed over a much shorter time 
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Figure 5.1. Hydrogen exchange kinetics on full length WT and A4V mAS-SOD1.  
The extent of hydrogen exchange in full-length WT (black squares) and A4V (red circles) 
mAS-SOD1 was monitored by ESI-MS and the number of exchange protons are plotted 
as a function of the log of time allowed to exchange with the deuterated buffer. Both 
proteins exhibit exchange kinetics consistent with a single exponential phase, where the 
number of exchanged protons for the A4V variant reaches a maximum at 105 s, while the 
exchange for the WT protein reaches a maximum at 6×106 s. 
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Figure 5.1. Hydrogen exchange kinetics on full length WT and A4V mAS-SOD1.  
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course making comparisons difficult.165 However, the time-scale for hydrogen-deuterium 
exchange observed for both of these variants, which must be controlled by the unfolding 
rate of the protein, is inconsistent with the unfolding relaxation time measured by kinetic 
folding experiments, τ = 50000 s for WT, and τ = 833 s for A4V. These results may 
suggest that some compact structure in the unfolded state may be preventing the 
exchange of these amides with solvent.   
 
Peptide specific detection of hydrogen exchange in the SOD1 dimer. 
The sequence coverage of immobilized pepsin digested apo-AS-SOD1 is shown in Figure 
5.2A. Only the highest signal peptides are shown, but more peptides are present in the far 
N and C termini providing increased overlap but not increased coverage. Peptide digests 
were performed at six time points: 5 s, 60 s, 2 min, 1 hour, 2 hours, 1 day, 2 days. Digests 
were also performed on the unexchanged and fully exchanged peptides in order to define 
the start and endpoints of the exchange.  
 
The protection against hydrogen exchange was ranked qualitatively based on the 
observed exchange over 2 days. Unprotected peptides, depicted in red, show immediate 
and full exchange at the earliest time points. Not surprisingly this peptide maps to the Zn-
binding loop (Figure 5.2B), which is unstructured in these experiments due to the absence 
of metals. 
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Figure 5.2. Sequence coverage and peptide specific resistance against hydrogen 
exchange.  
The sequence, secondary structure map, and sequence coverage of apo-AS-SOD1 by 
immobilized pepsin digestion is shown in (A). The peptide coverage is shown by the 
blue, yellow and red solid lines, which represent the length of the observed peptides. The 
color coding is based on the resistance to hydrogen exchange, which can be mapped on 
the crystal structure of SOD1 (PDB: 2C9V), where blue peptides are strongly resistant, 
yellow peptides show intermediate resistance, and the red peptide shows little or no 
resistance (B).  
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Weakly protected peptides, highlighted in yellow, show exchange kinetics between the 5 
s and 2 hour time points and are protected after that. These peptides are found in the 
dimer interface, in the edge β-strands, β5 and β6, as well as the electrostatic loop (Figure 
5.2B). The time constant for these exchange reactions, while not quantitatively measured, 
is consistent with the relaxation time of dimer dissociation, τ = 1351 s.117 It is interesting 
that the exchange in the electrostatic loop is not as rapid as the exchange observed for the 
Zn-binding loop. It is possible that the electrostatic loop is more compact in the apo-state 
than previously thought based on NMR and x-ray scattering experiments, which 
suggested that it is completely disordered. Furthermore, the electrostatic loop and β5-β6 
are considered gatekeepers against the exposure of the hydrophobic core of SOD1.123; 124 
The exchange observed in these regions of the apo-protein may serve to explain the 
observed increased aggregation potential of disulfide-reduced, and therefore monomeric, 
proteins.8 
 
 Strongly protected peptides exhibit no increased exchange between 5 seconds and 2 
days, and closely resemble the mass of the unexchanged peptide. These peptides are 
solely found in the hydrophobic core of the SOD1 monomer, in β2-β4 and β7 (Figure 
5.2B). This is identical to the critical folding nucleus determined by the phi analysis 
performed by Nordlund and co-workers, suggesting that these peptides likely exchange 
only from the unfolded state.124 
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Future directions 
The ultimate goal of these experiments is to obtain structural insights into aggregation 
prone species of SOD1.193 This will be facilitated by a comparison of the hydrogen 
exchange profile of soluble SOD1 and aggregated SOD1. Hydrogen exchange of SOD1 
in aggregates can be performed by incubating in vitro aggregated SOD1 in deuterated 
buffer followed by disaggregation in high concentrations of denaturant and then digestion 
by immobilized pepsin, identical to the treatment of the soluble protein. Similar studies 
utilizing HX-MS or HX-NMR have been performed previously to gain insight into the 
structure of aggregated α-synuclein,194 which is natively disordered in solution, and β2-
microglobulin.196  
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Section II. Small-angle x-ray scattering 
 
Background and Rationale 
Numerous structural studies, both by x-ray crystallography and by NMR have been 
performed on SOD1 and ALS-inducing variants of SOD1. X-ray crystal structures have 
been primarily reported for the fully metalated, or partially metalated proteins, revealing 
little or no structural perturbations of the native state of the protein for the disease 
variants, even for a highly destabilizing mutation such as A4V.97; 98 Similar structural 
insights were obtained for the holo-G37R SOD1 by NMR, suggesting that this is not 
simply an artifact of crystallization. For this particular variant, it was shown that the 
addition of metals to the apo-G37R SOD1 restored the ALS variant to the dynamic 
properties of the WT protein, despite being more dynamic in the apo-state.99 These 
results are consistent with the high catalytic activity observed for many ALS variants, 
suggesting that the native structure of the protein is likely intact.171 Considering the high 
thermodynamic stability of holo-SOD1 and the observation that many ALS-variants of 
SOD1 can lead to the destabilization of their metal-free44; 115; 117; 120; 121 or metal-bound 
states,32; 44; 116; 127 it is possible that the addition of metals obscure structural differences 
that may exist in immature species of SOD1, which may be important for inducing 
aggregation. 
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Immature species of SOD1, such as the apo-protein, show significant differences in the 
dynamics of the loops and the extent of hydrogen bonding in the β-sheet architecture, 
reflecting the significant loss of stability upon the loss of the metals.35 One might expect 
that this more loosely structured protein may be able to better accommodate changes to 
the amino acid sequence, yet studies on the apo, disulfide-reduced ALS variants suggests 
that amino acid replacements in the β-sandwich lead to considerable destabilization even 
in immature species.43; 44 For these reasons, structural differences in the immature species 
of SOD1 may explain the aggregation propensity of ALS variants. Small angle x-ray 
scattering provides a straightforward, but low resolution probe of solution structure that 
can be performed at relatively low concentrations and is amenable to destabilized 
variants, which may be prone to aggregation at the concentrations required for 
crystallization or NMR. Furthermore, data acquisition is relatively rapid, potentially 
allowing for the screening of dozens of variants. 
 
Materials and Methods. 
 
Data acquisition.  
Small angle x-ray scattering data were collected at the BioCAT beamline at the 
Advanced Photon Source at Argonne National Labs. Samples, at a concentration of 1-2 
mg/ml were flowed continuously through a 1 mm capillary during data acquisition. This 
procedure reduces the effective exposure time of the protein to the x-ray beam to 10 ms, 
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greatly reducing the possibility for radiation damage. A matched buffer sample was also 
collected for each sample to ensure appropriate blank subtraction. The scattering data 
were acquired with an exposure time of 1 s and an average of 6-10 exposures were used 
in the analysis. The samples were equilibrated and measured at the ambient temperature 
of the BioCAT beamline, ~25 °C. 
 
Data analysis. 
The data were analyzed using IGOR Pro (Wavemetrics, Inc, Lake Oswego, OR) macros 
written at BioCAT. The radius of gyration, Rg, was obtained using the Guinier 
approximation in the range where RgQ < 1.3. The bead modeling was performed using 
the simulated annealing program GASBOR197 using the default parameters and a 
maximum length of 45 Å and then superimposed on a monomeric subunit of the crystal 
structure of SOD1 (PDB: 2C9V) using SUPCOMB.198  Repeated simulations of the bead 
modeling led to visually similar structures but a consensus structure of multiple bead 
models was not generated. Due to the statistical nature of the output of these programs, a 
more rigorous analysis may be required to gauge the accuracy of the results.  
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Results and discussion. 
 
In order to specifically monitor differences in immature species of SOD1, the pseudo-WT 
monomeric and variant C6A/F50E/G51E/C111S SOD1, mAS-SOD1, was used. This 
model has been repeatedly used in our lab and others as a faithful representation of the 
native SOD1 monomer. Small angle x-ray scattering spectra on the WT and five ALS-
variants of SOD1 were measured in order to obtain structural insights into the 
conformations of the protein in solution.  
 
Guinier analysis.  
The radii of gyration determined by the Guinier approximation and are reported in Figure 
5.3. Measurements reported with error bars represent the average of two or more 
independent measurements. The largest differences in the radii of gyration are observed 
for the disulfide-reduced β-sandwich variants compared to the WT protein. These 
variants are destabilized to such an extent that the unfolded state is partially populated 
under these conditions.44 The small angle x-ray scattering intensity increases non-linearly 
with the size of a molecule and significant populations of the larger unfolded state should 
inflate the apparent radius of gyration. Therefore, these measurements likely represent an 
overestimate of the size of the folded, disulfide-reduced protein. Interestingly, the S134N 
variant also appears larger than WT, despite exhibiting no difference in thermodynamic 
stability.44; 117 Upon oxidation of the disulfide bond, all β-sandwich variants exhibit 
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increased compactness. Once again, this is likely due to the increased fraction of folded 
protein and may not reflect a significant change in the native structure. Furthermore, 
addition of Zn leads to a significant compaction for the A4V variant, while all other 
variants either compact very slightly or remain unchanged. Surprisingly, the S134N 
variant shows no change with respect to either Zn binding or disulfide-bond oxidation, 
suggesting that this protein may have structural differences compared to the WT protein 
in both the apo and Zn-bound states.   
 
Kratky analysis. 
The Kratky plots, a plot of I(q)q2 vs q, for the same scattering data are shown in Fig. 5.4. 
The sharp peak observed near q = 0.1 Å-1 is indicative of a globular species and can be 
compared to the unfolded spectra taken at 6 M urea. Interestingly, a difference can be 
observed between the reduced and oxidized unfolded spectra, suggesting that simply 
circularization of the chain can contribute to the peak. Similar observations have been 
noted for circular DHFR in which the N- and C-termini were linked by an engineered 
disulfide bond.199 Since contributions to the scattering intensity from the unfolded state 
for disulfide-reduced variants make it difficult to deconvolute an appropriate spectrum 
for the native species, only the disulfide-oxidized apo and Zn-bound proteins were 
compared in their Kratky spectra. Analysis of the Kratky spectra parallels the Guinier 
analysis. The addition of Zn leads to small changes in the spectrum relative to WT, where 
the Zn-bound proteins more closely resemble WT. On the other hand, the spectrum for 
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Figure 5.3. Guinier analysis of ALS variants.   
Guinier analysis of the WT (black), A4V (red), L38V (cyan), G93A (green), L106V 
(yellow), and S134N (blue) mAS-SOD1 scattering data, obtained by fitting data where 
Rg·qmax < 1.3,  reveals differences in the size of ALS variants of SOD1. Though the 
greatest differences are observed for the disulfide-reduced protein, this result is partially 
exaggerated due to the contribution from the unfolded state for these proteins. 
Introduction of post-translational modifications lessens structural differences between the 
variants and the WT protein. Error bars reflect the standard deviation of the mean 
between measurements of two or more identically prepared samples. 
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Figure 5.3. Guinier analysis of ALS variants. 
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 S134N remains unchanged regardless of the presence of Zn. The increased intensity in 
the high q region for the L38V variant is likely due to the aggregation of the sample prior 
to data acquisition. 
Bead modeling. 
In order to visualize structural differences that may be present in the apo, disulfide-
oxidized state of the SOD1 variants, the SAXS data were bead modeled using the 
simulated annealing program GASBOR.197 A comparison of bead models generated for 
each of the ALS variants and the WT protein, superimposed on the crystal structure of the 
WT holo-SOD1, can be seen in Figure 5.5. While the ALS variants seem to be slightly 
larger than the WT protein, consistent with the increased Rg, no specific structural 
difference stands out. It is possible that this low resolution technique is not sufficiently 
sensitive to determine the structural differences between these variants. Surprisingly, the 
most different protein is the S134N variant, which shows a loss of scattering density in 
the center of the protein. This result, in combination with the Kratky and Guinier analyses 
suggest that this particular variant exhibits structural defects even in the absence of 
metals. 
 
Conclusions and future directions 
Overall, these results suggest that many ALS variants destabilize SOD1, increasing the 
population of the unfolded state, rather than significantly altering the native structure. 
This is consistent with little or no differences in the native CD spectrum of the disulfide- 
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Figure 5.4. Kratky analysis of ALS variants. 
Kratky of plots of WT (black), A4V (red), L38V (green), G93A (brown), L106V (teal), 
and S134N (blue) reflect the globularity of the protein. The magnitude of q2I(q) has been 
normalized by I(0) to correct for concentration differences between the samples. (A) 
Disulfide-oxidized (solid lines) and disulfide-reduced (dotted lines) folded (black) and 
unfolded (cyan) WT mAS-SOD1 are shown. (B) In the apo-state, both A4V and L106V 
resemble the WT protein, while the reduced amplitude at q=0.1 for L38V, G93A and 
S134N indicates that these proteins are less globular. (C) The addition of Zn alleviates 
some of these differences for the β-barrel variants but S134N remains largely unchanged. 
This may reflect the inability of Zn to structure the electrostatic loop for this variant and 
also suggests that the electrostatic loop may be compact in the apo-state. The increased 
amplitude at high q for L38V may be indicative of some aggregation in this sample. 
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Figure 5.4. Kratky analysis of ALS variants. 
A) 
 
 
 
B) 
 
 
 
 
C)  
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Figure 5.5. Bead models of disulfide-oxidized mAS-SOD1 variants. 
Bead modeling of the scattering data was performed to visualize differences observed in 
the Kratky plots and the Rg. Bead modeling of the WT data is represented by the gray 
spheres, while the ALS variants are in color. The bead models were generated by the 
simulated annealing program GASBOR and overlaid on the crystal structure (PDB: 
2C9V) using SUPCOMB. While some clear differences are visible for the S134N variant, 
the four β-barrel variants fill the expected density of the protein fairly similarly to WT. 
  
 Figure 5.5. Bead models of disulfide-oxidized mAS-SOD1 variants. 
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oxidized ALS variants studied here.44; 117 Previous SAXS studies on the native dimeric 
I113T and A4V SOD1 had revealed structural differences inconsistent with the crystal 
structures determined from the same protein.98 While it is not stated explicitly in the 
paper, it appears that the authors used as-isolated protein samples which contain a 
variable amount of metals.83 Therefore, while the crystals may have formed from the 
least dynamic, fully metalated species, the SAXS data represent an average of the various 
metalation states of the protein. Since apo- SOD1 is more dynamic and extended than the 
holo-protein,35 it is possible that the differences observed are due to the differences in the 
populations of metal-bound and metal-free SOD1 species. Alternatively, it is possible 
that dimerization induces structural constraints on the SOD1 monomer, exacerbating the 
deleterious effects of the amino acid replacement. A comparison of the SAXS spectra of 
monomeric and dimeric versions of these variants is required to test this hypothesis. 
 
Even with these low resolution experiments, the apo-state of the monomeric ALS 
variants seems different than WT, though the magnitude of these differences may be 
small. Measurements with increased sensitivity, either using a variety of protein 
concentrations and/or repeated measurements, should allow more accurate measurements 
of the structural differences. Additionally, the ability to access the unfolded state by 
modulating the populations of highly destabilized, disulfide-reduced ALS variants with 
temperature allows for a unique opportunity to study the unfolded state in the absence of 
denaturant. A systematic survey of the scattering intensity as a function of temperature 
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should allow for the deconvolution of the native and unfolded spectra since the 
populations of the folded and unfolded species as a function of temperature have been 
measured.  
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Chapter VI. Future Directions and Summary  
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Future directions 
 
Our continued interest in SOD1 as a model system arises from both a desire to further 
understand the role of amino acid sequence in defining the folding pathway and native 
structure of a protein and to discover the molecular mechanism underlying the link 
between mutations in SOD1 and ALS. Therefore, future studies can be divided into two 
specific categories: (1) studies of structural elements that may play a role in aggregation, 
which studies the link between SOD1 and ALS, and (2) the study of the nature of the 
slow folding reaction of SOD1, which explores the question of how proteins fold into 
their native structure. 
 
Aggregation arising from residual structure in the unfolded state. 
Currently, the consensus of the SOD1 field is that mutations in SOD1 lead to a gain-of-
function toxicity, which is lethal to motor neurons due to some unknown susceptibility, 
and that this lethality may be linked to the formation of soluble or insoluble aggregates. 
The thermodynamic destabilization of the SOD1 is a consequence of a majority of SOD1 
mutations identified in patients, raising the possibility that the aggregation prone species 
exists naturally in the folding pathway of SOD1 and that ALS variants simply increase 
the populations of this species. Based on our results, a likely candidate for this 
aggregation prone species is the unfolded state. Thus, we propose a kinetic mechanism 
for SOD1 aggregation, where the combination of increased turnover and high populations 
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of the unfolded state for ALS variants of SOD1 lead to increased opportunities for off-
pathway folding reactions leading to aggregation (Figure 6.1). 
 
The observed increase in unfolded state populations (Chapter III) motivates the study of 
the unfolded state as a relevant aggregation prone species. The intrinsic aggregation 
propensity of the unfolded state may be due to compact, possibly non-native structure in 
the unfolded state. A phi analysis performed by the Oliveberg group suggests that the 
formation of long-range contracts between β2-4 and β7 are likely critical in the transition 
state to productive folding.124 On the other hand, more sequence-local residues may be 
involved in the formation of structure in the unfolded state. The two most likely 
candidates are the β1-3 hairpin module and β5+β6 - the most sequence local of the 
secondary structural elements that make up the native structure of SOD1. The other 
connected β strands, β4+β5 and β7+β8, are separated by the long Zn binding and 
electrostatic loops, respectively. These loops are unstructured in the absence of metals, 
and given the relatively low affinity of the unfolded state for Zn, it is unlikely that they 
would form stable structures in the unfolded state in vivo. 
While it seems reasonable that these sequence local elements could form compact 
structures, evidence demonstrating the existence of such structures in the unfolded state is 
currently lacking. No global compaction was observed in refolding studies probed by 
small angle x-ray scattering, nor is there a significant burst phase in refolding reactions 
monitored by circular dichroism.114 
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Figure 6.1. Proposed pathway for SOD1 aggregation. 
ALS variants lead to increased populations of unfolded species after synthesis, either by 
significantly destabilizing the apo, disulfide-reduced state or by partially inhibiting Zn 
binding. Combined with the relatively low Zn affinity of disulfide-reduced SOD1, these 
premature species may persist for significant amount of time and represent a likely 
candidate for aggregation. While chaperones may compensate for the low stability of 
some ALS variants and aid in folding them, the diminished activity of these pathways 
with age will eventually result in a buildup of misfolded and aggregated protein. 
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It is possible that these spectroscopic probes are simply insensitive to structures in the 
unfolded state. Therefore, more sensitive fluorescence spectroscopic techniques will be 
employed, utilizing Fӧrster resonance energy transfer between the intrinsic tryptophan, 
W32, and EDANS, a fluorescent dye. The EDANS moiety can be covalently attached to 
judiciously positioned cysteine residues using maleimide chemistry, creating probes of 
local and/or global structure (Table 6.1 and Figure 6.2). In these experiments, the pairs 
D11C-W32 (Figure 6.2A) and T2C-W32 serve as probes of local structure, while T88C-
W32 serves as a probe of global structure. If the β1-β3 module is in fact compact in the 
unfolded state, then energy transfer from the donor to the acceptor should be observed for 
the D11C-W32 and T2C-W32 FRET pairs, but not for T88C-W32. The use of multiple 
independent FRET pairs may also help rule out false positive results arising from 
structure induced by the dye itself, or minimize the consequences of perturbations to the 
native structure from the dye modification. 
 
Another drawback of the existing studies was the requirement of denaturants to access 
the unfolded state, which can disrupt weakly formed structures in the unfolded state. In 
order to avoid the requirement for denaturants, future experiments can be performed on 
the disulfide-reduced protein containing one of the highly destabilizing mutations, such 
as G93A, which is >90% unfolded at 37 °C in the absence of denaturant. Alternatively, 
peptides can be utilized in order to monitor local structures in the absence of the entire 
protein. One such peptide, consisting of the N-terminal 37 residues of SOD1 with an 
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Figure 6.2. D11C-W32 and E0-W32 peptide FRET pairs. 
Two probes for structure in the unfolded state were created by utilizing FRET between 
the intrinsic W32 and EDANS molecules covalently attached to cysteine at position 11 
(A) or glutamic acid residue added to the N-terminus (B) (zeroth position).  Both these 
constructs probe for residual structure in the sequence local β1-β3 module. 
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additional glutamate residue modified with an EDANS moiety at the N-terminus is 
shown in Figure 6.2B.  
 
Preliminary data on the labeled D11C-W32 pair can be seen in Figure 6.3A. Titrations in 
urea and Gdn-HCl, and monitored by tryptophan fluorescence, show shorter lifetimes in 
the absence of denaturant, characteristic of energy transfer between the donor tryptophan 
and the acceptor EDANS. Upon unfolding, the average tryptophan lifetime increases, 
consistent with the increase in the donor-acceptor distance and concomitant loss of 
energy transfer. Compactness in the unfolded state is evident from a comparison of the 
N-terminal peptide with free tryptophan and EDANS (Figure 6.3B). The increased 
fluorescence from the acceptor EDANS in the absence of denaturant is likely due to 
energy transfer from a compact structure in this peptide, as an unfolded peptide of the 
same length would be expected to exhibit only 2% energy transfer (Table 6.1). 
 
In order to measure the distance between the donor and acceptor molecules for these 
FRET pairs, a comparison of the labeled and unlabeled molecules is required, and these 
experiments are currently under way. Small angle x-ray scattering may also be used as a 
complementary technique to measure the radius of gyration for the peptide, as 
demonstrated for the full length protein in Chapter V. In working with this peptide, it is 
clearly soluble enough to reach the concentration requirements for these experiments, 
~1-2 mg/ml. These experiments have the added advantage of not requiring the additional 
227 
 
Table 6.1. Distances and expected FRET efficiencies of the unfolded state probes.* 
Donor-
Acceptor Pair 
Structural 
element 
Unfolded 
distance 
FRET 
efficiency 
Folded 
distance 
FRET 
efficiency 
W32 – T88C Global 59 Å 0.2% 13.7 Å 94% 
D11C – W32 β1-β3 33.5 Å 2% 25.1 Å 31% 
T2C – W32 β1-β3 41.3 Å 7% 14.3 Å 93% 
E0-W32 
(Peptide) β1-β3 43.6 Å 2%  14.4 Å 93% 
 
*Distances in the folded state were measured from the crystal structure of the holo-SOD1 
(PDB: 2C9V). Distances in the unfolded state were calculated from predictions based on 
a space filling random coil.200 Expected FRET efficiency was calculated using: E = 
1/(1+D/Ro)6), where Ro is the distance for 50% energy transfer, 22 Å for Trp-EDANS, 
and D is the donor-acceptor distance.188 
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Figure 6.3. Evidence for energy transfer between tryptophan and EDANS. 
(A) Urea (white squares and solid line) and Gdn-HCl (blue circles) titrations were 
performed to determine the stability and observe the change in FRET efficiency between 
the folded and unfolded states. The addition of the fluorophore did not significantly affect 
the stability of the protein. (B) Energy transfer between Trp32 and the N-terminal 
EDANS moiety was confirmed by an increase in EDANS fluorescence (blue line) above 
that measured for free tryptophan and EDANS (black line).  
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Figure 6.3. Evidence for energy transfer between tryptophan and EDANS 
A) 
 
B) 
 
230 
 
glutamic acid residue and the covalently attached fluorophore, more accurately 
recapitulating the unfolded state of SOD1. 
 
Aggregation from higher energy folded states of SOD1. 
These increased populations of the unfolded state observed in Chapter III do not entirely 
rule out a role for folded species in aggregation. The S134N variant shows no 
destabilization relative to WT in the apo-states44; 117 and the x-ray scattering  studies 
presented in Chapter V suggest that structural differences may exist in the disulfide-
reduced and oxidized Zn-free states of the SOD1 monomer. These results are consistent 
with the native-state hydrogen exchange studies, which show that the regions of structure 
flanking the hydrophobic core of the SOD1 monomer undergo exchange, while the core 
remains protected (Chapter V). In combination, these results imply that the folded SOD1 
monomer may also be aggregation prone. This is likely due to the exposure of the 
hydrophobic core, which becomes less protected when the dimer is dissociated, 
increasing the potential for intermolecular interactions.123; 124 This property may be 
further exacerbated by ALS variants which alter the native fold of the SOD1 monomer. 
 
A comparison of the hydrogen exchange profile of soluble SOD1 and aggregated SOD1 
may give insights into the structural differences between soluble and aggregated SOD1, 
thereby discriminating between whether an unfolded state or a folded state is giving rise 
to aggregation. Similar studies utilizing HX-MS or HX-NMR have been performed 
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previously to gain insight into the structure of aggregated α-synuclein and β2-
microglobulin.194; 196 The differences in protection patterns can be directly related to the 
structure of the aggregation prone species. If most of the β-sandwich structure of SOD1 is 
participating in aggregation, one would expect most of the β-strands to be protected in the 
aggregate, as they are in the soluble dimer. If a partially unfolded, higher energy state of 
the protein is the source of the aggregate, then the fraying and loss of protection in the 
edges of the β-sheet may be observed. Alternatively, if the unfolded state of SOD1 is 
giving rise to aggregation through some entirely non-native structure, then altered 
protection patterns throughout the sequence should be observed. 
 
Small molecule screen to stabilize SOD1 monomers. 
While the determination of the molecular mechanism of aggregation may lead to 
important discoveries in preventing it, knowledge of the mechanism is not a strict 
requirement in developing therapeutic strategies. Work in the Lansbury group have 
demonstrated that stabilizing the native dimer of SOD1 by engineering and 
intermolecular disulfide bond in the dimer interface can prevent aggregation.201 Taking 
this a step further, utilizing in silico screening, they were able to identify small molecules 
which stabilize the native dimer of SOD1, thereby lowering its aggregation propensity.202 
These studies essentially mimic the effect of Zn and reduce the populations of 
monomeric species. 
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If monomeric species are prone to aggregation due to increased dynamics of the native 
fold, or due to their propensity to sample the unfolded state, could stabilizing the native 
fold of the SOD1 monomer also reduce aggregation? As stated above, the large fraction 
of unfolded species observed for the disulfide-reduced G93A under physiological 
conditions make this variant an excellent candidate to study the unfolded state in the 
absence of denaturant via the FRET pairs in Table 6.1. The large change in tryptophan 
lifetimes between the folded and unfolded states, ~0.8 ns, as seen in Figure 6.3A, allow 
for the rapid determination of the relative folded/unfolded populations of a sample by 
fluorescence. These properties can be utilized for a small molecule screen for stabilizers 
of SOD1 monomeric folding (Figure 6.4). 
 
This assay will utilize the cysteine free variant, C6A/C57A/C111S/C146A SOD1, 
mimicking the disulfide-reduced protein, without the requirement for reducing agents. 
The removal of the cysteines also enables site specific labeling with introduced cysteines 
without complications of disulfide-interchange in the unfolded state. Furthermore, 
intermolecular crosslinking is no longer a problem because reducing agent can be present 
without concern for breaking the native disulfide bond. Also, since the disulfide-reduced 
SOD1, in the absence of metals, is natively monomeric, the F50E/G51E mutations are no 
longer required. This experiment will likely utilize T88C-EDANS-W32 FRET pair, as 
this combination results in the highest difference in FRET efficiency between the folded 
and unfolded states. Since the donor and acceptor sites are not local in sequence, this pair 
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Figure 6.4. A small molecule screen for SOD1 monomer stabilizers. 
The naturally low thermodynamic stability of the disulfide-reduced β-sandwich variants 
of SOD1 (Chapter III) allow for a small molecule screen to be constructed for stabilizers 
of the native fold. In this assay, an increase in temperature will reduce folded 
populations, while small molecule stabilizers will increase them. Utilizing the large 
change in average tryptophan lifetimes between the folded and unfolded populations of 
EDANS labeled molecules, fluorescent screening can be used to rapidly determine 
whether molecules have successfully folded the protein. 
 
 
  
 Figure 6.4. A small molecule screen for SOD1 monomer stabilizers. 
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 also provides a measurement of the global structure of the protein. Unpublished results 
in the Matthews lab suggest that labeling at T88C with EDANS, or even a much larger 
fluorophore like Alexa-488 does not significantly perturb the stability of SOD1 (AM, 
JAZ, CRM unpublished). 
 
The role of dehydration in the enthalpic barrier to folding of SOD1 monomers. 
As described in Chapter IV, enthalpic barriers dominate both the folding and unfolding of 
SOD1. In unfolding, this can be explained by the disruption of existing structure in the 
native state. In refolding, since no significant structure is thought to exist in the unfolded 
state, dehydration of the chain presents a plausible model. The β-sandwich of SOD1 is 
comprised of a pair of 4-stranded sheets. 28 isoleucines, leucines and valines, present in 
these sheets, form a large hydrophobic cluster in the core of the sandwich. The 
improbability of locally organizing, dehydrating and then docking these two sheets may 
be the underlying reason for the slow folding reaction of SOD1. 
 
The dehydration hypothesis can be tested by replacing selected buried valines and 
leucines in the core of SOD1 with their isosteric and polar counterparts, threonine and 
glutamine. If removal of water is playing a role in the activation energy of SOD1 folding, 
then the presence of more polar residues will make desolvation more difficult, thereby 
increasing the observed activation energy in refolding. This technique has been 
previously used to map out the extent of solvation in the folding pathway of Im7.203 
236 
 
 
For SOD1, which exhibits two-state behavior, these experiments provide an analytical 
tool to measure the extent of solvation in the TSE. In effect, if the TSE buries the residue 
of interest, the replacement with the polar amino acid serves to stabilize the unfolded 
state relative to the TSE. Amino acids that are highly desolvated in the TSE will 
significantly slow the refolding rate and diminish the global stability. On the other hand, 
residues which become desolvated in the native state or remain exposed to solvent will 
only affect the global stability or show no affect on the stability, respectively. If large-
scale desolvation of the sheets is playing a significant role in defining the barrier to 
folding in SOD1, then these studies should identify a significant number of polar 
substitutions which perturb the refolding rate. 
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Summary 
 
This project has advanced the SOD1 folding field by the detailed study of the monomer 
folding reaction of SOD1 and by quantitatively measuring the thermodynamic and 
structural consequences of SOD1 mutations on a variety of post-translational states of 
SOD1. The thermodynamic analysis of SOD1 folding has revealed that a large enthalpic 
barrier, potentially due to the desolvation of the chain, is playing a significant role in the 
activation energy of refolding. The involvement of a large fraction of the amino acids 
which make up the core of the β-sandwich may serve to explain the slow folding reaction 
of SOD1, as well as the higher dependence of the observed folding rates of β-sheet rich 
proteins on the topological complexity as compared to the α-helix rich counterparts.  
 
The study of the coupling between post-translational modifications and amino acid 
replacements and their effects on the folding free energy surface of SOD1 revealed 
insights into the properties of this protein and has significant implications for ALS. Zn 
was found to bind progressively tighter along the folding pathway of SOD1, thereby 
shifting the equilibrium towards natively folded dimers. Studies on the monomeric 
species of SOD1 revealed that ALS variants greatly increased the population of the 
unfolded state, a potentially aggregation prone species. These detailed analyses pave the 
way for future experiments to identify the regions involved in aggregation and to develop 
small molecule screening assays for stabilizers of SOD1 monomers.  
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